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Bacterial microcompartments were initially observed in the 1950s and since that 
time, research in the field has focused on the unique properties of their 
proteinaceous structures and their role in the bacterial cell.  
This thesis investigates the properties of the propanediol utilization (Pdu) and 
ethanolamine (Eut) utilization microcompartments and applications of their 
components in the cells of Lactobacillus reuteri, and Escherichia coli 
predominantly, with additional investigation into Yersinia spp. 
The experimental chapters of this thesis initially investigate the application of 
bacterial microcompartments as tools for compartmentalizing metabolic 
reactions, in particular regarding the uptake of phosphate from extracellular 
environment and the retention of polyphosphate intracellularly. This was 
observed experimentally through the engineering of recombinant constructs 
containing genes encoding microcompartment-directed polyphosphate kinase 
enzyme. Bacterial phenotypes conferred by these constructs with respect to 
enhanced net uptake of phosphate from the environment were defined, and 
potential applications as a clinical therapy addressed in an animal trial, which 
utilized the phosphate-uptake constructs which had been created. In the trial, 
recombinant bacteria expressing these constructs were successfully delivered in 
therapeutic quantities to the target (small intestine) of rats experiencing induced 
renal failure, with no adverse effects were observed. However inter-group animal 
variation regarding baseline blood mineral content was larger than the expected 
therapeutic effect and therefore no therapeutic effect could be demonstrated. 
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Additionally, novel phenotypic differences conferred by induction of Pdu and 
Eut microcompartments and empty recombinant microcompartments on host 
cells were identified.  These identified an observable phenotypic difference in 
buoyant density between strains expressing the Pdu and Eut microcompartments. 
Futher investigation into the potential function and phenotypic differences of 
strains expressing microcompartments were supported by methodological 
developments including the use of imaging instruments such as the FIB-SEM, 
and microcompartment extraction from cells. These technical developments 
enabled additional observations regarding the characteristics of 
microcompartments and provided novel information. 
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Bacterial microcompartments (MCPs) offer promise for the future of synthetic 
biology and metabolic engineering. The ability to offer increased reaction and 
enzymatic efficacy through cellular compartmentalization is common in 
eukaryotes, but was presumed non-existent in prokaryotes. However, levels of 
compartmentalization offer benefits to natural, and potentially synthetically 
engineered bacterial systems. The possible retention of toxic intermediates, or 
volatile metabolites are all possible roles discussed for native 
microcompartments, which have been identified in many diverse bacterial 
genera, including pathogens and commensals, Gram positives and Gram 
negatives. 
Those genera that produce microcompartments attribute a large number of genes 
to their generation and the identification of >50 microcompartments within a 
single bacterial cell under electron microscopy indicates an important role in the 
limited spatial arrangement of the bacterial cell. 
Knowledge of mechanisms by which bacteria gain energy and resources from 
microcompartment-mediated metabolism may illustrate potential vulnerabilities 
in the processes by which some pathogens multiply in the gut, or alternatively 
may indicate potentially biotechnological or clinical applications such as the 
ability to accumulate intracellular phosphate within a microcompartment, which 
is to be a focus point in the experimental chapters of this thesis.  
Phosphate and polyphosphate act within the prokaryotic bacterial cell to regulate 
aspects of metabolic and stress responses. Within the human body, phosphate 
levels are regulated in parallel with calcium by the parathyroid hormone, and a 
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resulting dysfunction in this balance can lead to disruption of the blood and renal 
system, resulting in the illness hyperphosphatemia. This accumulation of 
phosphate in the blood requires treatment using a variety of interventions 
including the use of oral phosphate binders, and dietary control of phosphate 
intake. 
The potential to apply a microcompartment-mediated uptake system, expressed 
in a probiotic host, may offer some alternative options for relieving excess 
phosphate and hyperphosphataemia.  
Sections 1.1-1.3 will discuss the functionality and characteristics of bacterial 
microcompartments, particularly focusing on the Pdu and Eut 
microcompartments. Sections 1.4-1.7 will then discuss the role of phosphate 
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1.1. Discovery of bacterial microcompartments 
Bacterial microcompartments (MCPs) are small proteinaceous structures 
originally observed within bacterial cells in the 1950s (Drews & Niklowitz, 
1956). They possess a distinct polygonal shape, which triggered their 
identification by electron microscopy. This unusual geometric shape caused 
MCPs to be initially mistaken for phage capsids (Peters, 1974). However 
expanding research into the structures and their properties identified MCPs as 
being distinctive novel structures. 
Initially observed in the cyanobacterium Phormidium uncinatum in 1956 (Drews 
& Niklowitz, 1956) these MCPs were dismissed as being inclusion bodies or 
aggregates. After some time, their distinct polygonal shape was identified in 
many more bacterial species, primarily cyanobacteria including Nostoc 
punctiforme (Yeates et al., 2010) However since the early 1970s, 
microcompartments have been identified, through genome sequencing, in 
approximately 400 genomes, including diverse genera such as Lactobacillus, 
Clostridia, Klebsiella, and Salmonella (Kerfeld et al., 2010).  
Due to their distinct proteinaceous composition, it is possible to extract 
microcompartments as a distinct fraction from the bacterial cell, originally 
through the use of sucrose density gradient centrifugation, which produced the 
first extracted MCP from Halothiobacillus neapolitanus in 1973 (Shively et al., 
1973). 
On extraction, the unique structure now associated with MCPs could be 
identified, distinguishing them from inclusion bodies or other vacuoles. These 
polyhedral structures were then denoted as carboxysomes, due to the presence of 
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ribulose-1,5-bisphosphate carboxylase/oxygenase (RuBisCO) within the MCP 
(Shively et al., 1973).  
1.1.1. The function of the microcompartment 
Due to the wide range of bacteria that produce bacterial MCPs, they appear to 
have varying functions, mainly centered on either anabolic (building up) or 
catabolic (breaking down) activities.  This division into anabolic (typically 
carboxysomes) and catabolic (typically metabolosomes) is dependent upon their 
cargo enzymes (Aussignargues et al., 2014). 
 
Figure 1.1. Schematic illustrating the anabolic and catabolic MCPs (Axen et al., 2014) 
For carboxysomes, which are predominantly observed in autotrophs, their role is 
primarily anabolic carbon-fixation, particularly in cyanobacteria. Cyanobacteria 
are one of the key contributors to the global carbon cycle, where they play roles 
in marine and terrestrial ecosystems (Cameron et al., 2013). The carboxysome 
plays a key role in the Calvin-Benson-Bassham cycle, where it is a core factor in 
the carbon concentrating mechanism (Price et al., 1992). In the carboxysome, 
CO2 fixation is enhanced through the encapsulation of key enzymes ribulose 1,5-
bisphosphate carboxylase/oxygenase (RuBisCO), a carbon fixing enzyme, and 
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carbonic anhydrase. This shift reduces the reaction with O2, which is a 
competitive substrate (Heinhorst et al., 2006). 
 
 
Figure 1.2. Illustration of the carboxysome microcompartment (Kerfeld et al., 2010) 
In contrast, in heterotrophic bacteria, the two most common MCPs are the 
propanediol (Pdu) and the ethanolamine (Eut) microcompartments. As 
mentioned, these MCPs are more directly focused on catabolic activity - 
breaking down substrates within their enclosed shells.  
1.1.2. The common structure of the microcompartment 
A unifying structural feature of the MCPs is a thin enclosing shell composed 
mainly of thousands of small protein subunits, which all belong to a family of 
homologous BMC (bacterial microcompartment) shell proteins. The BMC shell 
proteins have been identified across many bacteria; originally in the 
carboxysome (English et al., 1994) and then subsequently in the pdu operon of 
Salmonella (Chen et al., 1994) and also the ethanolamine (eut) operon of 
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Salmonella (Stojiljkovic et al., 1995). Currently, 1700 unique BMC-containing 
proteins have been identified, in 10 different phyla (Yeates et al., 2011). The 
typical length of the commonest BMC domain is approximately 90 amino acids, 
with an alpha/beta fold (Kerfeld et al., 2005). The shell proteins form hexamers 
that go on to act as the foundation of the shell (Figure 2.1). The commonest 
BMC proteins (hexameric shell subunits) contain a single copy of the Pfam 
domain PF00936, and are called BMC-H.  Longer shell proteins (BMC-T) are a 
fusion of two of the PF00936 domains and form trimers (pseudohexamers). 
Another non-homologous Pfam domain PF03319 is associated with a minority of 
shell proteins including some that form pentamers (BMC-P) (Axen et al., 2014). 
Each hexamer has a two-sided shape, with a prominent bowl-shaped depression 
on the side containing the N-termini and C-termini (Yeates et al., 2010). A 
narrow pore also exists through the middle of the hexamer, along the six-fold 
axis of symmetry (Yeates et al., 2011). 
The carboxysome typically assumes an icosahedral shape, which is guided by the 
homologous proteins CcmL and CsoS4A (PF03319, BMC-P), which form a 
small proportion of the overall shell proteins and are present in different 
carboxysome types. These are pentamers and are hypothesized to form the 
vertices of the MCP shell, resulting in the distinct and recognizable icosahedral 
shape (Tanaka et al., 2008), which was identified using EM cryotomography 
(Schmid et al., 2006). However in structural assembly studies of Pdu and Eut 
MCPs, these pentameric proteins proved more difficult to crystallise. In fact 
Salmonella EutN, which is homologous to CcmL, was found to form hexamers 
on crystallization (Tanaka et al., 2008). However, charge-based native gel 
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separation shows EutN from E. coli is pentameric in solution, despite this 
hexameric crystal structure (Wheatley et al., 2013) and it has been proposed that 
these proteins should be called BMV (bacterial microcompartment vertex 
proteins).  
 
Figure 1.3. Figure illustrating simplified microcompartment shell assembly  
(credit: Yeates et al., 2011) 
Surprisingly, within the various BMC domain proteins, there is a large degree of 
variation regarding confirmation and tomography. Many of the BMC proteins 
contain tandem-BMC domains, which have been identified in all MCPs (e.g. 
PduT, EutN, PduB) These tandem-BMC domains result in the construct of a 
symmetric trimer with pseudo six-fold symmetry (Klein et al., 2009). These 
variants have been observed to cause conformational changes which affect the 
central pore of the hexamer. In addition, there both single and tandem-domain 
BMC can be permuted shell proteins (PduU, EutS, EtuB), which result in the 
production of the N-terminus and C-terminus at different spatial locations, and 
allow the blocking of the pore by an extended 6-stranded beta barrel tail (Tanaka 
et al., 2009). 
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To build further on these findings, different tandem-BMC domain proteins can 
be arranged in opposite order in the pseudohexamer, including those assembled 
from two circularly permuted domains (EutL, EutD) and two canonical BMC 
domains (PduT); (Crowley et al., 2010) (Tanaka et al., 2010). Other variations 
include enzyme components and co-factors. Recent bioinformatics analysis has 
found 23 different types of BMCs encoded in 30 distinct locus subtypes found in 
23 bacteria phyla (Axen et al., 2014). The focus of this study will be however 
primarily be on the Pdu and Eut MCPs, and their genetics, structure and 
metabolic roles are further detailed further in the sections below. 
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Table 1.1. Table illustrating known structures of shell proteins from bacterial 
microcompartments (Yeates et al., 2011) 
 
α-Carboxysome (e.g. Halothiobacillus neapolitanus) 
CsoS1A Single-BMC domain hexamer Major shell component (Tsai et al., 2007) 
CsoS1C Single-BMC domain hexamer Major shell component (Tsai et al., 2009) 
CsoS1D Tandem-BMC domain 
(permuted) trimer 
Trimers stack to form a hexamer with D3 
symmetry; open and closed conformations suggest 
gated transport (Klein et al., 2009) 
CsoS4A/B Pentamer (non-BMC domain) Minor shell component; believed to form 
icosahedral vertices. 
β-Carboxysome (e.g. Synechocystis PCC6803) 
CcmK1 Single-BMC domain hexamer Major shell component (Tanaka et al., 2008) 
CcmK2 Single-BMC domain hexamer Major shell component (Samborska & Kimber, 
2012) 
CcmK4 Single-BMC domain hexamer Minor shell component (Kerfeld et al., 2005) 
CcmL Pentamer (non-BMC domain) Minor shell component; believed to form 
icosahedral vertices. 
Pdu Microcompartment (e.g. Salmonella enterica, Lactobacillus reuteri) 
PduA Single-BMC domain hexamer Major shell component (Pang et al., 2014) 
PduB Tandem-BMC domain trimer Major shell component, subunit pore rather than 
central pore  (Pang et al., 2012) 
PduT Tandem-BMC domain trimer Pore likely involved in electron transport or Fe-S 
cluster transport (Pang et al., 2011) 
PduU Single-BMC domain hexamer 
(permuted) 
Minor shell component; pore is blocked by 6-
stranded β-barrel in crystal structure (Crowley et 
al., 2008) 
Eut Microcompartment (e.g. S. enterica & E. coli) 
EutK Single-BMC domain fused to 
helix-turn-helix (HTH) 
domain 
HTH motif with positively charged surface 
suggests role in nucleic acid binding (Tanaka et 
al., 2009) 
EutL Tandem-BMC domain trimer Pore observed in open and closed conformations; 
probable role in gated transport (Sagermann et al.,  
2009) 
EutM Single-BMC domain hexamer Major shell component (Tanaka et al., 2009) 
EutN Non-BMC domain hexamer Crystallizes as a hexamer despite homology to 
pentameric CcmL/CsoS4 family; pentameric 
association from gel. 
EutS Single-BMC domain 
(permuted) hexamer 
Hexamer forms bent structure with C2 symmetry; 
possible role in edge formation within shell 
(Tanaka et al., 2009) 
Other Microcompartments 
EtuB Tandem-BMC domain 
(permuted) trimer 
Part of presumptive ethanol utilization 
microcompartment in Clostridium kluyveri. 
PduT homolog Tandem-BMC domain trimer Part of microcompartment of uncharacterized 
function in De 
sulfitobacterium halfniense. 
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1.1.3. Why compartmentalize?  
In bacteria that produce MCPs, they often dedicate a large amount of genetic 
information to its function – Salmonella has 40 genes encoding the Pdu MCP 
(Bobik et al., 1999). The BMC domains, which encode for the MCP shell, are 
also highly conserved across MCP-associated species. There are benefits for 
cellular compartmentalization; enzymes like RuBisCO can have slow reaction 
turnover, which could be alleviated by access to a local concentration gradients 
of substrates (Eichelmann et al., 2009). Metabolites can also be required to 
participate in many competing reactions, which can reduce their availability and 
lead to pathway bottlenecks (Xu et al., 2011). 
In eukaryotes, this method of metabolic compartmentalisation is not uncommon 
– the perixosome is a membrane organelle that contains reactions relating to the 
catabolism of hydrogen peroxide (Gehrmann & Elsner, 2011). Bacterial MCPs, 
due to their hexameric shell proteins, contain a number of pores postulated to 
regulate substrate transport (Klein et al., 2009). This allows isolation of reaction 
intermediates from the rest of the cell, providing high concentrations of 
substrates, removing the problem of enyzmes such as RuBisCo. 
Compared to the cytoplasm as a whole, quantification calculations indicate that 
there is a significant concentration effects which apply to enzyme kinetics within 
the MCP. A bacterial MCP is approximately 1000th the volume of a bacterial cell 
(a typical E. coli cell is approximately 1µm3), (Vendeville et al., 2011). Utilising 
Avogadro’s number (6.02 x 1023) and calculating 1 litre = 1.0 × 1015 µm3, this 
indicates that in the cytoplasm, a single enzyme molecular represents an enzyme 
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concentration of approximately 10-9 M (nanomolar), whilst the same molecule 
within the MCP actually is equivalent to micromolar concentration.  
In addition, based on stochastic modeling, classical Michaelis-Menten kinetic 
calculations likely underestimated the rates of catalyzed reactions occurring 
within the MCP (Conrado et al., 2007), (Grima, 2009). This information 
indicates that the fundamental effects of molecular crowding prompt the process 
of compartmentalization within the MCP. 
 
This is also research indicating that the presence of MCPs within a cell is 
associated with spatial organisation. Carboxysomes align themselves along the 
main axis of the cell, with the cytoskeletal component ParA required for this 
correct alignment to occur (Cornejo et al., 2014). This connection is still not 
fully elucidated, but may provide information that could aid the design of novel 
synthetic structures (Chen & Silver, 2012).  
There is also evidence for a contribution of the Pdu and Eut microcompartments 
to the mitigation of potentially toxic aldehyde intermediates (Penrod & Roth, 
2006), (Sampson & Bobik, 2008). The relevant studies for each 
microcompartment are included under their individual sections. 
 
	  	  	  	  	  	  




Figure 1.4. (1) Differing enzyme kinetics may result in flux imbalances. (2) Intermediates may be lost 
through the cell membrane. (3) Toxic intermediates can result in growth inhibition. (4) Competing reactions 
can divert flux through undesired pathways. (b) Compartmentalization systems specifically solve challenges 
1–4, respectively, by: (1) creating areas of local concentrations to favour reaction kinetics; (2) sequestering 
intermediates; (3) reducing toxicity; and (4) reducing competition. (Credit: Lee et al., 2012; Chen & Silver, 
2012). 
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1.2. Propanediol utilization (Pdu) Microcompartment 
1.2.1. Identification 
The propanediol utilization (Pdu) microcompartment was initially identified in 
1994, when homologues of carboxysome shell proteins were identified in a gene 
cluster associated with the metabolism of 1,2-propanediol in the strain 
Salmonella enterica serovar Typhimurium (Chen et al., 1994). This coenzyme-
B12 dependent metabolism was hypothesized to take place within the 
encapsulation of the proteinaceous MCP, thus protecting the cell from the toxic 
intermediate, propionaldehyde (Havemann et al., 2002). This demonstrated that 
bacterial MCPs were involved in additional metabolic processes beyond CO2 
fixation, and heralded the discovery of the Pdu microcompartment in the 
presence of 1,2-propanediol.  
1.2.2. Genetics 
The Pdu operon is approximately 19kbp long, encoding for up to 23 genes with 
products related to the metabolism of 1,2-propanediol (Crowley et al., 2010). 
The breakdown of this operon can be observed in Table 3.1. 
The Pdu microcompartment appears more complex than its related counterpart, 
the carboxysome, with more enzymatic capabilities. It contains the key enzymes 
for 1,2-propanediol metabolism (Parsons et al., 2010). The genes encoding 1,2-
propanediol utilization can be identified in a contiguous cluster (pocR, pduF, and 
pduABB’CDEGHJKLMNOPQSTUVWX), which encodes enzymes for the 
breakdown of 1,2-propanediol and cobalamin recycling, along with the formation 
proteins for the MCP (Bobik et al., 1997). 
	  	  	  	  	  	  




No. of genes Genes Encoding Source 
7 pduA, pduB, pduB’, 
pduJ, pduK, pduN, 
pduU, pduT* 
Eight shell proteins 
(further details Table 
2.1)  
Frank et al., 2013 
7 pduCDE, pduL, 
pduP, pduQ, pduW 
Metabolic enzymes Leal et al., 2003; Liu et 
al., 2007 





Bobik et al., 1997; Cheng 
and Bobik, 2010; Johnson 
et al., 2001; Parsons et 
al., 2010b 
1 pduX Cobalamin synthesis Fan and Bobik, 2008 
1 pduF Propanediol diffusion 
faciliator 
Chen et al., 1994 
1 pduV MCP/cytoskeleton 
interaction 
Parsons et al., 2010a 
1 pduM Structural protein Sinha et al., 2012 
Table 1.2. Table indicating the gene breakdown of the Pdu microcompartment (Frank et al., 
2013)  
* not present in L. reuteri Pdu MCP (Sriramulu et al., 2008) 
1.2.3. Structure 
Appearing relatively heterogeneous in size, the Pdu microcompartments have 
been observed as being between 120-160 nm in diameter (Havemann et al., 
2003). Their shape, as previously mentioned in Section 2.1.2., is less regular than 
that of the icosahedral carboxysome, and tends be appear more polyhedral with 
various irregular facets (Kerfeld et al., 2005). The MCP shell is estimated to 
contain approximately 4000 protein subunits (Yeates et al., 2008), which 
surround an additional <15,000 protein molecules (Cheng et al., 2008). In the 
Pdu microcompartment, the first shell protein to be crystalized was PduU 
(Crowley et al., 2008). 
	  	  	  	  	  	  




Figure 1.5. The Pdu operon, including structural and enzymatic genes. (Crowley et al., 2010) 
 
As mentioned in Section 2.1.2., and Table 2.1., the Pdu MCP shell is formed by 
the paralogous structural proteins belonging to BMC Pfam domain PF00936  
PduA,B,J,K,T and U, and PduN (Pfam 033190). This involvement of multiple 
distinct BMC domains appears to be a highly conserved feature amongst the 
MCP family (Beeby et al., 2009). 
A distinct feature of the Pdu microcompartment is the presence of two forms of 
PduB; PduB and PduB’. The difference between these two forms is a mere 37 
amino acids, and occurs due to two translation start sites on the polycistronic 
message (Parsons et al., 2008). This produces a slight variance in protein size; 
PduB is 28kDa, whilst PduB’ is 24kDa. This can be identified by SDS-PAGE 
analysis. The crystal structure relates to the full length PduB  (Pang et al.,  2012). 
Targeting of a heterologous protein to a microcompartment has been achieved by 
fusion with the N-terminal 42 AA of PduV (Parsons et al., 2010). Sequence 
alignment suggested the presence of an 18 amino acid extension in the N-
terminal of the propionaldehyde dehydrogenase (PduP) protein only present in 
homologues associated with MCP function (BMC proximal) and not homologues 
of PduP which were not MCP-associated (Figure 3.2) (Fan et al., 2010). The 18 
amino acid sequence, present in the N-terminal of the propionaldehyde 
dehydrogenase (PduP) protein, was necessary and sufficient when fused with 
fluorescent proteins (e.g. GFP) or other heterologous proteins to localize the 
	  	  	  	  	  	  
	  	  	  	  	  	  
 
28 
targeted protein within the Pdu microcompartment ( Fan et al., 2010). In order to 
demonstrate that this PduP peptide is important for encapsulation within the 
microcompartment, PduP mutants that lacked these distinct N-terminal amino 
acids were engineered. Once purified, these mutant MCPs had far less PduP vs 
the wild-type strain. This observation demonstrated that the deletion or removal 
of these N-terminal amino acids from PduP impaired its association to the MCP ( 
Fan et al., 2010).   
The structure of the p18 sequence from PduP (aldehyde dehydrogenase) of 
Citrobacter freundii has since been reported (Lawrence et al., 2014), indicating a 
well-defined helical conformation along its whole length. Further studies have 
also since indicated that these target sequences are not limited to the N-terminus, 
with the C-terminal region of an α-carboxysomal protein (CcmN) interacting 
with the shell (Kinney et al., 2012), (Field et al., 2015). 
Peptides, mostly derived from viruses or prions, are recognized for organelle-
targeting within eukaryotic cells, and protein export target sequences are well 
recognized in bacteria, but physiological internal peptide targeting is novel for 
bacterial cells. There are more of these specific enzyme targeting sequences 
across the MCP systems, with a number of proteins successfully directed into the 
MCP using terminal targeting peptides (Lawrence et al., 2014). 
 
Figure 1.6.  Multiple sequence alignment highlighting the extended N-terminal sequences seen in 4 out of 5 
microcompartment-associated aldehyde dehydrogenase PduP and absent in 5 homologues which are not 
MCP-associated (Fan et al., 2010) 
	  	  	  	  	  	  
	  	  	  	  	  	  
 
29 
Recently, a key structural requirement for three or four conserved residues 
exposed on the edges of assembled hexamers for shell assembly has been 
demonstrated  (Pang et al., 2014), (Sinha et al., 2014). 
1.2.4. Metabolism of 1,2-Propanediol 
The pdu operon in Salmonella was originally regarded as being unimportant to 
the overall metabolic and competitive capacity of the bacteria, despite the fact 
that Salmonella maintains approximately 40 genes for the metabolism of 
propanediol and biosynthesis of cobalamin B12 (cob genes) (Bobik et al., 1999). 
The utilization of 1,2-propanediol did not appear to offer an in vivo competitive 
advantage, as it is not readily available in the environment and required the use 
of an electron acceptor (Bobik et al., 1997).  
The observation that the electron acceptor tetrathionate in the presence of a 
functioning tetrathionate reductase operon not only could support the anaerobic 
use of 1,2-propanediol as a sole carbon and energy source via the use of 
endogenously synthesized B12 , but actually lead to increased growth on this 
source (Price-Carter et al., 2001), was finally integrated into the enteric 
pathogenesis strategies of Salmonella in an in vivo model. This model showed 
that the production of tetrathionate, from the reaction of thiosulphate resulting 
from anaerobic bacterial metabolism with reactive oxygen species produced by 
inflammatory damage to the large intestine, provided the necessary electron 
acceptor to allow anaerobic respiration of 1,2-propanediol produced from fucose 
catabolism and offered a major growth advantage to Salmonella over commensal 
bacteria (Winter et al., 2010). Microcompartment-mediated metabolism is thus 
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an important contributor to the dysbiosis of intestinal infection (Winter & 
Baumler, 2013) . 
In Salmonella and Lactobacillus reuteri, the Pdu MCP is formed in response to 
the presence of 1,2-propanediol, which acts as a transcriptional control. 1,2-
propanediol is a fermentative product of the sugars rhamnose and fucose 
(Obradors et al., 1998). Fucose is present in the glycoconjugates of intestinal cell 
where it plays a role in host-parasite interactions in the digestive tract (Bry et al., 
1996). As such, 1,2-propanediol is hypothesized to act as a persistent carbon and 
energy source for aerobic and anaerobic metabolism in enteric bacteria (Bobik 
2006).  
 
Figure 1.7.  Schematic illustrating the metabolic processes of the Pdu MCP. (Kerfeld et al., 
2010) 
 
The Pdu MCP provides an encapsulated space for the initial enzymatic steps for 
1,2-propanediol metabolism; i) 1,2-propanediol is first converted to 
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propionaldehyde by the B12 dependant diol dehydratase enzyme and ii) this 
toxic intermediate propionaldehyde is further converted to propionyl-CoA, by 
the actions of coenzyme-A and NAD+-dependant propionaldehyde 
dehydrogenase (Bobik et al., 1997).  
There are a number of additional enzymes present in the Pdu MCP which are 
involved in 1,2-propanediol metabolism; an NADH-dependent cob(II/III) alamin 
reductase, an ATP-dependent adenosyltransferase which triggers the activation 
of coenzyme B12 and finally an ATP-dependent diol dehydratase reactivase, 
which releases deactivated B12 (Crowley et al., 2010). Because there is no 
means of ATP generation within the microcompartment, for these enzymes to 
function means that ATP must be able to access the microcompartment interior 
from outside.  
In L. reuteri, PduCDE contributes to the formation of beta-
hydroxypropionaldehyde (3-HPA) from glycerol co-fermentation, which is the 
foundation (through its monomeric and dimeric forms) of the production of the 
antimicrobial agent reuterin (Morita et al., 2008). The L. reuteri Pdu MCP differs 
from that of Salmonella by an association of the L. reuteri PduL enzyme with the 
MCP structure (Sriramulu et al., 2008) and by the absence of PduS and PduT (a 
single electron channel) (Pang et al., 2011). 
1.2.5. The role of the Pdu microcompartment 
Synthesizing the many thousands of proteins required for the formation of the 
Pdu MCP is a large energy investment by the cell, therefore its formation is 
typically strictly limited to environments containing 1,2-propanediol – a fact 
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which has hampered research into its functionality in bacteria such as Salmonella 
(Bobik et al., 1997). 
Although much research focuses on the pathogenic association of the presence of 
the Pdu MCP, it has also been identified in the commensal probiotic 
Lactobacillus reuteri DSM 20016, where it degrades 1,2-propanediol to 
propionaldehyde (Sriramulu et al., 2008). The production of aldehydes within 
MCPs has lead to hypotheses regarding a potential role in the presence of the 
MCP in mitigating aldehyde toxicity. This idea was initially based upon 
comparative genomics (Stojilkovic et al., 1995), as both the 1,2-propanediol and 
ethanolamine degradation pathways proceed via aldehyde intermediates. Studies 
involving the deletion of the pduA gene indicated that when MCP formation was 
prevented, culture growth was halted at high concentrations of 1,2-propanediol, 
suggesting that a toxic metabolite (propionaldehyde) was accumulating from the 
catabolism of 1,2-propanediol (Havemann et al., 2003). In this study, pdu 
mutants (pduJ, pduK, pduB) also released significant amounts of 
propionaldehyde versus the wild-type strain, indicating a potential structural role 
for the MCP in the retention of the aldehyde. 
In contrast, other studies proposed an alternative role for MCP based on the Eut 
microcompartment, suggesting the role of the MCP was to prevent acetaldehyde 
loss from the cell, which can occur due its volatile state as a gas (Penrod & Roth, 
2006). (Cheng et al., 2011), (Huseby & Roth, 2013). In either case, the 
mechanism of retention of small aldehyde molecules within a protein structure is 
not fully understood.  
	  	  	  	  	  	  
	  	  	  	  	  	  
 
33 
Horizontal transfer of the MCP is possible by cloning (Parsons et al., 2008), with 
the use of an artificial operon, which contains the core structural genes, allowing 
the expression of an empty structurally viable MCP (Parsons et al., 2010). This 
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1.3. Ethanolamine utilization (eut) Microcompartment 
1.3.1. The role of ethanolamine 
Ethanolamine is an amino alcohol produced in the gastrointestinal tract of 
mammals as a product of the degradation of phosphatidyl ethanolamine, which is 
present in large quantities in eukaryotic membranes. Due to rapid turnover of 
membrane cells in the digestive tract – approx. 25% of enterocytes per day are 
released into the gut per day – ethanolamine is present at high levels in the 
mammalian gut (Snoeck et al., 2005). Ethanolamine is a valuable source of key 
nutrients such as carbon and nitrogen, which may offer a competitive advantage 
amongst the many bacteria present in the mammalian gut (Thiennimitr et al., 
2011), particularly some pathogenic bacteria such as enterohaemorrhagic E. coli 
(EHEC) (Bertin et al., 2011). For pathogens capable of metabolizing, 
ethanolamine, like 1,2-propanediol, can be respired by the cell through the 
availability of tetrathionate (as an electron acceptor) (Price-Carter et al., 2001) in 
an inflamed gut (Thiennimitr et al., 2011). Expression of the eut operon is 
quantitatively greater in enterohaemorrhagic E. coli (EHEC) than commensal E. 
coli on exposure to ethanolamine (Bertin et al., 2011). 
In E. coli O157:H7, free ethanolamine has been identified to act as a nitrogen 
source, which had been previously observed in Salmonella (Penrod & Roth, 
2006), (Stojilkovic et al., 1995). A functional ethanolamine ammonia-lyase 
(EAL) is required for nitrogen metabolism, whilst acetaldehyde dehydrogenase, 
alcohol dehydrogenase and phosphotransacetylase do not appear to contribute to 
the process (Bertin et al., 2011). 
	  	  	  	  	  	  




The ethanolamine utilization (Eut) microcompartment and its gene cluster were 
initially identified in E. coli in 1995 (Stojiljkovic et al., 1995). Its dependence on 
the presence of B12 was noted and its association with the presence of genes 
encoding a bacterial microcompartment. The eut operon has been identified in a 
number of enteric bacterial genera, typically pathogenic. The complete eut 
cluster has been identified in a number of E. coli strains; particularly those 
associated with mammalian enteric infection e.g. EHEC (enterohaemorragic E. 
coli), EPEC (enteropathogenic E. coli) and ETEC (enterotoxigenic E. coli). 
However this same gene cluster was also identified in a number of commensal or 
K-12 strains including MG1655 (Bertin et al., 2011), other Enterobacteriaceae 
such as Salmonella, and Gram positives such as Listeria (Korbel et al., 2005) and 
Enterococcus.  Despite the consistent presence of the Eut operon in E. coli, 
images of the Eut microcompartment in E. coli are rare  (Shively et al., 1998) but 
they seem similar to Pdu microcompartments. 
1.3.3. Genetics 
The arrangement of the eut operon in E. coli is highly similar to the pdu operon. 
The eut operon contains a number of BMC domain genes that are identifiable 
across MCP-producing bacteria (Section 2.1.2., Table 2.1.). 
  
	  	  	  	  	  	  




Table 1.3. Table indicating the gene breakdown of the eut microcompartment. (Yeates et al., 
2008) 
 In total, the eut operon contains 17 encoding genes, with a number of these 
involved in the transport and metabolism of ethanolamine (Roof & Roth, 1992). 
Key genes include eutR, which acts a transcriptional activator for the expression 
of the eut operon in response to the presence of ethanolamine (Yeates et al., 
2008) and the structural genes eutS, eutM, eutN, eutL and eutK, which encode the 
formative shell proteins (Kofoid et al., 1999). Recent studies have indicated an 
unexpected importance for eutD with regards to long-term growth on 
ethanolamine  (Huseby & Roth, 2013). It has also been observed that in strains 
with defective MCP shell genes, excess acetaldehyde is released versus the wild-
type, indicating a role for the MCP in acetaldehyde retention (Penrod & Roth, 
2006). 
1.3.4. Function of the Eut microcompartment 
The main role of the Eut microcompartment, like the Pdu microcompartment 
(Section 3.1.5.) is a matter of debate; one hypothesis is that its role is in the 
No. of genes Genes Encoding Source 
1 EutT Corrinoid adenosyltransferase & cobalamin 
recycling 
Kofoid et al., 1999 
1 EutD Phosphotransacetylase  Kofoid et al., 1999 
1 EutE Aldehyde dehydrogenase Kofoid et al., 1999 
1 EutJ Possible chaperone function Kofoid et al., 1999 
1 EutG Alcohol dehydrogenase Kofoid et al., 1999 
1 EutH Permease Kofoid et al., 1999 
1 EutA Ethanolamine ammonia-lyase reactivase Kofoid et al., 1999 
2 EutB, 
EutC 
Ethanolamine ammonia lyase  Kofoid et al., 1999 
1 EutR Transcription activator Kofoid et al., 1999 
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retention of the volatile aldehyde intermediate, which would otherwise be lost 
during the gas phase (Penrod & Roth, 2006). This is similar to the retention of 
the less volatile aldehyde propionaldehyde in the Pdu microcompartment but the 
advantage drawn from it is different. Penrod and Roth suggested that the 
mechanism of aldehyde retention may be that all microcompartments sustain an 
internal pH lower than that of the exterior cytoplasm. This acid environment may 
promote the conversion of aldehydes to less volatile acetals. A primary 
advantage of microcompartment enclosure in preventing aldehyde metabolite 
loss rather than cytoplasmic toxicity was supported by lack of acetaldehyde 
toxicity in mutants unable to form the Eut MCP (Penrod & Roth, 2006). 
Other studies have indicated a role of the Eut MCP in the sequestering of toxic 
aldehyde (Brinsmade et al., 2005). polA (DNA repair polymerase) mutants were 
unable to grow on ethanolamine (Rondon et al., 2005). However, the possibility 
of increased ethanolamine sensititity in these mutants (at non-toxic levels for the 
wild-type) was indicated by a later study (Penrod & Roth, 2006).  
The eut operon genes have also been identified in Listeria monocytogenes, where 
knockout studies of eutB (required for ethanolamine metabolism) illustrated 
intracellular growth of Listeria in mammalian tissue culture is greatly reduced 
(Joseph et al, 2005) and the eut operon is strongly induced in infecting Listeria 
(Archambaud et al., 2012) . 
1.3.5. Metabolism 
Ethanolamine is metabolized in the eut microcompartment in two steps; i) 
Ethanolamine ammonia-lyase initially requires the co-factor adenosyl cobalamin 
which is synthesized in anaerobic conditions, but crucially transported under 
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aerobic conditions (Jeter et al., 1984). Once B12 is present, ii) ethanolamine is 
then cleaved to produce ammonia plus acetaldehyde, which is further converted 
to acetyl-coenzyme A (acetyl Co-A) by oxidoreductase, which is NAD-
dependent. Within Chapter IV, there is further detail concerning ethanolamine 
metabolism with respects to its importance and contribution to the cell. 
 
Figure 1.8. Schematic illustrating the metabolic processes of the eut MCP. (Kerfeld et al., 2010) 
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1.4. Phosphorus and Phosphate 
Rarely existing as a free chemical, phosphorus (P) is an element that is 
predominantly identified within nature as part of the phosphate molecule (PO4). 
Organic phosphate is typically defined as phosphate associated with a carbon-
based molecular structure, such as animal tissue. In contrast inorganic phosphate 
is any available phosphate not associated with organic material, and is the 
dominant source within nature. 
1.4.1. The phosphorus cycle 
The phosphorus cycle typically begins through plant matter assimilating 
inorganic phosphorus and converting this to organic phosphorus. Through the 
consumption and decomposition of these plants, animals can then obtain this 
converted organic phosphorus. Continuing the cycle, as animals excrete waste 
and die, their consumed organic phosphorus dissolves into the soil bed or water 
table, where bacterial saprophytes reconvert it back to inorganic phosphorus. 
This is then once again available for assimilation by plant matter, and the cycle 











Figure 1.9. Image illustrating the natural cycle of phosphorus (Science Learning Hub, University 
of Waikato, 2013) 
	  	  	  	  	  	  




Terrestrial phosphorus cycle is predominantly influenced by agricultural 
practices, with increasing off-flow accumulation in rivers and soils threaten 
eutrophication (Bennett et al, 2001). Few minerals bear enough phosphorus in 
meaningful quantities. In igneous rock, fluorapatite, which is typically associated 
with ferromagnesian minerals, is one of the main phosphorus-bearers, whilst in 
sedimentary rock, the majority of phosphorus is present in authigenic (formed in 
situ) carbonate-fluorapatite (Fillipelli, 2008). 
Within the ocean, authigenic formation of calcium phosphate minerals in 
sediments results in a large phosphorus sink. The source for apatite in oceanic 
phosphate sediments in some coastal regions is thought to be polyphosphate from 
the giant sulphur bacterium Thiomargarita namibiensis (Schulz & Schulz, 2005) 
and a significant proportion of apatite in all oceanic sediments may derive from 
deposition of polyphosphate-containing diatoms (Diaz et al, 2008),  
1.4.2. Polyphosphate in nature 
Inorganic polyphosphate (polyP) exists as a linear chain of hundreds of 
phosphate residues linked by energy-rich phosphoanhydride bonds, the same as 
those found in adeno-tri-phosphate (ATP), which is the molecular energy 
currency of cells.  
Highly conserved across nature, and stable over a range of temperatures, pH and 
oxidants (Rao et al, 2009), polyP is present in bacterial, animal, fungal and plant 
cells (Brown & Kornberg, 2004). Within nature, polyP has been identified in 
deep oceanic vents and volcanoes, where it has been generated through the 
dehydration of orthophosphate or phosphate rock, at elevated temperatures 
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(Kornberg, 1995). Orthophosphates are the inorganic forms of phosphate, such 
PO4-, HPO4- and H2PO4-, and the most common form used for fertilizers (Johnson 










Figure 1.10. Inorganic polyphosphate (PolyP). The value of n, the number of PO3- residues, may 
vary from 3 to over 1,000. (Rao et al, 2009). 
 
1.4.3. The role of polyP in bacterial cells 
PolyP was initially observed as metachromatic granules within the bacterium 
Spirillum volutans, which lead to the term “volutin granules” being bequeathed 
on these unusual clusters. These clusters could be stained pink using toluidine 
blue (Meyer, 1904). Using microscopy, the volutin granules could be correlated 
against the presence of polyP, an observation that led to the renaming from 
volutin to polyP granules, nearly 50 years after their initial discovery (Wiame, 
1937). Typically in prokaryotes, polyP granules are composed of acid-insoluble, 
long chain polyP and present in the cytoplasm (Wood & Clark, 1988), (Kulaev & 
Vagabov, 1983). In some bacteria cells however, acid-soluble, short chain polyP 
can also be identified beyond the cytoplasm, in cellular compartments such as the 
periplasm or plasma membrane (Wood & Clark, 1988). In Helicobacter pylori, 
polyP granules have been observed in the cell membrane (Achbergerova & 
Nahalka, 2011) and in the sporulating prespore of Acetonema longum (Tocheva 
et al., 2013). 
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1.4.3.1. PolyP as an energy source 
As previously mentioned, polyP is a rich source of energy. Within the microbial 
cell, granules of polyP act as reservoirs for energy and phosphate storage, which 
can be degraded to release ATP or phosphate (Achbergerová & Nahálka, 2011). 
It has been observed in polyP-deficient cells, that cells compensate for this 
energy gap by increasing the flow of energy generating pathways such as the 
citric acid cycle and oxidative phosphorylation (Varela et al, 2010). There are a 
number of key enzymes involved in this important process of polyP metabolism, 
including polyphosphate kinases (PPK), (Kornberg et al, 1956) and 
exopolyphosphatases (PPX) (Akiyama et al, 1993). 
1.4.3.2. PolyP as a phosphate source 
In prokaryotes, polyPs are the dominant regulators of intracellular phosphate. 
The amount of polyP within a bacterial cell typically depends on its surrounding 
environment, with bacteria associated with wastewater typically exhibiting high 
levels of polyP (Kulaev & Kulakovskaya, 2000). However to ensure a standard, 
stable level of intracellular phosphate, a polyP reservoir which can be changed to 
phosphate via exopolyphosphatases, is essential. PolyP, due to its polymeric 
form, is ideal to act as a large-scale phosphate sink within the cell, as its 
aggregations have little effect on cellular osmotic pressure (Kulaev et al, 2004). 
As phosphorus is a life-limiting factor, this ability to uptake and retain vast 
amounts of phosphate in the form of polyP is crucial for cell survival, 
particularly in environments where phosphate is limited (Kulaev and Vagabov, 
1983). 
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1.4.3.3. PolyP as a regulator 
Due to important contribution of polyP storage and phosphate metabolism to 
cellular function, polyPs contribute to the regulation of enzymatic activities and 
gene expression. This influence can be observed in stress conditions and on 
adaptation into the stationary-growth phase (Kulaev et al, 2004). There is a close 
responsive relationship between polyP and the alarmone guanosine 3,5-
bispyrophosphate (ppGpp), a key factor in the bacterial stringent response 
(Kulaev et al, 2004). The crucial role that polyP kinase (PPK) plays in cellular 
survival under stress and starvation was highlighted by PPK-mutant studies 
(Crooke et al, 1994). 
PolyP has been observed to have an impactful role in the oxidative stress 
response in both prokaryotic and eukaryotic cells (Gray & Jakob, 2015). 
Previous studies demonstrated increased stress sensitivity from heat and H2O2 
when the polyphosphate kinase gene (PPK) of Escherichia coli was disrupted 
(Akiyama et al, 1992), and polyP deficiency was also observed to be associated 
with increased sensitivity in Mycobacterium tuberculosis on exposure to 
nitrosative stress (Singh et al., 2013). Studies on Proteus mirabilis additionally 
identified loss of colonization ability, along with a loss of swarming and biofilm 
formation where attenuation of the ppk gene had occurred (Peng et al., 2015). 
 More recently, similar stress sensitivity has been identified in Lactobacillus 
spp., where again, disruption of the PPK gene led to diminished growth under 
extreme conditions (high salt or low pH) and an increased sensitivity to oxidative 
stress (Alcantara et al, 2014).  
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1.5. Polyphosphate kinases (PPK) 
As previously mentioned, in bacteria, the main enzyme known to be involved in 
polyP synthesis is polyphosphate kinase (PPK), which, in an ATP-dependent 
reaction, catalyzes the creation of a phosphoanhydride bond between a polyP 
chain and orthophosphate (Rao et al, 2009). Due to this connection with the 
utilization of ATP, PPKs are key enzymes within the cell, as they are capable of 
alternating the balance of energy and phosphate, from storage to consumption 
(Achbergerova & Nahalka, 2011). 
 
 2 PO43− + 2 H+   P2O74− + H2O 
 
Figure 1.11. Equation illustrating the condensation reaction resulting in the production of polyphosphates. 
Equilibrium status is given as the opposite hydrolytic reaction is also possible. 
 
 
The typical reaction leading to the formation of polyP within the cell essentially 
arises from the polymerization of phosphoric acid derivatives. This condensation 
reaction is energy consuming (ATP-dependent) and consists of two phosphate 
molecules together forming polyphosphate. 
 
 This forward reaction can continually repeat, with an additional phosphate 
added at each step. The reaction is reversible, with a hydrolytic reverse reaction, 
but predominantly the reaction favors polyP synthesis (Rao et al, 2009). This 
reaction is catalyzed by what was originally perceived as the only PPK, but when 
PPK knockout studies in Pseudomonas spp., still displayed up to 20% of polyP 
levels, the novel PPK2 was identified, leading to the reclassification of the 
“original” PPK as PPK1.  (Ishige et al, 2002).  
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1.5.1. Polyphosphate kinase 1 (PPK1) 
PPK1 (EC 2.7.4.1) was the first PPK identified, and is the key catalyzer of the 
polymerization of the terminal phosphate of ATP into a polyP chain (Kornberg et 
al, 1956). Across the majority of species, prokaryotic and eukaryotic, PPKs have 
been identified (Achbergerova & Nahalka, 2011), although no definitive proof 
has demonstrated their presence in mammalian cells (Pavlov et al., 2010). In 
particular, PPK1 and its homologues have been identified in >100 species, across 
pathogens like Klebsiella pneumoniae sp pneumoniae and probiotics like 
Lactobacillus delbrueckii (Rao et al, 2009). This makes PPK1 the most highly 
conserved enzyme involved in polyP metabolism.  
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PPK2 PPK1 only Neither PPK1 nor PPK2 
PPK2 and PPK1 Genome complete Aeropyrum pernix 
Agrobacterium tumefaciens Bacillus anthracis Aquifex aeolicus 
Brucella melitensis Bacillus halodurans Archaeoglobus fulgidus 
Burkholderia fungorum(2) Clostridium acetobutylicum Bacillus subtilis 
Campylobacter jejuni E. coli Borrelia burgdorferi 
Caulobacter crescentus Helicobacter pylori Buchnera aphidicola str. Sg 
Chlorobium tepidum Mycobacterium leprae Buchnera sp. APS 
Chloroflexus aurantiacus Neisseria meningitidis Chlamydia muridarum 
Deinococcus radiodurans Salmonella typhi Chlamydia trachomatis 
Magnetospirillum 
magnetotacticum (2) 
Salmonella typhimurium Chlamydophila pneumoniae 
Mesorhizobium loti(2) Xylella fastidiosa Clostridium perfringens 
Methanosarcina acetivorans(2) Yersinia pestis Fusobacterium nucleatum 
Methanosarcina mazei(2)  Haemophilus influenzaeRd 
Mycobacterium tuberculosis Genome incomplete Halobacterium sp. NRC-1 
Myxococcus xanthus Acidithiobacillus 
ferrooxidans 
Lactococcus lactis 
Nostoc punctiforme (2) Acinetobacter baumannii Listeria innocua 
Nostoc sp. PCC7120 (2) Acinetobacter calcoaceticus Listeria monocytogenes 
Prochlorococcus marinus Acinetobacter sp. ADP1 Methanococcus jannaschi 
Pseudomonas aeruginosa(3) Aphanizomenon sp. TR183 Methanopyrus kandleri 
Pseudomonas fluorescens(2) Aphanizomenon baltica Methanothermobacter 
Ralstonia metallidurans (5) Arthrobacter sp. KM thermautotrophicus 
Ralstonia solanacearum Bordetella pertussis Mycoplasma genitalium 
Rhodobacter sphaeroides (2) Burkholderia cepacia Mycoplasma pneumoniae 
Rhodopseudomonas palustris Campylobacter coli Mycoplasma pulmonis 
Rhodospirillum rubrum Cytophaga hutchinsonii Pasteurella multocida 
Sinorhizobium meliloti(3) Dictyostelium discoideum Pyobaculum aerophilum 
Streptomyces coelicolor Geobacter sulfurreducens Pyrococcus abyssi 
Synechococcus sp. WH 8102 Haloferax volcanii Pyrococcus furiosus 
Synechocystis sp. PCC6803 Klebsiella aerogenes Pyrococcus horikoshii 
Thermosynechococcus elongatus Leuconostoc mesenteroides Rickettsia conorii 
Vibrio cholerae Microbulbifer degradans Rickettsia prowazekii 
Xanthomonas axonopodis Mycobacterium marinum Saccharomyces cerevisiae 
Xanthomonas campestris Mycobacterium ulcerans Schizosaccharomyces pombe 
 Neisseria gonorrhoeae Staphylococcus aureus 
 Nitrosomonas europaea Streptococcus pneumoniae 
PPK2 only Nodularia spumigena Streptococcus pyogenes 
Corynebacterium glutamicum(2) Oenococcus oeni Sulfolobus solfataricus 
MagnetococcusMC-1 (2) Porphyromonas gingivalis Sulfolobus tokodaii 




 Rhodocyclus tenuis Thermoplasma acidophilum 
 Salmonella Dublin Thermoplasma volcanium 
 Serratia marcescens Thermotoga maritima 
 Shigella flexneri Treponema pallidum 
 Streptomyces griseus Ureaplasma urealyticum 
 Streptomyces lividans  
 Thermobifida fusca  
Table 1.4. Table indicating PPK1 and PPK2 homologues among microorganisms (credit: Zhang et al, 
2002) 
Structurally, PPK1 a homotetramer, formed from 80kDa monomers, which inter-
lock together as a dimer. Within a highly conserved structural tunnel, the 
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enzymatic active site is located and is likely the accommodation site for freshly 
synthesized polyP (Zhu et al, 2005).  
This tunnel is a crucial feature in the functionality of PPK1, where it 
accommodates ATP and highly conserved, charged residues. These residues 
interact with polyP during polyP chain elongation (Zhu et al, 2005). Purified 
recombinant PPK catalyses the elongation of polyP, resulting in termination of 
polyP synthesis when the chain reaches approximately 750 phosphate groups 
















Figure 1.12. Crystal structure of E. coli PPK1 dimer. Each monomer of ppk1 contains amino terminal 
domain (N) (red), the “head” domain (H) (yellow) and two carboxyterminal domains (C1 and C2) (blue and 
green). (Achbergerová & Nahálka, 2011) 
 
1.5.2. Polyphosphate kinase 2 (PPK2) 
However, PPK1 is not the only universal polyP-associated enzyme. PPK2 is a 
polyphosphate-dependent ATP/GTP regenerating enzyme, which was first 
identified in Pseudomonas aeruginosa (Zhang et al, 2002). This novel PPK2 was 
initially identified whilst observing PPK1-null Pseudomonas mutants, which 
retained polyP granulations despite the enzyme knockout. In contrast to PPK1, 
which is completely ATP-dependent, PPK2 can utilize both ATP and GTP to 
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synthesis polyP (Ishige et al, 2002). However, PPK1-deficient cells have been 
observed to lack functionality in abilities such as quorum sensing and virulence 
(Rashid & Kornberg, 2000). Structurally, PPK2 is diverse depending on its state 
and role. On isolation from the cell, it appears as a 44kDa protein, however this 
differs in vivo depending on polyP (Ishige et al, 2002). In Pseudomonas 
aeruginosa, two 1-domain (dimeric) and one 2-domain (tetrameric) PPK2 
proteins are produced, the latter probably resulting from a gene duplication 
(Nocek et al, 2008). One domain PPK2 catalyzes ATP and GTP synthesis from 
the respective nucleoside diphosphates and polyP, while the 2-domain PPK2 
catalyzes ADP and GDP synthesis from nucleoside monophosphates and polyp 
(Nocek et al, 2008). A. phosphatis widely associated with enhanced biological 
phosphorus removal (EBPR) systems, contains multiple ppk2 paralogues in a 
representative metagenome, leading to a suggestion that the metabolism of polyP 
by PPK2 is important for its survival in such a system (Martin et al, 2006). A 
recent study (Motomura et al, 2014) (Fig 3.5) has identified a new subfamily of 
PPK2, which is phylogenetically distinct from the 1-domain and 2-domain 
PPK2. This subfamily appears to catalyse both nucleoside monophosphate and 
nucleoside diphosphate phosphorylation. 
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Figure 1.13. P. aeruginosa PPK2 contains two monomers. Each monomer contains two domains coloured 
in yellow and green connected by a flexible linker coloured in red (Achbergerová & Nahálka, 2011). 
 
Figure 1.14. Unrooted phylogenetic tree of PPK2, generated by ClustalW and GeneDoc programs using 
amino acid sequences of 17 characterized and 192 putative PPK2 homologs ((Motomura et al, 2014) 
 
 
Figure 1.15. PPK1 and its phosphorylation efficacy, where ADP is preferentially used to all others 
(Achbergerova & Nahalka, 2011) 
 
Figure 1.16.. PPK2 and its phosphorylation efficacy, where both GDP and ADP can be utilized. 
(Achbergerova & Nahalka, 2011) 
1.5.3 Exopolyphosphatases (PPX) 
As previously mentioned, polyP synthesis typically occurs in the forward 
condensation reaction as PPK1 catalyzes this reaction. However the reverse 
hydrolytic reaction can be carried out by a specific enzymatic class, the 
exopolyphosphatases (EC 3.6.1.11), which split phosphate from the ends of poly-
P chains (Akiyama et al, 1993). So far, two types of these enzymes have been 
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classified; those encoded by the ppx gene, and those guanosine pentaphosphate 
(pppGpp) phosphohydrolase (GppA; EC 3.6.1.40).  These two classes produce 
enzymes which are sequentially related, but with differing actions. PPX typically 
splits long-chain polyP, whilst GppaA is also involved in the hydrolysis of 
(p)ppGpp, which are alarming compounds involved in the trigger of the stringent 
response (Potrykus & Cashel, 2008). 
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1.6. Polyphosphate metabolism 
1.6.1. Metabolism in bacteria 
As previously mentioned, polyP is strongly associated with the stress and 
stringent response in a number of microorganisms, due to its direct linkage with 
numerous physiological processes such as mobility and virulence (Rashid & 
Kornberg, 2000). These subsequent studies have broadened the interpretation and 
importance of polyP beyond the role of a phosphate and energy storage 
molecule. However, no one mechanism illustrates how polyP influences such 
various cellular processes and response. 
Within the bacteria cell, polyP has many biologically advantageous properties. 
Due to its polymer structure, it is an osmotically neutral form of phosphorus and 
can also readily form complexes with cellular components such as nucleic acids 
or proteins, influencing their biological activities (Kulakovskaya et al, 2012). In 
E. coli, polyP can form a complex with the ATP-dependant Lon protease, leading 
to the degradation of free ribosomal proteins (Kuroda, 2006), whilst polyP-RNA 






 Figure 1.17. Uptake of phosphate and intracellular polyP metabolism (Hirota et al. 2010) 
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Within the cell, the production of polyP can be manipulated through the 
introduction of additional copies of the ppk gene and inducing these recombinant 
inserts (Smolke, 2010). Previous studies analyzing over-expression of PPK1 
have demonstrated increased polyP:AMP phosphotransferase (PAP) activity 
(Ishige & Noguchi, 2000), and also the observance of an accumulation of 
adenylate kinase and phosphatases, and inclusion bodies (Nahálka et al, 2006). 
This highlights the ability to manipulate and influence the intracellular 
metabolism of polyP within the bacterial cell. 
1.6.2. Metabolism in humans 
Within humans and mammalian cells, polyP also plays an identifiable role. 
Previous studies have recognized polyP as being an influential regulator of blood 
homeostasis (Morrissey et al, 2012). PolyP can be identified within granules in 
platelets, where their function has been well elucidated (Mueller et al, 2009).  
Within platelets, the role of polyP is part of the response to endothelial damage. 
Platelets are alerted to the site of damage, where secreted granules of polyP aid 
in the blood coagulation process.  
The body relies heavily on access to phosphorus via polyphosphate, as 
phosphorus to essential to develop and maintain bones and teeth, in parallel with 
calcium. Approx. 85% of phosphorus is stored within the bones and teeth 
(Cupisti et al, 2013). This relationship with calcium is also clinically important, 
as calcium and phosphate work conversely; as phosphate levels increase in the 
blood, calcium levels fall. This balance is overseen by the parathyroid hormone 
(PTH), but this relationship can be disrupted due to illness. 
  
	  	  	  	  	  	  




The distribution of electrolytes and minerals within the body is a delicate 
balance. An excess or depletion of one can have an enormous effect on the body, 
and can indicate more serious health issues. Hyperphosphatemia is the excess 
accumulation of phosphate within the body. In the kidneys, the majority of 
inorganic phosphorus is ultra-filterable at the glomerulus, with approximately 7g 
of phosphorus filtered daily. Reabsorption occurs in the renal tubules, with the 
remainder excess excreted in urine (Knox et al, 2006). Under normal conditions, 
parathyroid hormone (PTH) influences phosphate balance by preventing the 
kidneys from re-absorbing excess phosphate, directing its excretion into urine. It 
acts as a mediator of phosphate excretion per nephron, regulating phosphate ion 
loss in urine. Serum PTH level, which is central to calcium homeostasis, also 
plays a key role in phosphate homeostasis. When renal function declines, and 
chronic kidney disease (CKD) develops, phosphate retention levels increase and 
lead to a dysfunction of the phosphate-calcium-PTH balance (Peacock, 2010). 
Hyperphosphatemia is therefore indicative of renal disruption or failure, as the 
kidneys fail to excrete phosphate into urine. 
1.7.1. Association with renal failure and cardiovascular disease 
In chronic kidney disease, hyperphosphatemia is associated with decreased 
serum calcium levels and vascular calcification; this is referred to as mineral and 
bone disorder associated with chronic kidney disease (CKD-MBD) (Guo et al, 
2013). Observation of patients suffering from end-stage renal disease (ESRD) 
also indicate the population are highly vulnerable to infection due to their 
immunocompromised state, which can be observed by a notable decrease in the 
	  	  	  	  	  	  
	  	  	  	  	  	  
 
54 
killing capacity of neutrophils (Anding, 2003). Therefore, despite the fact that 
hyperphosphatemia is a consequential condition of ESRD, it requires its own 
intensive treatment to alleviate its effects – typically in the form of oral 
phosphate binders (Guo et al, 2013). 
Cardiovascular morbidity and mortality is also clinically associated with 
hyperphosphatemia, particularly in patients undergoing dialysis treatment 
(Kendrick & Chonchol, 2011). According to literature, the leading cause of death 
in patients with chronic kidney disease (CKD) is in fact cardiovascular disease, 
with the progression of vascular calcification acting as a key impact factor 
(Andrade & Ignaszewski, 2008), (McCabe et al, 2013). Adiponectin (ADPN), a 
secretory protein from the adipose tissue, can be observed in the serum of ESRD 
patients at high levels, and is associated with a number of cardiovascular risk 
factors including heightened HDL cholesterol levels (Zoccali et al, 2002). 
1.7.2. Prevention and Therapies 
Control and prevention of hyperphosphatemia is difficult, particularly if patients 
are involved in dialysis treatment, with previous data observing increased 
mortality in patients in patients suffering from ESRD and receiving dialysis 
(Block & Port, 2000). This is likely due to inadequate phosphate removal 
through conventional dialysis treatment, which often displays a consequential 
post-dialysis rebound from mobilization of intracellular phosphate (Coladonato, 
2005).  Typical treatment options therefore consist of optimal dialysis removal, 
methodical use of oral phosphate binders, and dietary control of phosphorus 
intake all in unison (Cupisti et al, 2013). 
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1.7.2.1. Phosphorus absorption 
Guidelines issued by the Food and Nutrition Board of the Institute of Medicine (a 
division of the National Academies of Sciences, Engineering, and Medicine, 
USA) have indicated a recommended dietary allowance of 700 mg/d of 
phosphorus in healthy adults. In pregnant women, this allowance increases to 
<1250 mg/d (Food & Nutrition Board, 1997). Within the body, phosphorus is 
primarily removed by two systems; the gastrointestinal tract (150mg/day) and via 
urine excretion (800mg/day) (Hruska et al, 2008). In a healthy individual, after 
the body ingests phosphorus, phosphatonins such as PTH trigger phosphaturia 
(phosphate excretion in urine) to regulate the body’s phosphorus balance 
(Isakova et al, 2009). 
As previously mentioned, his process becomes dysfunctional with a decrease in 
renal function, with decreased glomerular filteration of phosphorus and 
attempted compensation with decreased tubular reabsorption (González-Parra et 
al, 2012) 
1.7.2.2. Polyphosphate absorption 
In mammals, absorption of polyP occurs in the small intestine, where it is 
degraded to orthophosphate by the alkaline phosphatase of the intestinal wall 
(Lorenz & Schroder, 2001). Intestinal absorption proceeds via a co-transport 
system for active sodium/phosphate co-transporters. This gastrointestinal 
interaction provides an opportunity for phosphate intake control via dietary 
restrictions and oral medication. The main factors governing the rate of 
phosphate absorption via the small intestine include i) the amount of phosphorus 
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in the diet, ii) its bioavailability and iii) the presence of natural or pharmacologic 
phosphorus binders (Noori et al, 2010). 
Inorganic phosphate is obtained by the body mainly through the ingestion of 
food, particularly processed food, with estimations that up to 50% of our dietary 
phosphorus intake is from phosphorus-containing food additives, which are 
rarely quantified on food labels (Winger et al, 2012). In addition, polyphosphate 
is often used as a preservative additive (E452). This is due to its high buffering 
capacity, helping to maintain optimal pH and its polyanion status, which are all 
beneficial technological properties. (Kulakovskaya et al, 2012). Phosphate is also 
naturally present abundantly in food in the form of phospholipids and 
phosphoproteins (Massey, 2003). This consistent presence in food makes the 
avoidance or restriction of phosphate very difficult for patient management. 
However in dialysis patients with ESRD, the largest complication regarding 
control of dietary polyP intake is the correlation between phosphate and protein 
intake. Dietary protein is a major source of phosphorus and phosphate (Boaz & 
Smetana, 1996), however recent literature has indicated that dietary restriction of 
phosphate intake can have a negative effect on protein intake as a result, leading 
to potentially increased mortality (Shinaberger et al, 2008). Therefore dietary 
control is not alone sufficient in the majority of cases. 
1.7.2.3. Phosphate binders 
Regarding the use of phosphate binders, as dialysis and dietary is rarely 
sufficient; there is a large reliance upon the use of medicinal intervention. The 
most frequently used phosphate binders can be arranged into three property-
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based classifications: i) aluminium-based binders, ii) calcium-based binders and 
iii) aluminum and calcium-free binders (Cupisti et al, 2013), (Table 5.1). 
In previous years, aluminium-based binders were a popular choice for the 
treatment of hyperphosphataemia, however more recently they have fallen out of 
favour due to concerns regarding their long-term usage (LTU). Longitudinal 
studies have linked LTU of aluminum-based phosphate binders with aluminum 
accumulation causing induced osteomalacia (KDIGO, 2009).  
Calcium-based binders have also been a popular choice since the 1980s, and 
appear well tolerated across the majority of patient groups. Degree of dosage is 
once again an aspect of concern however, due to the sensitivity of PTH to the 
calcium-phosphate balance. A positive increase toward calcium can lead to 
hypercalcemia causing vascular calcification, which can in turn lead in increased 
cardiovascular disease (McCabe et al, 2013).  
An improvement from the traditional failings of calcium-based binders is 
lanthanum carbonate, a novel non-calcium, non-aluminum binder. Literature 
studies have identified lanthanum carbonate as beneficial in reducing the risk of 
vascular calcification and reducing serum phosphate levels (Neven et al, 2009). 
Sevalamer is an ion exchange resin made in Waterford (Genzyme, now Sanofi) 
with worldwide sales of over 800 million euro per annum. It is also used in 
therapy of hyperphosphataemia (ref) However the requirement for oral 
medication increases pill burden on patients and adds to an increased medication 
load (Chiu et al, 2009). Therefore treatment of hyperphosphatemia remains a 
multi-disciplinary approach between clinician, dietician and the patient. 
 
	  	  	  	  	  	  












Table 1.5. Table indicating the advantages and disadvantages of the three major phosphate binders  
(credit : Cupisti et al, 2013 
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Phosphate granules, or volutin granules have been observed in lactobacilli since 
the 1950s. Phosphate is an essential ion for bacterial cells, and polyphosphate is a 
means of storing phosphate residues as a polymer connected by high-energy 
phosphoanhydride bonds such as that in ATP (Brown & Kornberg, 2004). 
Cellular metabolism depends on the appropriate concentration of intracellular 
inorganic phosphate (Pi) (Dick et al., 2011) in response to the presence of 
pyrophosphate (PPi) and can also be influenced by molecules produced during 
synthesis of cellular polymers such as DNA or RNA (Chen et al., 1990). 
Through various mechanisms, it can be taken up from the surrounding 
environment or culture media, and utilized in the cell as orthophosphate (Henry 
& Cosson, 2013). Orthophosphates are the inorganic forms of phosphate, such 
PO4-, HPO4- and H2PO4-, and the most common form used for fertilizers (Johnson 
et al., 2007). 
In lactobacilli, the reactive process from phosphate to polyphosphate is a highly 
dynamic process. This process has been observed to fluctuate greatly during cell 
cycle, and it has been hypothesized that phosphate metabolism is intrinsically 
linked to the stress response of the cell. This is particularly noteworthy during 
the transition stages from cell starvation to glycolysis (Alcantara et al., 2014), 
(Levering et al., 2012), 
This chapter describes manipulation of phosphate uptake and polyphosphate 
accumulation by Lactobacillus reuteri DSM20016, a commensal of the 
mammalian gut, by cloning and  expression of recombinant polyphosphate 
kinase genes (ppk1) from E. coli and L. reuteri. In addition, the effect of adding a 
	  	  	  	  	  	  
	  	  	  	  	  	  
 
84 
microcompartment targeting  sequence to ppk1 from L. reuteri was assessed. 
Cloning steps towards expressing an empty recombinant microcompartment 
from L. reuteri genes are described. 
For this study two host strains were used; Lactobacillus reuteri DSM 20016 and 
Escherichia coli BL21. The wild-type characteristics of the strains were noted, 
and compared against recombinant constructs utilizing the polyphosphate kinase 
1 gene (ppk1). Recombinant constructs were analyzed for polyphosphate 
formation and phosphate uptake against backgrounds of rich media, minimal 
media, and single sugar sources. 
Incubation in media known to induce the Pdu microcompartment operon 
increased polyphosphate formation in L. reuteri. Recombinant ppk expression 
enhanced polyphosphate formation and phosphate uptake  in both L. reuteri and 
E. coli.  Recombinant E. coli ppk was functional when expressed in L. reuteri 
and was achieved more phosphate uptake than expression of the recombinant L. 







	  	  	  	  	  	  




Phosphate, or phosphorus is one of the fundamental elements essential to the 
survival and propagation of the prokaryotic cell (Brown & Kornberg, 2004). The 
mechanisms of phosphate uptake and the transition into polyphosphate have not 
been directly studied in many bacterial species. This study particularly focused 
on the strains Lactobacillus reuteri DSM 20016, and Escherichia coli BL21. 
L. reuteri is a Gram-positive, facultative anaerobic bacterium, typically 
associated with gut fermentation of mammals, particularly cattle (Kullen & 
Klaenhammer, 2000) It has a GRAS (Generally Regarded As Safe) status, and 
has displayed probiotic effects in the gastrointestinal tract. It has a naturally 
occurring bacterial microcompartment (MCP), which is produced in response to 
the presence of 1,2-propanediol (Pdu microcompartment) (Sriramulu et al., 
2007).  
L. reuteri also produces the antimicrobial substance reuterin by using the Pdu 
microcompartment for metabolism of glycerol (Rodriguez et al., 2003), 
(Sriramulu et al., 2007) (Santos et al., 2011). Reuterin is a compound that 
consists of a variety of hydrated, non-hydrated, and dimeric forms of 3-
hydroxypropionaldehyde (3-HPA) (Stevens et al., 2011). Its antimicrobial 
activity is due to a number of beneficial attributes; it is water-soluble, active 
across a wide range of pH values and resistant to proteolytic and lipolytic 
enzymes (Schaefer et al., 2010). Originally identified in the 1950s, the first 
patent for its usage as an antimicrobial compound was filed in the 1980s 
(Dobrogosz & Lindgren, 1988). It has been identified to induce oxidative stress 
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within cells, where the aldehyde interacts with thiol groups of small molecules, 
leading to inhibition of bacterial growth (Schaefer et al., 2010). 
An association between the presence of bacterial MCP and polyphosphate 
accumulation was suggested (Iancu et al., 2010) on observation of the fact that 
carboxysomes (carbon-fixing microcompartments) cluster near polyphosphate 
granulations within Halothiobacillus neapolitanus cells. 
The bacterial microcompartment is a unique structural organelle that has been 
identified in 400 genera of bacteria, via genome sequencing (Kerfeld et al., 
2010). Bacterial microcompartments are small proteinaceous structures 
originally observed within bacterial cells in the 1950s (Drews & Niklowitz, 
1956). They possess a distinct polygonal shape, which triggered their 
identification by electron microscopy. Initially observed in the cyanobacterium 
Phormidium uncinatum in 1956 (Drews & Niklowitz, 1956), their distinct 
polygonal shape has been identified in many more bacterial species, primarily 
cyanobacteria including Nostoc punctiforme (Yeates et al., 2010). However since 
the early 1970s, they have been studied in approximately 20% of all bacterial 
genera, including diverse genera such as Klebsiella, Lactobacillus and 
Salmonella (Kerfeld et al., 2010).  
It is known that E. coli, a bacterium which does not normally accumulate 
polyphosphate, can do so if the native polyphosphate kinase enzyme is over 
expressed (Kato et al., 1993), (Keasling et al., 1998).  
During the period of polyphosphate accumulation, orthophosphate is taken up 
from the culture medium. However, as the cell cycle progresses polyphosphate is 
degraded and phosphate returned to the culture medium. Work in the Prentice 
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laboratory has shown that if polyphosphate kinase is targeted to a recombinant 
microcompartment, intracellular polyphosphate can be stabilised in E. coli with 
prolonged retention of phosphate (Liang et al., 2015). One of the aims of the 
thesis was to engineer the same genetic constructs in the GRAS organism L. 
reuteri for potential therapeutic applications of enhanced phosphate retention. In 
addition, due to the aforementioned association between the presence of the 
bacterial MCP and an increased accumulation of polyphosphate in a bacterial 
cell, it was hypothesized that the induction of the native microcompartment 
within L. reuteri could lead to increased polyphosphate formation and hence 
phosphate uptake from an environmental source, versus a lower phosphate 
uptake without microcompartment induction.  
The planned strategy was to create an empty L. reuteri recombinant 
micocompartment from L. reuteri pduABJKNU genes to facilitate expression in 
L. reuteri and compare the phenotype of constructs with microcompartment 
targeted PPK from E. coli and L. reuteri. Because of issues regarding vector 
integrity and difficulties in obtaining an original sequenced vector, the 
integration of a recombinant microcompartment in L. reuteri could not be 
achieved so this chapter reports progress in constructing an empty 
microcompartment from L. reuteri pdu genes and the effects on polyphosphate 
formation and phosphate uptake of native microcompartment induction in L. 
reuteri and overexpression of recombinant PPK1 from L. reuteri and E. coli in E. 
coli. Because the planned in vivo experiment (Chapter III) required lyophilized 
bacteria suspended in water for oral administration of fresh daily suspensions, 
the effect of prior lyophilisation on these phenotypes was assessed. 
Supplementation of sorbitol to cultures before the freeze-drying process has been 
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found to increase storage viability (Carvalho et al., 2003) As the immediate 
substrate for polyphosphate is ATP (Chapter 1b) optimizing energy generation in 
bacterial hosts could also be important and the effect of suspending bacteria in 
isotonic solution containing different carbon sources was assessed.  
Both E. coli and L. reuteri can use gluconate, through the fermentation by the 6-
phosphogluconate/phosphoketolase (6-PG/PK) pathway. Here it is transported by 
an inducible gluconate-PTS, and the resulting 6-phosphogluconate enters the 
pathway (Jenkins, 2005). This is unavailable in mammals therefore gluconate 
was assessed as a potential additive for animal administration (Jones et al., 
2008), (Jenkins, 2005). Sorbitol was also tested in water. 
A previous construct from our collaborators in the University of Kent was also 
used; this construct contained the structural genes associated with the Pdu MCP 
from Citrobacter freundii (Parsons et al., 2008). 
Using shuttle vectors, a number of constructs were made – a recombinant MCP 
from Citrobacter, and Lactobacillus, along with a recombinant ppk enzyme from 
Lactobacillus reuteri. 
In addition, we observed the effect of the p18 targeting sequence on the 
functionality of ppk. The p18 sequence is an 18-amino acid long sequence 
initially identified in the N-terminal of the PduP protein (Fan et al., 2010) 
(Chapter 1b).  
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2.2. Methods & Materials 
In order to observe potential differences in gene expression of ppk in E. coli and 
L. reuteri hosts, a number of different constructs were created to observe 
phosphate uptake both strains. These constructs were made in collaboration with 
Dr. Mingzhi Liang, University College Cork. This work has been accredited 
accordingly throughout the thesis. For the majority of constructs, shuttle vectors 
were used to enable the constructs to be expressed in both E. coli and L. reuteri 
hosts. 
2.2.1. Bacterial strains and culture conditions 
Bacterial strains used in this study are listed in Table 2.1.  
Strain Origin Genotype 
Lactobacillus reuteri 
DSM20016 
National Collection of Dairy 





DPC, Dairy Products Research 
Centre, Moorepark, Fermoy, 
Co. Cork culture collections. 
n/a 
E. coli MG1655 Dr. Mingzhi Liang, University 
College Cork 
F- λ- ilvG- rfb-50 rph-1 
E. coli JM109 Dr. Mingzhi Liang, University 
College Cork 
endA1 glnV44 thi-1 relA1 gyrA96 
recA1 mcrB+ Δ(lac-proAB) e14- 
[F' traD36 
proAB+ lacIq lacZΔM15] 
hsdR17(rK-mK+) 
E. cloni 10G 
Electrocompetent cells 
Lucigen, Wisconsin, USA F- mcrA D(mrr-hsdRMS-mcrBC) 
endA1 recA1 f80dlacZDM15 
DlacX74 araD139 D(ara,leu)7697 
galU galK rpsL (StrR) nupG l- tonA 
E. coli EC1000 J. W. Sanders, Groningen 
University, The Netherlands 
(Cotter et al, 2001) 
 
F– mcrA ∆(mrr-hsdRMS-mcrBC) 
ϕ80dlacZ∆M15 ∆lacX74 recA1 
endA1 araD139 ∆(ara, leu)7697 
galU galK λ– rpsL nupG. repA- 
E. coli BL21 (DE3) Novagen, Merck Biosciences F– ompT gal dcm lon hsdSB(rB- mB-) 
λ(DE3 [lacI lacUV5-T7 gene 1 ind1 
sam7 nin5]) 
 
Table 2.1. Table indicating strains used. 
	  	  	  	  	  	  
	  	  	  	  	  	  
 
90 
Escherichia coli was routinely cultured in Luria-Bertani (LB) broth (Merck, 
Darmstadt, Germany) at 37°C. Lactobacillus reuteri was routinely cultured in de 
Man-Rogosa-Sharpe (MRS) broth (Merck, Darmstadt, Germany) in static 
anaerobic conditions at 37°C. For minimal growth conditions, E. coli was 
cultured in 1X MOPS minimal media (Neidhardt et al., 1974) supplemented with 
K2HPO4 and glucose (Sigma Aldrich), whilst L. reuteri was cultured in Minimal 
Lactobacillus Media (Hebert et al., 2004) which was a formation of essential 
amino acids supplemented with glucose, sodium acetate, K2HPO4 and MgSO4 
(Sigma Aldrich). Breakdown of media composition is indicated below section 
2.2.2.3.  All other chemicals from Sigma Aldrich unless indicated.  
2.2.2. Preparation of lyophilized bacteria 
2.2.2.1. E. coli culture preparation 
Luria Bertani (LB) broth, 50mL, supplemented with antibiotics was inoculated 
with -80°C bacterial stock.  Culture was grown overnight at 37°C shaking, and 
subcultured into 1L LB broth, supplemented with antibiotics. Culture was grown 
until OD 600nm 0.4-0.6. Culture was then spun down by centrifugation using 
Beckman Coulter JA10 rotor, at a speed of 7000xg. Supernatant was removed 
and pellets were washed twice with Ringers buffer solution, to clean the pellet 
and remove excess media residue. Pellets were then inoculated into 1X MOPS 
minimal media (Table 2.6) supplemented with antibiotics and IPTG to induce 
present genes. At OD 600nm 1.0, cells were spun down by centrifugation and 
washed twice again with Ringers solution. These pellets were then frozen for 1 
hour minimum at -80°C and lyophilized for 8-12 hours.  
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2.2.2.2. Lactobacillus culture preparation 
MRS broth, 50mL (Table 3.3) supplemented with antibiotics, was inoculated 
with -80°C bacterial stock.  Culture was grown anaerobically overnight at 37°C 
shaking, and subcultured into 1L MRS broth, supplemented with antibiotics. 
Culture was grown until OD 600nm 0.4-0.6. Culture was spun down by 
centrifugation using Beckman Coulter JA10 rotor, at a speed of 7000xg. 
Supernatant was removed and pellets were washed twice with Ringers buffer 
solution, to clean the pellet and remove excess media residue. Pellets were 
inoculated into Minimal Lactobacillus Media (Table 2.7). At OD 600nm 1.0, 
cells were spun down by centrifugation and washed twice again with Ringers 
solution. These pellets were frozen for 1 hour minimum at -80°C and lyophilized 
for 8-12 hours.  
Post-lyophilisation, the bacterial pellets were kept at 4°C, until use.   
2.2.2.3. Media Composition 
Material Quantity 
Tryptone from casein 10g/L 
Sodium chloride 10g/L 
Granulated Yeast Extract 5g/L 
Deionized Water 1L 
Table 2.2. Recipe for Luria Broth (LB) for the growth of E. coli 
Material Quantity 
MRS broth 55g/L 
Deionized Water 1L 
Table 2.3. Recipe for de Man-Rogosa-Sharpe (MRS) for the growth of lactobacilli 
  
	  	  	  	  	  	  






Granulated Yeast Extract 2g/L 






* Supplemented with 40mM 1,2-propanediol and 200nM B12 to 
induce the pdu microcompartment 




0.01M FeSO4.H20 10mL/L 
1.9M NH4Cl, 50mL/L 
0.276M K2SO4 10mL/L 
0.02M CaCl2-2H2O 0.25mL/L 
2.5M MgCL2 2.1mL/L 
5M NaCl 20mL/L 
Micronutrient stock 0.2mL/L 
Table 2.5 Recipe for 10X MOPS minimal media. 
Material Quantity 
10X MOPS 50mL/L 
Glucose 10g/L 
1M K2HPO4 10mL/L 
Thiamine 5uL/L 
Table 2.6. Recipe for 1X MOPS minimal media. 
  
	  	  	  	  	  	  










L-Aspartic Acid 0.20g/L 
L-Cysteine 0.20g/L 











Nicotinic acid 0.001g/L 






Table 2.7. Recipe for Minimal Lactobacillus Medium (MLM) for the growth of lactobacilli. 
 
Different carbon compounds were assessed for effect on viable counts when used 
in aqueous isotonic solution to re-suspend lyophilized constructs. Phosphate 
uptake from added phosphate was determined to identify which would aid most 
in sustained viability of the lyophilized culture over the necessary extended time 
period. Sorbitol (a sugar alcohol) and sodium gluconate (an organic acid) were 
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the chosen carbon sources, utilized at a concentration of 2% (Zhan et al., 2011), 
(Santivarangkna et al., 2006) and supplemented with 15, 10 or 5mM phosphate. 
1mL samples were then taken at hourly intervals and tested with 
molybdovandate as previously described. 
Compound Concentration of solution Reference 
Sorbitol 
(MW 182.17) 
20g in 1L (2%) Carvalho et al., 2003  
Sodium Gluconate 
(MW 196.16) 
20g in 1L (2%) 
8g in 1L (0.8%) 
Jones et al., 2008 
Table 2.8: Table illustrating the chosen carbon sources. 
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2.2.3. Molecular Methods  
Figure 2.1. Flow chart indicating the cloning process utilized for the development of the 
constructs in this study. 
 
2.2.2.2 Vectors 
As previously mentioned, in order to allow direct expression of the inserted 
genes in both E. coli and Lactobacillus reuteri, a number of shuttle vectors were 
studied (Table 2.9) in particular pNZ44, which is a vector in the well-known 
Transformation into competent       
E. coli cells 
Polymerase Chain Reaction 
Gel extraction and purification 
Ligation of insert and vector 
Digestion with restriction enzymes 
Growth on selective media; pick 
transformants 
DNA Sequencing of inserts 
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pNZ series of lactobacilli vectors (Kok, 1991). pNZ44 was created in University 
College Cork (McGrath et al., 2001) from the backbone of the pNZ8048 vector, 
replacing the inducible nisin promoter with the constitutive p44 promoter from 
Lactococcus lactis (van der Vossen et al., 1987). For E. coli-based cloning, the 
pET23 vector was also used for cloning purposes. For integration, the pORI280 
vector was utilized. 
Vector Size Antibiotic selection Replicon 
Type 
Original reference 
pNZ44 3.394kb Chloroamphenicol 
10mg/mL 
pNZ8048 McGrath et al., 2001 
pET23 3.666kb Ampicillin 100mg/mL pBR322 Studier and Moffatt, 1986 
pORI280 5.263kb Erythromycin 
200mg/mL 
pWV01 Leenhouts et al, 1998 
pEX-A 2.450bp Ampicillin 100mg/mL pUC18 n/a 
Table 2.9. Table indicating vector information. 
 
 
Figure 2.2. Vector map for pnZ44 (credit: Dr. Lorraine Draper, University College Cork) 
	  	  	  	  	  	  




Figure 2.3. Vector map for pET-23a (credit: Novagen, Merck Biosciences) 
 
 
Figure 2.4. Vector map for pORI280 (credit: Dr. Lorraine Draper, University College Cork) 
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2.2.3.2. Primer design & PCR Conditions 
All primers utilized in this study were designed by the author (unless specifically 
indicated otherwise) and produced by MWG Eurofins. Primers mostly adhered to 
a maximum length of 30bp, and a melting temperature of between 57°C and 
70°C, unless specific requirements challenged this. 
PCR reactions were performed using a pre-prepared program as indicated in 
Table 2.11. All reactions utilized the Fermentas Phusion High-Fidelity DNA 
polymerase (#M0530S). Phusion has 5’-3’ polymerase activity and a 3’-5’ 
exonuclease activity, and generates blunt-ended products. The reason for the use 
of a high-fidelity enzyme was to alleviate the frequency of amplification errors 












Table 2.10. PCR program for amplification of E. coli and L. reuteri DSM20016 ppk gene. 
  
Step Temperature Duration 
Denaturation   
1 95.0°C 2 minutes 
2 95.0°C 30 seconds 
Annealing   
3 62°C 30 seconds 
4 72°C 2 minutes 30 seconds** 
Return to Step 2 and repeat cycle 29 
times 
  
Extension   
5 72°C 10 minutes 
Storage   
6 4°C Infinity loop 
**For amplification of L. reuteri ppk, time is extended to 3 minutes 
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Reagent Quantity Final Concentration 
Polymerase Buffer 10µL 5X 
dNTP 2.5 µL 200µM per dNTP 
Primers (MWG) 1  1µM per primer 
Genomic template 1 µL <250ng 
Phusion DNA Polymerase 1 µL 1X 
Deionised water 33.5 µL - 
Table 2.11. PCR reaction mix. 
 
	  	  	  	  	  	  




Table 2.12. Table indicating primers used during this study. All produced by MWG Eurofins. 
Restriction sites shown in bold 




KMC1A (L. reuteri ppk 
Forward) 
5’- GGC CCATGG ATG TAT AAG 
GAG TTT TAT AAG -3’ 
NcoI 2.2kb 
KMC1B (L. reuteri ppk 
Reverse) 
5’-GCC AAGCTT TCA AGA AAG 
TTA GAT CGA CGG-3’ 
HindIII 2.2kb 













5'-TGA CTG GAT CCT AAG TTC 





5'-TGA CTG AAT TCG TTC AAG 





5'-TGA CTA AGC TTG TTC AAG 




5'-GCC GAG CTC GGG CAT GCG 




5'-GCC GCA TGC TAT GTT CGT 
GTA ATT TCA-3' 
SphI 2.6kb 
KMC4C  (SphI.LRppk 
Reverse) 
5'-GCC GCA TGC TTA CTC ATC 




5'-GAT GCA TGC ATG CAA CAA 




5'-GAA GAG CTC TTA TGT CCG 




5’-TG ACT GGA TCC TAA GTT 




5’-TG ACT GAATTC GTT CAA 




5’-TG ACT AAGCTT GTT CAA 









5’-TCA ACT AAC GGG GCA GGT 
TAG TG-3' 
n/a 3.3kb 




5’-A TGC AGA TTA ATG ATA TTG 
AAA GTG CTG TAC GCA AAA TTC 
TTG CCG AAG AAC TA– 3’ 
n/a 110bp 
P18 sequence (E. coli) 
(purchased double 
stranded) 
5’–ATG AAC ACT TCA GAA CTT 
GAA ACC CTT ATT CGT AAC ATT 
TTG AGT GAG CAA CTT GCC-3’ 
n/a 110bp 
	  	  	  	  	  	  






2.2.3.3. DNA Modification Protocols  
Extraction of the whole genomic DNA of both L. reuteri and E. coli was 
achieved using the Wizard Genomic DNA Purification Kit (Promega, Madison, 
USA) with protocol followed as per manual provided for Gram positive/Gram 
negative bacteria. This kit utilizes a series of lytic enzymes, protein precipitation 
and isopropanol to elucidate high quality DNA from the bacterial cell. 1mL of 
overnight (approximately stationary phase) culture was pelleted for extraction. 
Following this procedure, the isolated genomic DNA was stored in the -20ºC 
freezer for future use in PCR. Confirmation of gene size was obtained using gel 
electrophoresis. Sequenced plasmids were extracted and purified using a plasmid 
purification kit (Fermentas GeneJet Plasmid Extraction kit #12703194). This kit 
utilizes lytic enzymes, RNAase and silica-based membranes for centrifugation 
purification. 1mL of culture is pellet for plasmid extraction purposes. Digested 
PCR products were extracted from agarose gels, and purified using using a PCR 
purification kit (Fermentas GeneJet PCR Purification kit #12790091). This 
purification kit utilizes silica-membrane-based purification to remove any traces 
of agarose or other debris from PCR products.  
2.2.3.4. Electrophoresis 
For this study, 0.48g of powdered agarose was added to 60mL of 10x TAE 
buffer to create a 0.8% gel, which offers the best resolution of DNA fragments 
<10kb. This solution was mixed with approximately 1µL of ethidium bromide 
(Sigma Aldrich E1510) and allowed to set in a loading tray. 3-5µL of DNA 
sample was added, with 4µL of marker dye to facilitate loading. A 1kb DNA 
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ladder (N3232S New England Biolabs) was also added to the gel as a standard 
DNA size marker. Samples are run for 20 minutes at 100mV.  
2.2.3.5. PCR 
L. reuteri ppk1 was amplified from L. reuteri genomic DNA using primers 
KMC1A and KMC1B. The E. coli ppk gene was amplified from E. coli MG1655 
by PCR with primers KMC2A and KMC2B (PCR protocol Table 2.12, primers 
Table 2.12).  
Following confirmation of gene size, the ppk gene amplicons and pnZ44 vector 
were digested and single bands excised from agarose. pNZ44 is a Lactobacillus-
E. coli shuttle vector (obtained from Dr. Lorraine Draper, UCC) and uses a 
constitutive p44 promoter and has chloramphenicol resistance (Cm 10mg/mL); 
(Table 2.9). The ppk genes and the pNZ44 vector were digested respectively 
using 1µL NcoI (Fermentas FastDigest #FD0574) and 1µL HindIII (Fermentas 
FastDigest #FD0504), along with 4µL of buffer reagent and 30µL of sample  
Following this purification step, the ppk gene and the pNZ44 vector were ligated 
together, to create a new genetic construct. The ligation reaction was carried out 
in PCR tubes, which are placed in a thermocycler on a specially calibrated 
ligation programme. 4µL of T4 ligase (Invitrogen #15224-017) is added to the 
reaction mixture, along with 10µL of the insert DNA and 5µL of the vector 
DNA.  
The resulting ligate was electroporated in E.cloni 10G electrocompetent cells 
(#60107-1 Lucigen, Wisconsin, USA). After plating on chloramphenicol 
selective agar, colonies were sequenced to confirm presence of L. reuteri ppk-
pNZ44. DNA sequencing was obtained by the Value Read service, MWG-
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Eurofins. This sequencing service utilizes provided primers to confirm the 
presence of genes of interest, along with a BLAST analysis. 
The resulting plasmid was then further transformed into L. reuteri DSM20016 
using a specific protocol provided by Prof. J.P. van Pijkeren (section 2.2.3.9.). 
2.2.3.6. p18 targeting sequence 
To observe the potential effect of the p18 targeting sequence with the E. coli ppk-
pNZ44 and L. reuteri ppk-pNZ44, a new construct was made with suitable 
restriction sites (MWG Eurofins). This double stranded DNA construct, or 
synthetic gene, consisted of an NcoI site, followed by 54 bases encoding the 18 
amino acid sequence of the p18 linker, ending in a PstI site (Figure 3.5) To allow 
ligation with both E. coli ppk and L. reuteri ppk, a BamHI site followed the PstI. 
This allowed observation of the effect of the linker on both the E. coli ppk and 
also the L. reuteri ppk. 
 
Figure 2.5. Plasmid map for the synthetic p18 linker gene, obtained from MWG Eurofins. The 
construct was initially provided on the pEX-A vector. 
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2.2.3.7. Microcompartment genes 
The Citrobacter propanediol microcompartment (Pdu MCP) consists of a 22 kb 
operon, which contains a number of shell genes. These shell genes encode for the 
assembly of the proteins required to form the functional MCP shell.  Previous 
subcloning has shown that the minimal gene set required for empty shell 
assembly is pduA, pduB, pduJ, pduK, pduN and pduU (Parsons et al., 2010). 
 
Figure 2.6. Map indicating the minimal genes required for empty microcompartment synthesis. 
 
Because it was planned to use E. coli and Lactobacillus hosts for operons 
encoding for this minimal shell assembly, two different cloning approaches were 
used to provide recombinant microcompartment operons of Gram positive and 
Gram negative origin suitable for co-expression with targeted PPK. Approach 1 
involved the use of two primers; a forward pduAB primer and a reverse pduU 
primer (Table 2.12) applied to the existing recombinant vector assembled using 
genes of Citrobacter origin (Parsons et al 2010). Approach 2 involved the 
amplifying the individual shell genes from the L. reuteri DSM20016 genome by 
PCR. The individual genes were linked on one after another using the “link and 
lock” multiple cloning strategy (McGoldrick et al., 2005) which was previously 
used by (Parsons et al., 2010) in the cloning of the empty Citrobacter pdu 
microcompartment.  
pduA	   pduB	   pduJ	   pduK	   pduN	   pduU	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Figure 2.7. Plasmid construction using Link and Lock method. N represents NdeI, S represents 
SpeI, X represents XbaI and H represents HindIII. The compatibility of SpeI and XbaI sites, 
which when ligated together do not reform a restriction site, means that these sites can be reused 
in successive rounds of cloning, allowing additional genes to be added on one after another. 
2.2.3.8. Chromosomal Integration 
In order to co-express a targeted ppk gene stably along with the key structural 
genes required for the MCP assembly in the murine strain L. reuteri 100-23, 
chromosomal integration was attempted. In the first instance the chromosomal 
integration of the structural genes pduABJKNU was attempted with the ppk gene 
remaining on a plasmid. 
A method for the chromosomal integration of Lactobacilli had been previously 
established using the temperature sensitive pVE6007 and the pORI280 vector to 
induce chromosomal integration (Russell & Klaenhammer, 2001). Internal 
fragments of the target genes were amplified by PCR, using specific primers 
(Table 2.12) and inserted into pORI28 (an Emr repA-negative derivative of 
pWV01) by directional cloning using E. coli EC1000 (which contains a copy of 
the pVW01 repA gene in the chromosome) as the host.  The next step would be 
the purification of the plasmids and electroporation into L. reuteri 100-23, 
containing the temperature sensitive pVE6007 (a Cmr repA-positive derivative of 
pWV01), with 35°C being the optimal temperature for phenotypic expression. 
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Lactobacilli carrying both plasmids are propagated overnight at 35°C in the 
presence of erythromycin and chloramphenicol. Through selection on 
erythromycin plates and an increased temperature of 44°C, transformants are 
recovered and propagated successively in MRS minus antibiotic for 90 
generations to assess stability of integration. 
For constructs, the p44 constitutive promoter was also required, to allow 
constitutive expression of the MCP structural genes on integration.  
2.2.3.9. Lactobacillus transformation 
A protocol for the transformation of L. reuteri was kindly provided by Prof. J.P. 
van Pijkeren, of Michigan State University. 
Day 1 :  
5mL MRS was initially prepared in a 15mL tube, and inoculated with L. reuteri 
DSM 20016 from glycerol stocks. Inoculate was grown statically and 
anaerobically for 16-24hrs at 37°C until stationary phase. 
Day 2 : 
After overnight growth and stationary phase has been reached, the culture must 
be accurately sub-cultured to an OD 600 of 0.1. This can be approximately 
calculated via the following e.g. if OD 600 of o/n culture is 1.25 then (4.57/0.1)= 
45.7. For a total volume of 40mL MRS, you need to add (40/45.7) = 0.875mL 
inoculation. This volume must then be once again verified by spectrophotometer 
readings. 
After 1.15 hours, OD 600 was measured again. Once an OD 600 of between 0.55 
and 0.65 (early exponential phase) was reached, cells must be cooled 
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immediately for 5 minutes. Once cooled, cells can be centrifuged in a precooled 
centrifuge for 5mins at 5000rpm. It is essential to keep the cells on ice at all 
times. 
Supernatant was removed and cells gently resuspended in 20mL ice-cold buffer 
(0.5M sucrose/10%v/v glycerol). Once resuspended, an additional 20mL buffer 
was added to reset the volume back to 40mL. Tubes and buffer were again 
maintained on ice and centrifugation repeated as above. 
Again, supernatant was removed, and cells resuspended in 20mL buffer before a 
final centrifugation. 
After final centrifugation, supernatant was carefully removed and adequate 
buffer added in order to set a total volume 1/50 of initial culture volume e.g. 
40mL/50=0.8mL. Cells were resuspended gently, and aliquoted out in 100ul 
volumes. 
For transformation, approx. 1ug plasmid DNA was added to one aliquot of cells. 
Cells were electroporated at 2500V, 25uF, 400Ω with anticipated time constants 
at approx. 8-10msec. Immediately after electroporation, 1mL MRS (room temp) 
was added to cells, which were then allowed to recover statically and 
anaerobically for 2.5hours at 37° C. After recovery, 100ul undiluted culture was 
plated on antibiotic selective MRS in an anaerobic jar for approx. 24-48hours. 
2.2.4. Expression & Phenotype of constructs 
2.2.2.3. Neisser stain protocol  
Neisser stain is a staining process which highlights intracellular polyphosphate 
granulations under a bright-field microscope (Machnicka, 2005). The stain 
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protocol involves three distinct stains, used in a particular order. Neisser Stain A 
consists of 0.1g methylene blue, 5mL glacial acetic acid and 5mL 96% ethanol to 
100mL dH2O. Neisser Stain B consists of 3.3mL of 10% crystal violet 
(suspended in 96% ethanol) and 6.7mL 96% ethanol to 100mL dH2O. Neisser 
Stain C consists of 33.3mL 1% aqueous chrysodin Y to 100mL dH2O. 
The actual stain protocol is based upon using the aforementioned stains to stain 
and counterstain polyphosphate. Initially fix a 10µL volume of the culture on a 
glass slide. Prepare a solution of 2 parts stain A with 1 part stain B. Apply this 
solution to the glass slide for 10-15 seconds. Rinse and dry. Apply stain C for 45 
seconds, rinse and dry. Allow the slide to dry, and view under 100x bright field 
microscopy. If there is polyphosphate present in the culture, purple 
accumulations will be observable within the bacterial cells. 
2.2.5 Polyphosphate observations in native lactobacilli 
Through the process of observing phosphate uptake and polyphosphate retention 
in L. reuteri, it was also possible to observe these processes in other wild-type 
lactobacilli, such as Lactobacillus delbrueckii subspecies bulgaricus 
ATCC11842. This was achieved using Neisser stain. In particular, for the 
observation of wild-type L. reuteri, samples were obtained from both pdu-
induced and un-induced cultures. Induced cultures were grown over a period of 2 
days in MRS, with 1,2-propanediol and vitamin B12 (cyanocobalamin) 
supplemented during growth (Table 3.5) to induce the presence of the Pdu 
microcompartment as described (Sriramulu et al., 2008). Un-induced cultures 
were grown exclusively in MRS without supplementation.  
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2.2.6. Phosphate Assay Test and Conditions 
2.2.6.1. Assay Design 
In order to identify and quantify the ability of the recombinant constructs to 
remove and uptake extracellular phosphate, it was necessary to establish a series 
of phosphate assays. The purpose of the phosphate assay was to establish i) the 
ability of the constructs to uptake extracellular phosphate and ii) to identify the 
factors that may enhance or retard the ability of the constructs to uptake 
phosphate. 
2.2.6.2. Assay Preparation 
As mentioned, assays were performed with washed cells in Ringers solution 
supplemented with a defined amount of K2HPO4. This was necessary because of 
the difficulty of measuring phosphate levels in rich media. Strains were grown 
initially in either defined media (Luria Bertani Broth for E. coli, MRS for L. 
reuteri) or minimal media (Supplemented MOPS media for E. coli, Minimal 
Lactobacillus media for L. reuteri). Minimal media was used for initial growth 
where possible to restrict the amount of phosphate provided to the culture pre-
assay. 
In order to grow the cells to stationary phase, 15mL defined/minimal media, 
supplemented with relevant antibiotics, was inoculated with the construct of 
interest and incubated overnight at 37°C. The overnight culture was subcultured 
in a volume of 500mL defined/minimal media and antibiotics, which was grown 
to an OD 600nm of 0.4. This would typically take 4-5 hours to occur, and would 
result in the cells being in early exponential stage. Cells were then pelleted by 
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ultracentrifugation using the J10 rotor at 7,000G for 5 minutes (Beckman 
Coulter).  
The pellet was washed twice with Ringers solution to remove excess media 
residue, which may affect the phosphate uptake. Following this washing step, the 
pellet was resuspended and inoculated into 100mL Ringers solution 
supplemented with K2HPO4. Samples were then obtained every hour for the 
initial 6-hour duration for testing. 
2.2.6.3. Phosphate Analysis of Samples 
2.2.6.2.2. Orthophosphate 
Orthophosphate content of the supernatant was determined by pelleting 1mL of 
culture, removing the supernatant and testing with molybdovanadate (#2076032, 
Hach, Colorado, USA) using a spectrophotometer at OD 430nm. 
Molybdovanadate is a reagent that binds to orthophosphate in solution, with the 
degree of yellow color formation quantitative to the amount of phosphate present 
(Fiske & Subbarow, 1925). Results were then plotted against a KH2PO4 standard 
curve.  
2.2.6.3.2. Polyphosphate 
Intracellular polyphosphate of the bacteria was tested by pelleting 4mL culture, 
where the pellet was then frozen for 24 hours at -80°C to induce softening and 
lysis of the cell membrane. Measurements of intracellular polyP were measured 
using the DAPI (4',6-Diamidino-2-phenylindole) fluorescence method 
established by the McGrath lab (Kulakova et al., 2011). Samples were obtained 
hourly along side phosphate measurements, and were frozen at -80°C for 
minimum 24 hours. DAPI measurements were done by Dr. Mingzhi Liang. 
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 Briefly, cells were harvested by centrifuging at 5000g for 10 min at 4° C. After 
washing in 50mM HEPES buffer (pH7.5) the cell pellet or microcompartment 
fraction was frozen at -80° C followed by defrosting at room temperature. Cell 
pellets/microcompartment fractions were resuspended in HEPES buffer at an 
appropriate dilution to ensure that the cellular polyP concentration was in the 
linear range of the DAPI assay (0-6 mg polyP/mL). Total assay volume was 
300µL which included 100 µL of polyP containing samples and 200 µL of DAPI 
assay buffer containing 150 mM KCl, 20 mM HEPES-KOH (pH 7.0) and 10 µM 
DAPI solution. After a 10 min incubation at room temperature DAPI 
fluorescence was measured with a platereader equipped with excitation and 
emission filters of 420 nm and 550 nm respectively. A polyphosphate standard 
curve was prepared using sodium phosphate glass Type 45 (S4379 Aldrich) and 
sodium hexametaphosphate (SX0583). Protein content of the bacterial culture 
was tested via Bradford assay (Bradford, 1976). 
2.2.7. Graphs 
All graphs were prepared using Microsoft Excel. Where present, error bars 
indicate standard deviations calculated from the use of three biological replicates. 
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2.3. Results & Discussion 
2.3.1. Molecular results 
Name Inserts Final size 
pKMC001 E. coli ppk+pNZ44 5.3.kb 
pKMC002 L. reuteri ppk + pNZ44 5.5kb 
pKMC003 E. coli p18+ppk + pNZ44 5.3kb 
pKMC004 L. reuteri p18+ppk + pNZ44 5.5kb 
pKMC005 E. coli p18 + pNZ44 3.3kb 
pKMC006 L. reuteri p18 + pNZ44 3.3kb 
pKMC007 L. reuteri pduABJKNU + pNZ44 6.0kb 
pKMC008 P44+xylA + pORI280 6.5kb 
pKMC009 L. reuteri pduAB + pet23 4.6kb 
pKMC010 L. reuteri pduABJ + pet23 4.9kb 
pKMC011 L. reuteri pduABJK + pet23 5.5kb 
pKMC012 L. reuteri pduABJKN + pet23 5.9kb 
pKMC013 L. reuteri pduABJKNU + pet23 6.3kb 
Table 2.13. Table indicating plasmids created during this study. 
 
The ppk1 gene was amplified from E. coli MG1655, by PCR, using primers 
KMC2A and KMC2B containing the restriction sites NcoI and HindIII (MWG 
Eurofins). The amplicon was the predicted size of approx. 2kb (Fig. 2.8) and 










Figure 2.8. Gel electrophoresis image indicating E. coli ppk amplicon in Lane 2&3. Lane 1 
indicates an unrelated PCR product. The brightest MW in the ladder indicates the 3kb mark. 
 
 
The ppk gene was amplified from the obtained L. reuteri DSM 20016 genomic 
DNA PCR with primers KMC1A and KMC1B (Table 2.12) containing the 
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restriction sites NcoI and HindIII.. The amplicon was the predicted size of 







Figure 2.9. Gel electrophoresis image indicating ppk amplicon (L. reuteri) in Lane 1 & 2. The 









The p18 sequence was designed and produced as a synthetic gene (MWG 
Eurofins), (Figure 2.5). It was flanked by additional restriction sites, which 
allowed ligation in multiple vectors for multiple fusions.  
On excision from the provided pEXa vector, the gene of interest was approx. 
100bp. Due to the small size of the L. reuteri p18 gene construct, gel 
visualization was difficult and therefore frequent sequencing was necessary to 
ensure its continued presence.  
 
Figure 2.10. Gel image indicating empty vectors pNZ8048 (Lane 1) and 
pnZ44 (Lane 2) digested with NcoI. The brightest MW in the ladder 
 1                   2                   3                      4      Ladder 


















	  	  	  	  	  	  












Figure 2.11. Gel image illustrating plasmid pKMC005 pnZ44 (3kb) containing the E. coli p18 
linker (100bp) in lane 3 & 4 after restriction digestion (arrow indicated). Lane 1 & 2 illustrate 
the pnZ44 vector without the linker. 
 
To produce an empty MCP, the minimum genes required for MCP expression 
were amplified and transformed into one vector. PduAB was amplified from the 
L. reuteri genome and ligated into the pET23 vector. It was excised from the 
vector via NdeI, which allowed inclusion of the ribosome binding site region of 
pET34, and a HindIII site. pduJ was then fused onto the pduAB gene via 
SpeI/XbalI, which have compatible ends, and HindIII, creating pduABJ-pET23 
(pKMC010).  
The compatibility of SpeI and XbaI sites, which when ligated together do not 
reform a restriction site, means that these sites can be reused in successive 
rounds of cloning, allowing additional genes to be added on one after another 
(Figure 2.7 for further information), (plasmids pKMC010-013). This resulted in 
the creation of pduABJK-pET23 (pKMC011), pduABJKN-pET23 (pKMC012) 
and pduABJNU-pET23(pKMC013).  
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Once DNA sequencing confirmed the presence of the insert of interest, it was 
excised from pET23 and transformed into pNZ44, to allow dual expression in E. 










Figure 2.12. Gel image illustrating L. reuteri pduAB pet23 (pKMC009) (Lane 1) and pduABJ pet 
23 (pKMC010) after restriction digest.  These genes were individually added on in pet23 before 










Figure 2.13. Gel image illustrating L. reuteri pduABJKNUpNZ44 (pKMC007) (Lane 2) after 
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Figure 2.14. Sequencing read out indicating the presence of L. reuteri pduABJKNU in pET23 
(pKMC013). This highlighted sequence is the beginning of the pduA sequence.  
Regarding the use of the integration vector, a method for the chromosomal 
integration of Lactobacilli had been previously established using the temperature 
sensitive pVE6007 to induce chromosomal integration (Russell & Klaenhammer, 
2001).  The xylose isomerase gene (xylA) was chosen as the candidate gene to be 
knocked out, allowing our genes of interest to be integrated in its place. This 
gene was selected due to previous literature (Walter et al., 2005) identifying this 
gene as nonessential to successful colonization of the murine gut by L. reuteri 
100-23. Using primers presented in the Walter study (Table 2.12), the xylA gene 
was amplified from the L. reuteri 100-23 genome using primers KMC3A and 
KMC3B (Table 2.12,) containing the restriction sites BamHI and EcoRI. The 
gene was then ligated into the pNZ44 vector and transformed into Ecloni E. coli 






Figure 2.15. Gel image illustrating empty vector pORI280, a band of approximately 5.3kb, in 
both lane 1 and 2. Band was digested once with BamHI. 














	  	  	  	  	  	  












Figure 2.16. Gel image illustrating xylA amplicon, a band of approximately 1.3kb, in lane 1. 
Band was amplified using primers KMC008. 
 
The p44-xylA construct was ligated into the suicide vector pORI280 (EmR rep-A 
negative derivative of pWV01) using E. coli EC1000 cells (which contain a copy 
of the pVW01 repA gene). However after successive unsuccessful attempts to 
obtain a clone with the insert, this protocol was abandoned. The pORI280 vector 
in our possession did not appear to match the vector map as digestion with the 
SphI restriction sites consistently resulted in an additional cut, indicating the 
presence of a second Sph site in the vector. At this point in the study, difficulties 
in obtaining an original sequenced pORI280 vector, which would facilitate the 
use of the required restriction sites, prevented further use of the integration 
technique and full integration was not achieved. 
2.3.2. Neisser stain imaging 
In order to observe polyphosphate accumulation and retention in the bacterial 
strains (wild-type and recombinant), samples of culture were obtained at various 
time points during growth for optimal observation and treated with Neisser stain. 
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2.3.2.1. Wild-type Lactobacillus strain imaging 
A recent study (Alcantara et al., 2014) noted polyP accumulation in a number of 
different lactobacilli. Lactobacillus delbrueckii subspecies bulgaricus 
ATCC11842 is a milk-adapted lactobacillus, particularly associated with dairy 
and yogurt production, whilst L. reuteri is a commensal bacterium typically 
associated with the mammalian gut. 
 
Figure 2.17: Image of L. delbrueckii subspecies bulgaricus ATCC11842, grown in 
unsupplemented MRS and stained with Neisser stain. Purple granulations indicate the presence 
of polyphosphate in the cell. Image taken after 8 hours of growth in MRS. 
 
 
Large quantities of polyP accumulations can be observed within the bacterial 
cells in image 2.17. The observation of an elongated cell shape is also a 
distinctive feature associated with intracellular polyP accumulation, and 
previously observed by (Alcantara et al., 2013). 
	  	  	  	  	  	  




Figure 2.18: Image of L. reuteri DSM20016  (grown in unsupplemented MRS) stained with 
Neisser stain. Image taken after 8 hours growth in MRS 
 
Figure 2.19: Image of L. reuteri DSM20016  (grown in MRS supplemented with 1,2-propanediol 
and B12) stained with Neisser stain. Image taken after 8 hours of growth. 
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Figure 2.20: Image of L. reuteri DSM20016  (grown in MRS supplemented with 1,2-propanediol 










Figure 2.21: Image of L. reuteri DSM20016  (grown in MRS supplemented with 1,2-propanediol 
and B12) stained with Neisser stain. Image taken after 30 hours of growth. 
  
 
In particular, in L. reuteri DSM20016, I observed a correlation between the 
induction of the wild-type Pdu microcompartment via the supplementation of 
1,2-propanediol and B12, and polyP formation detected by Neisser staining. This 
can be observed in the difference between Figures 2.18 and 2.19, 2.20. This 
accumulation of polyphosphate can be observed to reverse over time, decreasing 
after approximately 30 hours (Figure 2.21). 
2.3.2.2. Recombinant strain imaging 
 
 
	  	  	  	  	  	  




Figure 2.22. E. coli ppk-pNZ44 (pKMC001) expressed in L. reuteri DSM20016. Cultured in MRS 
with chloramphenicol. After 9 hours of growth, purple granulations within bacterial cell indicate 




Figure 2.23. E. coli ppk-pNZ44 (pKMC001) expressed in L. reuteri DSM20016. Cultured in MRS 
with chloramphenicol. After 15 hours of growth, purple granulations within bacterial cell 
indicate presence of polyphosphate granulation. 
 
	  	  	  	  	  	  




.Figure 2.24. E. coli ppk-pNZ44 (pKMC001) expressed in L. reuteri DSM20016. Cultured in 
MRS with chloramphenicol. After 30 hours of growth, polyphosphate granulations have 
decreased. 
 
As observed in the wild-type L. reuteri, dynamic fluctuation of intracellular 
polyP can be seen with expression of the recombinant E. coli ppk in L. reuteri 
during different periods of growth (Figure 2.22-2.24). However, the effect of 
recombinant L. reuteri ppk expression in L. reuteri is much less marked (Fig 
2.25).  
 
Figure 2.25. L. reuteri ppk-pNZ44 (pKMC002) expressed in L. reuteri DSM20016 cultured in 
MRS with chloramphenicol for 9 hours. Purple spots within bacterial cell indicate presence of 
polyphosphate granulation.  
	  	  	  	  	  	  




Polyphosphate levels measured by DAPI fluorescence showed accumulation 
followed by loss by the L. reuteri strain expressing E. coli ppk (Figure 2.26).  
 
 
Figure 2.26. Whole cell polyP assay wildtype L. reuteri 20016 and L. reuteri 20016 expressing 
the recombinant E. coli ppk gene (pKMC001), grown in MRS. Error bars represent standard 
deviation of three independent observations 
 
Therefore, Neisser stain microscopy and both quantitative polyphosphate assays 
show the expression of the recombinant E. coli ppk gene in L. reuteri DSM20016 
leads to a faster and increased accumulation of polyP in the cell compared with 
the wild-type strain, however retention time is ultimately not extended beyond 
that of the wild-type.  
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2.3.3. Phosphate Assays  
2.3.2.2. Phosphate uptake assays; live cultures 
All live cultures were grown in MRS, with resuspension in Ringer’s solution. 
 
Figure 2.27. Phosphate levels in supernatant in Ringers solution supplemented with K2HPO4, 
over 18 hour time period. Legend indicates the following constructs : WT wild-type cell ECppk 
(E. coli ppk pNZ44, pKMC001);  LRppk (L. reuteri ppk pNZ44, pKMC002),  p18LRppk (p18 
targeting sequence plus L. reuteri ppk pNZ44, pKMC004). All constructs expressed in L. reuteri 
DSM 20016. 0.9g of wet bacteria was added to 100mL solution (per group). 
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Figure 2.28 . Graph illustrating phosphate uptake in Ringers solution supplemented with 
K2HPO4, over 17 hour time period. Legend indicates the following constructs i) wild-type cell ii) 
cell containing E. coli ppk (pKMC001) iii) cell containing L. reuteri ppk (pKMC002) and iv) cell 
containing the p18 targeting sequence plus L. reuteri ppk (pKMC004). All constructs expressed 
in L. reuteri DSM 20016. 1.0g of wet bacteria was added to 100mL solution (per group). 
 
An initial difficulty of measuring phosphate uptake by live cultures was 
establishing a uniform phosphate starting value i.e. a uniform phosphate 
concentration in culture from time zero. These difficulties had been observed 
when strains were grown and tested in rich media e.g. MRS, therefore to 
alleviate these difficulties, strains were pre-grown for a brief period in MRS to 
develop initial growth and then assayed in Ringers solution containing an exact 
amount of phosphate.  
2.3.3.2. Phosphate assays; freeze-dried cultures 
These assays were performed using freeze-dried bacterial cultures containing the 
recombinant cultures and a wild-type negative control. Original culture for the L. 
reuteri was in MLM media and E. coli in MOPS Media. These were chosen to 
alleviate the difficulties in using phosphate rich MRS/LB media. The freeze-
dried cultures were resuspended in isotonic sorbitol, glucose or gluconate to 
observe the optimal carbon source for viability after resuspension. These carbon 
sources were chosen based on previous literature, where the viability of freeze-
dried Lactobacillus cultures was extended over a long-term period through the 
usage of these compounds (Carvalho et al., 2004). The selected carbon source 
was then supplemented with K2HPO4 as a phosphate source to assess phosphate 
uptake properties. Host strains, E. coli and L. reuteri were used for freeze-dried 
assays as both strains were considered for in vivo studies. Supernatant phosphate 
and cellular polyphosphate was measured over 6 hours (a period corresponding 
to the likely duration of orally dosed bacterial presence in the upper 
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gastrointestinal tract). Higher levels of phosphate than in the first experiments 
were employed, reflecting post-prandial intestinal levels (Moroz et al., 2011) 
 
Figure 2.29. Graph illustrating phosphate uptake over 5 hour time period in aqueous 2% 
sorbitol plus 5mM K2HPO4. Legend indicates the following constructs i) wild-type cell ii) cell 
containing E. coli ppk (pKMC001) iii) cell containing L. reuteri ppk (pKMC002) and iv) cell 
containing the p18 targeting sequence plus L. reuteri ppk (pKMC004). All constructs expressed 
in freeze-dried L. reuteri DSM 20016. 0.0.21g of bacteria was added to 100mL solution (per 
group). 
 
	  	  	  	  	  	  





Figure 2.30A&B. A) phosphate uptake over 5 hour time period in 0.8% gluconate plus 15mM 
K2HPO4 and B) intracellular polyphosphate. Legend indicates the following constructs i) wild-
type cell ii) cell containing E. coli ppk (pKMC001) iii) cell containing L. reuteri ppk (pKMC002) 
and iv) cell containing the p18 targeting sequence plus L. reuteri ppk (pKMC004). All constructs 
expressed in freeze-dried L. reuteri DSM 20016. 0.018g of bacteria was added to 100mL solution 
(per group). 
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Figure 2.31A&B. Graph illustrating A) phosphate uptake over 5 hour time period in 2% 
gluconate plus 15mM K2HPO4 and B) intracellular polyphosphate. Legend indicates the 
following constructs i) wild-type cell ii) cell containing E. coli ppk with pduABJKNU and the 
empty recombinant microcompartment and iii) cell containing the E. coli ppk. All constructs 
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Literature had suggested that the supplementation of sorbitol to cultures before 
the freeze-drying process would lead to increase storage viability (Carvalho et 
al., 2003). However based upon our study experience, the addition of sorbitol to 
our cultures disrupted the freeze-drying process and led to sticky, coagulated 
cultures. As an alternative, sorbitol was added to an aqueous solution and 
examined for viability post-freeze-drying. Observations of the use of sorbitol 
with the freeze-dried culture displayed a consistent growth spurt of the cultures, 
leading to cell death after approx. 6-8 hours (Figure 4.23). These observations 
ultimately led to sorbitol being discontinued as a supplement, as the cultures 
were required to be viable and sustainable for a longer time period. 
 
Figure 2.32. Growth curve of lyophilized cultures resuspended in water with 2% sorbitol. 
 
In contrast, at concentrations of 0.8% and 2%, gluconate provided positive, 
stable conditions for good phosphate uptake and sustained growth of the freeze-
dried cultures (Figure 2.29). For this reason, gluconate was selected as the most 
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suitable supplement, as cell viability and phosphate uptake indicated to be at 
stable levels based on assay results. 
 




No obvious trend for phosphate uptake was seen over time for lyophilized L. 
reuteri WT and clones resuspended in sorbitol solution (Figure 2.29). The same 
clones resuspended in gluconate solution showed a trend for phosphate uptake 
and polyphosphate accumulation by L. reuteri expressing E. coli ppk (Figure 
2.30). A control experiment with freeze dried E. coli BL21 expressing 
recombinant E. coli ppk and E. coli expressing recombinant E. coli 
microcompartment targeted ppk and an empty microcompartment showed that 
both clones took up phosphate and accumulated polyphosphate (Figure 2.32) . 
This would be the predicted phenotype of these clones from longer-term culture 
experiments (Liang et al., 2015). 
 
	  	  	  	  	  	  




The observation that Lactobacillus species differ in their propensity to 
accumulate visible polyphosphate granules (Fig 4.8, 4.9) is in agreement with a 
recent publication (Alcantara et al., 2013). Polyphosphate granulation has 
however not previously been reported in the dairy strain L. delbrueckii 
subspecies bulgaricus ATCC11842. This phenotype is reportedly correlated with 
possession of a ppk gene and could contribute to stress resistance because ppk 
knockout simultaneously abolishes this phenotype and decreases stress resistance 
(Alcantara et al., 2013). However the author found L. reuteri DSM20016, which 
contains a ppk gene, was phenotypically granule-free unless the pdu operon was 
induced (Fig 4.9-11). This connection between microcompartment induction and 
polyphosphate production in L. reuteri 20016 is novel and intriguing and could 
result from co-regulation or relate to stress from the production of the 
microcompartment itself or aldehyde leaks during propanediol metabolism. 
Further experiments (RNA-Seq, aldehyde challenge) would be required to 
investigate this. Investigation into the L. reuteri 100-23 pdu-negative strain 
would also provide potential analysis. 
As stated, the objective of this study was to manipulate phosphate uptake and 
polyP accumulation in L. reuteri DSM20016 and E. coli. By using recombinant 
ppk genes, I anticipated an increase in polyphosphate storage and phosphate 
uptake, and by introducing the empty structural microcompartment with 
microcompartment-targeted PPK, I anticipated stabilization in phosphate uptake 
and intracellular polyP accumulation vs. the wild-type strain and the strain with 
recombinant ppk alone. 
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Initial observations regarding expression of the recombinant E. coli ppk in L. 
reuteri indicated that the heterologous enzyme was functional. Increased 
phosphate uptake and polyphosphate accumulation compared to the wild-type 
was observed over a 3 to 15 hour time period (Figure 2.33, 4,17). Function of E. 
coli ppk in an L. reuteri host background has not to the author’s knowledge been 
reported before.  
Interestingly, over expression of the L. reuteri ppk in the L. reuteri host produced 
a much less marked phenotype (Figure 2.36, 2.37. 2.38), suggesting a 
discrepancy between the efficacies of recombinant E. coli and L. reuteri ppk 
when expressed in L. reuteri. This discrepancy was identifiable across phosphate 
uptake assays, and also in microscopy imaging of samples. The reason for this 
variation in efficacy when expressed in the same host (L. reuteri) is unclear and 
would require further investigation to confirm gene expression and translation of 
both PPK enzymes. However, the initial hypothesis that polyphosphate content 
and phosphate uptake can be modified in L. reuteri through the application of a 
recombinant ppk gene seems justified. 
Ultimately combining the microcompartment targeted PPK and the MCP 
together, with a view to expression in L. reuteri, was an aim of this project. The 
ppk gene from both L. reuteri and E. coli was cloned and expressed in both host 
strains respectively, allowing observation of the action of a recombinant PPK 
within these strains, whilst in parallel the MCP genes pduABJKNU of L. reuteri, 
the minimum necessary to form an empty microcompartment, were cloned in 
shuttle vector pNZ44.  
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The hypothesis regarding PolyP stabilization could however not be fully 
observed in L. reuteri due to cloning difficulties preventing successful 
integration of the pdu microcompartment and ppk gene. These difficulties arose 
from the selection of the integration vector, which did not allow integration of 
the empty pdu microcompartment into the L. reuteri genome due to 
discrepancies in restriction site availability of the vector in possession versus that 
of the original vector map. 
The instability of polyphosphate resulting from expression of PPK alone in E. 
coli was reproduced in L. reuteri in this study (Figure 2.37). However, previous 
studies, confirmed in this thesis (Figure 4.22) have shown positive increases in 
phosphate uptake and accumulation of polyphosphate in the short term by both 
ppk expression and targeted PPK and empty MCP expression in E. coli . For 
future investigations, it would be of interest to pursue successfully the 
establishment of a L. reuteri ppk-MCP expressed in L. reuteri, and also to 
investigate the interaction between the E. coli ppk-L. reuteri pdu MCP to see if 
the initial observations from this study regarding ppk discrepancy would 
continue to be applicable. 
Following demonstration of enhancement of phosphate uptake by the 
recombinant PPK in L. reuteri, a decision was made to explore the efficacy of 
the constructs in an in vivo murine study, where the constructs could be tested in 
an animal model with chronic renal failure and hyperphosphatemia (elevated 
blood phosphate). This study can be read in detail in Chapter III.  
In order for these strains to be delivered daily in water to an animal model, 
cultures were required to be lyophilized. As such, it was necessary to evaluate 
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how this process may potentially affect the efficacy and viability of these 
recombinant strains. Evaluation of lyophilized cultures (Figure 4.21, 4.22) 
identified that the recombinant strains still displayed highly dynamic shifts in 
phosphate uptake efficacy, with the recombinant E. coli ppk again indicating to 
be more effective versus the L. reuteri ppk, when expressed in the L. reuteri host. 
Culture viability and sustainability was identified to be influenced by the sugar 
source provided post-lyophilisation, with gluconate providing the most stable 
revitalizing environment for our strains. Estimates of short term orthophosphate 
in vitro uptake by lyophilized E. coli expressing E. coli PPK directed to an empty 
microcompartment and lyophilized L. reuteri expressing E. coli PPK were of 
potentially therapeutic levels for the rat model (Chapter III). This depended on 
carbon source and required resuspension in gluconate solution rather than 
sorbitol. It is known that sorbitol fermentation results in much higher 
cytoplasmic levels of NADH in E. coli than gluconate fermentation (and this 
may have global regulatory effects. Lyophilised bacteria would be more practical 
to administer on a daily basis.  
On searching through previous literature, it was difficult to obtain information 
regarding typical polyP accumulation levels in Lactobacillus, therefore this 
meant a lack of comparison with my findings. Regarding E. coli, previous studies 
have indicated polyP accumulation levels of approximately 48nmol/mg (Rao et 
al., 1998), which is higher than we observed. However my examinations 
involved the cultures uptaking phosphate in a defined restrictive environment 
(K2HPO4 and gluconate), which may offer an explanation for my observed lower 
levels. No previous literature could be identified which compared intracellular 
polyP levels between E. coli and Lactobacillus species.  
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Ultimately this study delivered novel observations regarding the role of ppk and 
the microcompartment in phosphate metabolism in L. reuteri DSM 20016, and 
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The usage of bacteria or probiotics to treat clinical illness is not a new avenue in 
medicine (Li et al., 2014; Medina et al., 2010). In recent years there has been an 
increase in the application of probiotics as delivery vehicles for clinical purposes 
(Reid, 2008; Solanki et al, 2013). Utilisation of probiotics in this fashion could 
enable reduction in the required dose of conventional therapeutics, which could 
be of benefit to patients. (Tomasello, 2008). 
The bacterial microcompartment (MCP) has displayed efficacy in providing an 
enclosed space for chemical or enzymatic retention e.g. the role of the Pdu 
microcompartment in the reactive process of 1,2-propanediol metabolism. This 
principle of action, with an associated enzyme targeting system formed the basis 
for a strategy concerning its use as a novel biological phosphorus removal 
system utilizing recombinant polyphosphate kinase and empty recombinant 
microcompartments. 
Previous observations (Chapter II) indicated increased phosphate uptake and 
polyphosphate retention by E. coli over expressing E. coli microcompartment-
targeted ppk and a recombinant empty microcompartment, and to a lesser extent 
by E. coli over-expressing E.coli ppk alone, and L. reuteri expressing E.coli ppk 
alone. The purpose of this study was, firstly, to devise a method to deliver doses 
of viable recombinant bacteria to the gastrointestinal tract of an experimental 
animal, sufficient to take up at least half of the phosphate which would normally 
be absorbed. Secondly the efficacy of these delivered constructs in alleviating 
hyperphosphataemia in a rat model of chronic renal failure (CRF) and 
hyperphosphataemia (elevated blood phosphate) was tested. Oral phosphate 
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absorbing compounds have shown efficacy in such models. Over this period, the 
experimental groups received a bacterial supplement, which contained the 
experimental constructs.  
Two bacterial strains were used for this study; Lactobacillus reuteri DSM 20016 
and E. coli MG1655, based on Chapter II observations.  
Gluconate water was demonstrated to be a suitable re-vitalization agent for 
lyophilized E. coli and L. reuteri, which both demonstrated the same levels of 
phosphate-uptake efficacy post-lyophilisation as they had done pre-lyophilsation.  
The strains were also successfully delivered to the animal models through the 
supplementation of gluconate water, and were also recoverable from faeces and 
intestinal contents. However, confounding factors regarding the baseline blood 
mineral content of the trial groups led to difficulties in attributing a direct linkage 
between the bacterial intervention and changes in blood calcium and phosphate, 
and tissue calcium and phosphate levels.  
  
	  	  	  	  	  	  




Hyperphosphataemia is an accumulation of excess levels of the mineral 
phosphate within the body, and is typically associated with end-stage renal 
disease (ESRD) (See Chapter 1A). Progressive deterioration of kidney function 
leads to an inability of the kidneys to excrete phosphate, which in turn can lead 
to consequential symptoms such as secondary hyperparathyroidism, renal bone 
disease, and vascular calcification (Guo et al, 2013). Typical management of 
hyperphosphataemia involves dietary intervention and increased medication, 
which can lead to a decrease in quality of patient life (Albaaj & Hutchison, 
2003). 
As discussed in Chapter 1A, mammalian phosphate absorption from the diet 
occurs primarily in the small intestine. Medical interventions in 
hyperphosphataemia include dietary limitation of phosphate and a variety of 
different phosphate absorbing materials taken by mouth. Renal failure reduces 
phosphorus excretion in urine. The normal renal excretion is estimated as 800 mg 
phosphorus per day (Bleyer et al., 2003), faecal excretion in renal failure taking 
oral binding agents is about 400 mg phosphorus/day (Sedlacek et al., 2000). 
Different animal models have been used to study the efficacy of oral binding 
agents in renal failure. The commonest non-surgical model of renal failure is 
through the use of dietary adenine in rats (McCabe et al., 2013); (Neven et al., 
2009); (Lacour et al., 2005). Considering the rat model, daily phosphate uptake 
in a normal rat diet is 1.3 mmoles phosphate (Berndt et al., 2007) approximately 
50% of which is absorbed. A target of 625 µmoles phosphate binding per day per 
rat in a renal failure intervention would therefore be appropriate.  
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The microcompartment enhanced biological phosphorus removal (MEBPR), 
system, which involves expression of a phosphate polymerising enzyme (ppk) 
within a MCP inside a bacterium (Chapter 2), offers a potential method of 
therapy to alleviate this accumulation of phosphate (Hall et al., 2010). By 
providing an intracellular space for increased polyphosphate storage in a 
bacterial cell, it was hypothesized that increased uptake of phosphate and 
retention of polyphosphate by the cell could be achieved.  Following on from 
this, this chapter tested the hypotheses that phosphate retaining bacteria could be 
delivered in sufficient numbers to the gut that phosphate uptake by the host could 
be affected, and that this would counteract phosphate retention associated with 
renal failure.  
In this thesis (Chapter II) a number of constructs were created to evaluate the  
first hypothesis in vitro. I observed increased phosphate uptake and 
polyphosphate retention via the use of the recombinant E. coli ppk, and in 
particular, the 2 plasmid E. coli ppk-pduABJKNU construct and L. reuteri 
expressing E. coli ppk. Based on the positive results observed in vitro and in 
order to explore the hypothesis further, a murine study was designed to test the 
constructs in vivo. 
The optimal constructs were selected from the previous study for in vivo studies; 
these include the aforementioned E. coli ppk, E. coli ppk-pduABJKNU 
(microcompartment) construct and L. reuteri expressing E. coli ppk. A short pilot 
study described below was performed prior to the large-scale trial to optimize 
delivery of the bacteria to the animals, and to observe the survival of the bacteria 
in a murine host. Due to observations from this trial, it was decided to utilize two 
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constructs in an E. coli strain (E. coli ppk and E. coli ppk-pduABJKNU) because 
these were recovered in higher numbers from the murine intestine than L. reuteri 
20016. A final experimental construct, L. reuteri 20016 expressing E. coli ppk, 
was selected  
For the purposes of an in vivo murine trial, four groups were therefore devised, 
with three experimental groups and one negative control group. All of the groups 
would receive an adenine-rich diet, initiating chronic renal failure (CRF) in all 
groups. The experimental groups would receive a lyophilized bacterial inoculate 
via their drinking water for a duration of five weeks, after which all groups 
would be culled and their internal vasculature and organs analyzed. Plasma was 
taken at set intervals during the trial to monitor renal activity, via fluctuations of 
phosphorus, calcium and creatinine levels. The strain of rat chosen was Sprague-
Dawley, because these had been used for at least three published trials looking at 
phosphate levels in an adenine induced renal failure model (Shobeiri et al., 
2013); (McCabe et al., 2013); (Price et al., 2006). 
This work was done under the license of Professor Edward Johns, Emeritus 
Professor of Physiology, University College Cork, who has previously utilized 
the rat model for kidney disease observation. His postgraduate student Elaine 
Barry also collaborated on this work and provided guidance regarding animal 
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3.2. Methods & Materials 
3.2.1. Experimental Design 
Experimental procedures were approved by the University College Cork Ethics 
Committee and carried out under animal licence B/100/3260 held by Professor 
Edward Johns in accord with EU Directive 86/609/EC. 14-week-old male 
Sprague Dawley rats (Harlan Laboratories, UK) were used for the experimental 
trial based on previous literature on renal failure models using 0.25% adenine 
(McCabe et al, 2013); (Lacour et al, 2005). Statistical analysis was with SPSS 
(IBM).  
In order to calculate an appropriate sample size, the size requirement for 
continuous variables such as serum phosphorus is based on the t-test derived 
formula (Institute for Laboratory Animal Research, 2003): 
 
Where n= sample size required, s = standard deviation of observation, d = 
difference to be detected, C is a constant which for power (1-ß) of 90% and a 
significance level (a) of 5% is 10.51.  
Using published lanthanum study data (Neven et al., 2009), where the renal 
failure group serum phosphorus was 12.07 mg/dl SD +/-3.44 and the treatment 
group 8.32 mg/dl. To detect a reduction of 3.75 mg/dl in phosphate in a treatment 
groups compared with a control (this was the reduction seen at 5 weeks with 2% 
lanthanum treatment) with a power of 90% and a significance level of 5%, 1 + 
21(3.44/3.75)2 = 18.67 subjects would be required.  On this basis, a planned 
€ 
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sample size of 20 per test group to allow for incidental mortality, with 10 in the 
normal diet control group this makes 70 animals. 
3.2.1.1 Strains and culture media 
Bacterial strains utilised in this study are listed in Table 3.1. 
Strain Plasmid Origin Reference 
Lactobacillus reuteri 
DSM20016 
None National Collection of Dairy 
Organisms, Reading, UK 
Sriramulu et al., 2010 
E. coli BL21 pAR3114 
(pduABJKNU+pp
k) 
Dr. Joshua Parsons, University of 
Kent 
Parsons et al., 2008 





pKMC004 (ppk) Author This thesis 
 
Table 3.1. Table indicating strains used.  
Escherichia coli was routinely cultured in Luria-Bertani (LB) broth (Merck, 
Darmstadt, Germany) at 37°C. Lactobacillus reuteri was routinely cultured in de 
Man-Rogosa-Sharpe (MRS) broth (Merck, Darmstadt, Germany) in static 
anaerobic conditions at 37°C.  
For minimal growth conditions, E. coli was cultured in 1X MOPS minimal 
media (Neidhardt et al., 1974) supplemented with K2HPO4 and glucose (Sigma 
Aldrich), whilst L. reuteri was cultured in Minimal Lactobacillus Media (Hebert 
et al., 2004) which was a formation of essential amino acids supplemented with 
glucose, sodium acetate, K2HPO4 and MgSO4 (Sigma Aldrich). Breakdown of 
media composition is indicated below. 
Material Quantity 
Tryptone from casein 10g/L 
Sodium chloride 10g/L 
Granulated Yeast Extract 5g/L 
Deionized Water 1L 
Table 3.2. Recipe for Luria Broth (LB) for the growth of E. coli 
	  	  	  	  	  	  





MRS broth 55g/L 
Deionized Water 1L 





Granulated Yeast Extract 2g/L 






* Supplemented with 40mM 1,2-propanediol and 200nM B12 to 
induce the pdu microcompartment 





0.01M FeSO4.H20 10mL/L 
1.9M NH4Cl, 50mL/L 
0.276M K2SO4 10mL/L 
0.02M CaCl2-2H2O 0.25mL/L 
2.5M MgCL2 2.1mL/L 
5M NaCl 20mL/L 
Micronutrient stock 0.2mL/L 
Table 3.5. Recipe for 10X MOPS minimal media. 
 
Material Quantity 
10X MOPS 50mL/L 
Glucose 10g/L 
1M K2HPO4 10mL/L 
Thiamine 5uL/L 
Table 3.6. Recipe for 1X MOPS minimal media. 
	  	  	  	  	  	  










L-Aspartic Acid 0.20g/L 
L-Cysteine 0.20g/L 











Nicotinic acid 0.001g/L 






Table 3.7. Recipe for Minimal Lactobacillus Medium (MLM) for the growth of lactobacilli. 
 
As previously discussed in Chapter II, strains were lyophilized (Section 3.1.2, 
Chapter II) and revitalized using gluconate supplemented water. 
  
	  	  	  	  	  	  





Compound  Concentration of solution  Reference  
SodiumGluconate  
(MW 196.16)  
20g in 1L (2%)  
8g in 1L (0.8%)  
Jones et al., 2008  
Table 3.8: Table illustrating the chosen carbon sources.  
3.2.1.2. Trial diet 
 An initial order was made for adenine supplemented purified diet via Harlan 
Laboratories (Madison, Wisconsin, USA) who are leading providers of adenine-
supplemented diets for previously published renal failure studies. (Price et al., 
2006); (McCabe et al., 2013); (Diwan et al., 2013). 
In March 2014, after the order had been accepted, practical difficulties with 
shipping the diet became apparent because of enforcement for the first time of 
legislation requiring an individual import licence arranged by the researcher for 
every shipment of animal feed from outside the EU from the Irish Department of 
Agriculture Food and the Marine. In practice this blocked all experimental diet 
imports from the USA for animal research in Ireland until resolved several 
months later for rodent diets on a University-wide basis. At this point the 
experimental animals had been ordered and the cages reserved in the animal 
facility. The only possibility to obtain the diets in the time frame required was to 
re-order from a company with a UK manufacturing plant (TestDiet Europe, IPS 
Product Supplies Ltd, London), but a 6 week delay ensued and in addition a 
quantitative error, which led to a shortfall in delivered diet, further delayed the 
start of the trial.  
This created a knock-on effect, as the initial animal groups (1 and 2) had begun 
receiving their adenine diet in a staggered fashion. To avoid disruption to groups 
which had already begun the trial, Group 4 did not begin their trial until 
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additional diet had arrived, meaning that they were 18 days  older than the other 
group rats by the trial start date. The rats received a high-adenine diet [0.5% 
adenine, 1% phosphorus, 1.39% calcium] (TestDiet, UK) for 3 weeks to induce 
CRF. The use of an adenine-rich diet has been previously utilized in literature to  
induce CRF (Neven et al, 2009). For this study, the adenine dosage was 
delivered in a gradient amount (Table 3.9) decreasing over the period of the trial.  
Table 3.9. Trial diet composition and dosage schedule 
After the initial three weeks after 0.5% diet, the animals were changed to a lower 
dosage adenine diet [0.3% adenine, 1% phosphorus, 1.39% calcium], and after 
an additional three weeks, the animals received an even lower dosage adenine 
diet [0.15% adenine, 1% phosphorus, 1.39% calcium], (Figure 3.1). The reason 
for the decreasing adenine percentage diets was to maintain CRF but avoid 
undue mortality in the animals. 
The bacterial intervention consisted of a lyophilized bacterial dosage, which was 
added to 2% gluconate drinking water at the beginning of the 0.3% diet for the 
experimental groups (ii, iii and iv). This would be given on a daily basis via the 
drinking water supply for a period of 5 weeks. Each of the experimental groups 
would receive 1 of 3 bacterial constructs that were previously assessed in vitro in 
studies from Chapter II. Gluconate was selected as carbon source based upon a 









Additional 3 weeks after confirmed CRF – 





Final 2.5 weeks of trial – continued 
bacterial dosage 
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previous study evaluating the most stable sugar source for revitalizing the 
lyophilized cultures (Chapter II). 
Figure 3.1. Diagram illustrating the schedule for diet treatment and blood sampling. 
3.2.1.3. Group design 
As previously mentioned, there were 4 groups in total, each group containing 20 
animals (see power calculation above). These groups consisted of Group 1: a 
control set receiving no specific bacterial intervention, but receiving gluconate 
water, Group 2: a set receiving E. coli ppk+pduABJKNU expressed in E. coli 
BL21 Group 3: a set receiving E. coli ppk expressed in E. coli BL21 and Group 
4: a set receiving E. coli ppk expressed in L. reuteri DSM20016. These strains 
were shown to survive in rats (culturable from faecal pellets following oral 
consumption) in the Pilot study.  
Within each group, there were 4 cages, each containing 5 animals. Each animal 
was colour-coded and physically marked for identification purposes. In each 
cage, there were 2 drinking bottles and one communal feeding trough. Each 
animal was weighed on a weekly basis. 
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3.2.1.4. Pilot Feeding Study 
In order to establish the viability of delivering the bacterial intervention to the 
animals via a water source, a pilot feeding study was undertaken. This was done 
over a 7 day period, and utilizing 8 rats. These rats were all Sprague-Dawley rats, 
but were considerably older than intended for the actual trial (these were surplus 
animals from the BSU). 
From the total of 8 rats, 7 animals received a bacterial dosage, whilst 1 did not. 
This bacterial dosage of between approximately 0.4-0.5g lyophilised bacteria 
was delivered over 3 days to 600mLs of 0.8% glucose water, followed by 4 days 
of glucose water only. 
 
Figure 3.2. Diagram illustrating the schedule for pilot trial 
1mL water sample was taken from each bottle after addition of bacterial dosage, 
for subsequent viability count plating. This would allow determination of 
bacterial survival numbers. Faecal pellets were also collected from each animal 
to observe successful passage through the animal or indeed potential 
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colonization. The findings from this pilot trial informed the strains and delivery 
system utilized for the large-scale trial. 
3.2.2. Dosage of lyophilized bacteria 
Details of the growth conditions and preparation of the lyophilized bacteria can 
be read in Chapter II, section 3.1.5 (Materials & Methods). Based upon previous 
study (Chapter II) bacteria were lyophilized during entry into stationary phase 
(OD600nm ~0.7) and were weighed prior to lyophilization and again afterwards. 
As these plasmids can be unstable, in order to ensure that the correct plasmid was 
present in each strain, multiple repeat cultures were created to avoid over 
passaging any one original culture. All samples were plated on selective 
antibiotic agar to confirm presence of plasmid before use and subjected to neisser 
staining to observe phosphate uptake ability. 
3.2.2.1.Bacterial dosage 
For rats, daily phosphate uptake is 1.3 mmoles phosphate (Berndt et al., 2007), 
approximately 50% of which is absorbed, making a requirement of up to 625 
µmoles phosphate binding per day in renal failure. An estimate from in vitro 
bacterial growth over 12 hours in vitro found the capacity of the best E. coli ppk-
pduABJKNU clone 16 µmoles phosphate/mg protein (Prentice, Liang 
unpublished) suggested 39 mg of final growth of E. coli bacterial protein was 
required to achieve 625 µmoles phosphate uptake corresponding to 
approximately 98 mg dry weight bacteria. Rat water intake is 10-12 mL/100g  
(Harkness & Wagner, 1989) or @ 50 mL per day for male rats and this could be 
achieved with 2 mg/ml bacterial protein in water intake.  
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Estimates based on shorter-term uptake from high bacterial loads in gluconate 
water (Chapter II) gave comparable results as follows. An inoculum of 0.0.2 g 
lyophilised E. coli ppk-pduABJKNU clone was able to uptake 0.41 millimoles 
phosphate from 100mL over a 5-hour period. Likewise, 0.018g lyophilised E. 
coli ppk expressed in L. reuteri took up 0.7 millimoles phosphate over a 5 hour 
period (Figure 4.21, Chapter II). 
Using this information, and assuming a baseline population of 1.6e8 bacteria per 
100mL resuspended (based upon viability plate counting) this would require a 
3.05e+08 bacteria would be required to uptake 0.65mM of phosphate.  
Based upon pilot feeding trial data and viability counts, the rats would need to 
intake a minimum of 18mL per day to achieve a sufficient bacterial intake, which 
is within the standard average water intake for a rat (John Hopkins University, 
Animal Care & Usage guidelines). 
As such, for the large-scale trial, a daily pellet of approximately 1.5-2g was 
delivered through cage bottles. The pellet was resuspended initially in 50mL 
gluconate water, and then transferred to the cage bottle (which typically totaled 
approximately 1L). 
3.2.2.2. Delivery of bacterial dosage 
As previously mentioned, the experimental bacterial constructs were delivered to 
the animals via their drinking water supply. This option was selected due to the 
constraints of gavaging 80 animals daily and consistently. By supplying the 
constructs through the water supply and through consistent monitoring of 
bacterial viability and passage, a baseline level of successful dosage can be 
deduced.  
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As mentioned, the bacterial constructs were lyophilized and maintained at 4°C. 
Each morning, at a consistent time, each water bottle was weighed and noted to 
monitor water uptake. As there were two bottles per cage, these were totaled 
together to represent the cage as a whole. The lyophilized pellets, which 
averaged a weight of between 1.5-2g were resuspended in 50mL 2% sodium 
gluconate before being added to each individual water bottle (totaling 
approximately 1L) and once again weighed and noted. This allowed a daily 
measurement of approximate water uptake, and bacterial uptake.  
Twice a week, samples of animal faeces from each cage were collected and 
plated on selective antibiotic agar to identify successful passage of the bacterial 
constructs. 
Experimentation on delivery of the bacterial solution via the dry feed was tried, 
but proved unsuccessful due to hard, dry nature of the diet pellets. Soaking them 
in water supplemented with bacterial cultures led to the pellets become 
excessively soft (likely unappealing to the animals) and also returned very low 
bacterial counts on plate culture. 
3.2.2.3. Faecal and water sampling for inoculated bacteria  
Water samples were obtained from the individual water bottles daily, and serially 
diluted using Ringers solution. Samples were plated on appropriate antibiotic 
selective agar, with colonies typically enumerated at 10-4 and 10-5. This was to 
ensure survival and viability of the bacterial in the drinking water. 
Faeces were also sampled twice weekly. 1g of homogenized faeces was added to 
10mL Ringers solution. The solution was homogenized using a Stomacher 400C 
(Seward) and 100µl was taken for serial dilution. Dilutions were then plated on 
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antibiotic selective agar (E. coli ppk+pduABJKNU and E. coli ppk both display 
ampicillin 100 mg/ml resistance, whilst E. coli ppk expressed in L. reuteri 
displays chloroamphenicol 10 mg/ml resistance). Monitoring the passage of the 
culture through the faeces allowed the deduction of successful delivery and 
passage of the bacteria through the animals. 
3.2.2.4. Faecal and water sampling for mineral content 
Water samples were obtained daily from cage water bottles to confirm the 
survival of the bacteria in the bottles. 1mL sample was removed approximately 
15 minutes after inoculation of bacterial culture, and serially diluted in the lab for 
plate culture within 3 hours of sample being obtained. Samples were then plated 
to a dilution factor of 10-6.  
In order to measure mineral content (phosphate and calcium) in faeces, samples 
of faeces were collected on a weekly basis. 1g of faeces was retained and stored 
at 4°C. However due to issues regarding collection access, inadequate faecal 
samples for Group 1 and Group 2 were obtained for mineral analysis. 
Information on mineral analysis can be found in Section 3.1.3.4.  
3.2.3. Vascular study and analysis 
3.2.3.1. Bloodwork and analysis 
Standard tail vein bleeds were obtained at i) the beginning of trial ii) at the end of 
0.5% adenine diet/confirmation of CRF iii) mid-way through bacterial 
intervention and iv) before sacrifice of the animal. Animals were sedated using 
isofluorine and blood obtained from the tail vein using 1mL syringes (BD 
plastipak #300013) and 25G needles (BD Microlance #300600). These bleeds 
	  	  	  	  	  	  
	  	  	  	  	  	  
 
162 
were performed by Elaine Barry from the Department of Physiology, University 
College Cork. Samples were then sent to the School of Veterinary Pathology, 
University College Dublin, for plasma serum analysis of phosphorus, creatinine 
and calcium levels.  
At the end of the trial, the groups were sacrificed by cervical dislocation and the 
major organs, including major circulatory vessels, were obtained for further 
biochemical and microbiological analysis. 
3.2.3.2. Tissue preparation 
Tissue samples were obtained at sacrifice. A selection of tissue samples (aortic 
arch, right carotid, right femoral) were fixed in neutral formalin and cut into 2–3 
mm thick rings that were embedded upright in the same paraffin block. This 
meant that every section contained, on average, 16 cross sections for the aortic 
arch and 5 cross sections for the carotid and femoral arteries at different sites 
along the vessel. Selections of µm sections were stained with Von Kossa staining 
method (Sheehan & Hrapchak, 1980), (Crookham & Dapson, 1991). This 
staining method utilizes 5% silver nitrate, followed by exposure to bright light 
for 1 hour, which will cause reduction of calcium present. The silver nitrate will 
deposit in place of the calcium, allowing visualization of metallic silver sports. 
Vascular calcifications were then evaluated histomorphometrically with image 
analysis software at magnification 100×. The absolute areas of tissue and 
calcified tissue were summed for each animal, and the ratio was expressed as 
area% calcification. This work was undertaken by Helen McCarthy and Dr. Amr 
Mahmoud, Department of Pathology, University College Cork. 
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The small intestine was also harvested on sacrifice, where it was weighted and 
stored in 10mL Ringers solution. Samples were then homogenized, with 1mL 
removed for serial dilution in Ringers solution. Dilutions were plated on 
antibiotic selective agar (ampicillin 100 mg/ml and chloramphenicol 10 mg/ml) 
to observe if the bacterial constructs had colonized the small intestine. The 
kidneys were also weighed and recorded on sacrifice. 
3.2.3.3. Tissue analysis 
Additional vascular vessels (thoracic aorta, abdominal aorta, renal artery, and 
carotid artery) were weighed and snap-frozen on collection. They were then 
thawed and homogenized in 0.6 N hydrochloric acid (HCl) for 24 h at 60°C. The 
samples were spun and the calcium content was determined colorimetrically 
using an O-cresolphthalein complexone assay kit (Cayman Chemicals #700550).  
This assay kit is based upon the principal of the main reagent, O-cresolphthalein 
forming a purple complex with calcium in samples, with resulting absorbance 
measured at 540nm (Microplate reader XS Spectrophotometer, Biotek). Samples 
were homogenized in Phosphate Buffered Solution (PBS) (pH7.4) and 
centrifuged at 10,000g for 15 minutes at 4°C (Beckman Coulter, rotor JA 25.50). 
The supernatant was removed, with 10µl of sample placed in test wells, along 
with 100µl of the detector agent provided by the kit. Samples were incubated for 
5 minutes, with absorbance read at 570nm.  
The tissue was also used to measure phosphate levels using ammonium 
molybdovanadate. Samples were initially acid digested with hydrochloric acid, 
which allowed orthophosphate to be converted to total phosphate (Biologic et al, 
1967). A solution of 5mL malachite green (0.122%), 3.4mL ammonium 
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molybdate and 0.2mL Tween 20 was prepared fresh and are added to the 
samples, and measured at 430nm by spectrophotometry (Heresztyn & Nicholson, 
2001), (McCabe et al, 2013). 
3.2.3.4. Faecal analysis 
Faeces samples were also analyzed for phosphate and calcium content, utilizing 
the O-cresolphthalein complexone assay kit and ammonium molybdovanadate 
method. However for faecal samples, specimens were divided, with 1 set being 
ashed in a muffle furnace, and the second set being resuspened as faecal water. 
This was done in order to obtain the most accurate mineral content (soluble 
phosphate measurements via faecal water and total phosphate via ashed faeces).  
As mentioned, ashing of faeces was done using a muffle furnace oven, and with 
guidance from Dr. Therese Uniacke, Food Science, University College Cork. 
Samples were weighed prior to oven treatment (1g maximum) and dry ashed for 
8 hours at 550°C. Phosphate was then measured with resuspension in 
hydrochloric acid. 
Faecal water was prepared for analysis by resuspending lyophilized faeces to 
25% of its dry weight (to mimic the natural colon conditions). After 
homogenization, samples were incubated for 1 hour at 37°C, followed by 
centrifugation at 15,000g for 10 minutes (Govers & Van der Meer, 1993). 10 ul 
of sample was then removed for assay testing. 
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3.3. Results & Discussion 
3.3.1. Pilot Feeding Trial 
As mentioned, an initial pilot trial was undertaken to observe the A) delivery 
system for the bacterial intervention and B) the success passage of the bacterial 
strains. This pilot trial provided important information regarding both, ultimately 
influencing the delivery and strain selection of the main trial. Beyond Day 1, 
none of the constructs expressed in Lactobacillus strains survived in the water 
source supplemented by glucose after inoculation, with only the E. coli-ppk 
construct, expressed in E. coli BL21 surviving with counts of 7.0x105 for up to 
three days. This was a notable result, with the lack of prolonged viability in 
Lactobacillus most possibly due to its more fastidious nature versus E. coli 
(Farnworth, 2008). The water sources and bottles utilized were tested for 
potential contamination with detergent or other bactericidal substances however 
no adverse factor was identified.  
On Day 1, viable counts were obtained from faecal samples for all strains, 
however the numbers were extremely low (170 cfu/mL from undiluted cultures). 
Beyond Day 1, no Lactobacillus strains were reobtained from faecal cultures, 
whilst E. coli-ppk was only obtained from undiluted samples.  
The results of the pilot study greatly influenced the ultimate delivery and design 
of the large-scale trial, with the difficulties in ensuring Lactobacillus survival 
and recovery leading to a higher proportion of E. coli strains being used for the 
larger-scale trial, with one Lactobacillus strain ultimately used. 
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Based upon the findings and difficulties encountered with this pilot trial, a 
number of quality control factors were introduced, to ensure strain delivery and 
viability and removal of adverse factors. These included use of a different carbon 
source in drinking water not accessible to the host (Chapter 2), a segregated 
animal housing room, serviced only by the author and Ms. Barry, the strict use of 
deionized water (no water of other origin), fresh preparation and delivery of 
lyophilized bacteria daily and sterile washing of dedicated plastic drinking 
bottles. A decision was also made to deliver an inoculum of the bacteria on a 
daily basis, as the pilot trial supported the viability of cultures for a 24 hour 
period, with problems appearing beyond Day 1. To ensure this did not continue 
to be an obstacle, each group received a daily dose of the bacterial supplement. 
3.3.2. Large-scale trial 
The mortality in this study was minimal. One animal of the experimental Group 
2 (E. coli ppk+pduABJKNU) died 3 weeks after CRF induction, and one animal 
of the experimental Group 4 (E. coli ppk L. reuteri) died the day before sacrifice.  
Table 3.10. Table indicating average group weight per week. Pre-sac indicates final weight 
before sacrifice. Group 1 = Control, Group 2 = E. coli ppk+pduABJKNU, Group 3 = E. coli 
ppk, Group 4 = E. coli ppk L. reuteri 
 
(grams) Wk 1 Wk 2 Wk 3 Wk 4 Wk 5 Wk 6 Wk 7 Wk 8 Pre-sac 
Group 1 321.7 290.2 290.5 289.8 311.8 304.0 308.2 311.9 331.7 
Group 2 343.9 300.3 301.5 306.8 314.4 319.0 319.0 311.1 329.1 
Group 3 338.8 314.0 314.2 325.6 330.3 338.6 330.2 357.4 355.2 
Group 4 367.0 323.6 333.7 332.5 326.4 326.5 316.4 332.3 336.3 
	  	  	  	  	  	  




Figure 3.3. Graph indicating average group weight per week (as in above table). 
 
 
Overall no extreme weight shifts can be observed. Across the duration of trial 
two groups gained weight; Group 1 (control) gained 10g of weight, whilst Group 
3 (E. coli ppk) gained 16.4g of weight. The remaining two groups both lost 
weight; Group 2 (E. coli ppk+pduABJKNU) lost 14.8g and Group 4 (E. coli ppk 
and E. coli ppk L. reuteri) lost 30.7g. Within the groups themselves there was no 
clear indication of food dominance in the group i.e. all the animals appeared 
healthy in appearance and weight, with no clear dominant animal in the group. 
3.3.3. Water Analysis 
Water bottles were monitored daily to observe survival of bacterial dosage and 
also to allow calculation of daily water uptake per cage, and calculation of an 
approximate bacterial dosage intake. 
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3.3.3.1. Water uptake rates 
Group 1 
(Control) 
(mLs) Average intake per cage Per rat per week Per rat per day 
Week 4 1686 337.2 48.17 
Week 5 1772 354.4. 50.62 
Week 6 2087 417.4 59.62 
Week 7 3259 651.8 93.11 
Week 8* 858 171.6 57.2 
Table 3.11. Table indicating water uptake breakdown. Table represents the 5 weeks after 






(mLs) Average intake per cage Per rat per week Per rat per day 
Week 4 1650 330 47.14 
Week 5 1798 359.6 51.37 
Week 6 1754 350.8 50.11 
Week 7 1864 372.8 53.25 
Week 8 1374 274.8 54.96 





(mLs) Average intake per cage Per rat per week Per rat per day 
Week 4 1992 398.4 56.91 
Week 5 2082 416.4 59.48 
Week 6 2690 538 76.85 
Week 7 2244 448.8 64.11 
Week 8* 593 118.6 59.3 
Table 3.13. Table indicating water uptake breakdown. Table represents the 5 weeks after 







	  	  	  	  	  	  




(mLs) Average intake per cage Per rat per week Per rat per day 
Week 4 1898 379.6 54.22 
Week 5 2025 405 57.85 
Week 6 2188 437.6 62.51 
Week 7 2544 508.8 72.68 
Week 8* 977 195.4 65.13 
Table 3.14. Table indicating water uptake breakdown. Table represents the 5 weeks after 
confirmed CRF.  
 
In all groups, water intake increased per week after confirmed renal failure. This 
was an expected effect, and illustrated the physiological effect resulting from the 
adenine rich diet and consequential renal failure.  
3.3.4. Delivery & Survival Analysis 
3.3.4.1. Water survival rates 





































Table 3.15. Table indicating viability of bacterial samples in 2% gluconate water source. Values 
averaged from all cages within a group (4 cages per group). Samples were obtained after 15 
minutes post inoculation and cultured within 3 hours. 
3.3.4.2. Faecal recovery rates of orally administered bacteria 





































Table 3.16. Table indicating viability of bacterial samples from faecal material. Values averaged 
from all cages within a group (4 cages per group). 
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To ensure delivery of the bacterial dosage to the animals, daily 1mL water 
samples were obtained from the water bottles and serially diluted, with plating on 
selective antibiotic agar. These values were averaged per group in total, and also 
per week for tabulating results. Likewise, to identify if the bacterial dosage had 
been uptaken by the animals, faecal matter was collect twice weekly, and plated 
on selective antibiotic agar. Based on these results, we can observe that there is 
an approximate logarithmic difference between the bacterial population present 
in the water supply (Table 3.15), and that being recovered from the faeces (Table 
3.16). 
3.3.4.3. Intestinal colonization results 





None of the experimental 















Table 3.17. Table illustrating the viability of bacterial intervention in the small intestine of the 
animals 
 
After sacrifice, the small intestines of the animals were harvested. Homogenizing 
and plating these on selective agar further demonstrated the successful delivery 
of the bacterial dosage from the inoculated water source. These results also 
indicated the colonization ability of the E. coli and L. reuteri hosts. 
  
	  	  	  	  	  	  
	  	  	  	  	  	  
 
171 
3.3.5. Tissue & Faecal Analysis 



























7.39 7.42 7.41 
Week 7 (Post-
intervention 7.64 7.39 7.56 7.50 
Week 8 (Post-
intervention 7.47 7.32 7.47 7.43 
Week 9 (Post-
interventio.n 7.40 7.44 7.31 7.28 
Table 3.18. Table illustrating the calcium content of faecal water. Due to scheduling issues, 




























3.86 2.66 2.97 
Week 7 (Post-
intervention 3.08 2.27 3.10 4.29 
Week 8 (Post-
intervention 2.85 2.82 3.05 3.04 
Week 9 (Post-
intervention 3.42 3.45 2.96 3.19 
Table 3.19. Table illustrating the calcium content of ashed faeces. Due to scheduling issues, 
samples were unavailable pre-intervention for Groups 1-3. Values are in mmol/L. 
  
	  	  	  	  	  	  




















intervention N/A N/A 837.64 1107.99 
Week 5 (Post-
intervention N/A 695.83 829.455 1018.93 
Week 6 (Post-
intervention N/A 879.54 1052.89 1000.55 
Week 7 (Post-
intervention 992.27 1111.058 810.72 1154.96 
Week 8 (Post-
intervention 1132.78 1101.57 1004.76 1149.56 
Week 9 (Post-
intervention 1109.94 1141.56 842.97 967.95 
Table 3.20. Table illustrating the total phosphate content of ashed faeces from animals. Due to 
scheduling issues, samples were unavailable pre-intervention for Groups 1-3. Values are uM/g. 
 
Testing of the water source supplemented with the bacterial constructs indicated 
that the addition of bacteria to the water source did not cause any detectable 
effects regarding phosphate/calcium content i.e. it did not cause any influential 












On addition to 
water 0.072 120.56 
126.77 131.56 













On addition to 
water 0.084 0.554 
0.453 0.284 
Table 3.22. Table illustrating the calcium content of the water plus bacterial addition. 
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3.3.5.2. Tissue mineral analysis 
 


































Table 3.23. Table illustrating the calcium content of blood vessels. 
 
On comparing these findings against the published Lanthanum study (Neven et 
al., 2009), some areas of similarity can be observed. The majority of the Neven 
samples appeared to test negative for the presence of calcium, however we 
discuss comparison against those positively testing for calcium. 
For the femoral artery, for the Neven study, many of the calcium positive 
samples within the control (untreated) group fell between the 1.5-2.5g/g range, 
which is lower than our averaged finding of 9.6mg/g for our control. For the 
Neven experimental groups, the majority of calcium positive samples were more 
widely distributed but fell within a range of 1.5-3.5 mg/g, which again is lower 
than the levels identified in our experimental groups (between 13mg/g and 
6.9mg/g).  
For the carotid artery, for the Neven study, the calcium positive samples within 
the control (untreated) group fell between the 5-8mg/g range, which is lower than 
our averaged finding of 13.2 mg/g. For the Neven experimental groups, the 
majority of calcium positive samples were between 2-4mg/g, with outliers 
peaking at 8mg/g. This is comparable with our experimental groups, which fell, 
on average, within a range of 8.4 to 3.5mg/g. 
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For the aorta, for the Neven study, the calcium positive samples within the 
control (untreated) group fell between the 10-15mg/g range, which is slightly 
higher than our average of 5.9mg/g. For the experimental samples, the average 
range for the calcium positive samples is between 5-10mg/g, which is 
comparable to the results of Group 2 and Group 4 (Group 3 has a much higher 
value of 20.8mg/g). 
Whilst it is unclear why the majority of our vessels appeared to show positive for 






































Table 3.33. Table illustrating the total phosphate content of blood vessels. 
 
It is difficult to compare phosphate tissue reading against other literature as many 
studies focus on serum phosphate level versus tissue phosphate. However on 
comparison against a previous renal failure study (McCabe et al., 2013), it can be 
observed that our tissue samples appear to have higher phosphate levels present 
across the board.  
	  	  	  	  	  	  































RC 5 1 34.8 7.2 Media  
C1
6 
RF 4 1 1.5 0.66 Media  
D2 AA 20 20 20 20 Intima/Media 70% 
max 
D2 RF 5 5 9.7 9.7 Intima  
D3 AA 15 9 6 3.2 Media  
D3 RF 4 4 8.2 8.2 Media  
D6 AA 18 18 22.9 22.9 Intima/Media 60% 
D6 RC 5 5 19.2 19.2 Intima/Media  
D6 RF 4 1 2.8 1.02 Media  
D7 RF 4 4 9 9 Media  
D1
0 
AA 11 2 30.9 9.8 Intima  
D1
0 
RC 7 2 20.7 11.6 Media  
D1
8 
RF 5 4 9.6 8.6 Media  
Table 3.34. Table illustrating the calcification content of sectioned arterial samples. 
 
 
	  	  	  	  	  	  




Figure 3.4. Scatter plot illustrating percentage calcification of the right carotid. 
 
Figure 3.5. Scatter plot illustrating percentage calcification of the right femoral. 
 
Figure 3.6. Scatter plot illustrating percentage calcification of the abdominal aorta. 
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Based on sectioning, the majority of vessels obtained from the animals did not 
appear calcified, although there were a number of positive calcified blood vessels 
from Group 4 (ECppkLR). Calcification can be observed in the right femoral, 
right carotid and abdominal aorta in 6 animals from Group 4. The reason for this 
observation of calcification in Group 4 is unclear and may be due to A) the 
delivery of Lactobacillus, although there is no literature indicating a potential 
link between the two, and B) due to the older age of the rats of Group 4. These 
animals were 4 weeks older than their counterparts in Groups 1-3 and came from 
a different batch, however again literature does not indicate excess calcification 
of rats within their age profile (Kieffer et al., 2000). 
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Figure 3.7. Sagittal section of the right aorta, showing calcification within the media of the 
arterial wall. Section obtained from animal #6, Group 4 (ECppkLR). 
 
Figure 3.8. Sagittal section of the right femoral artery, showing calcification within the media of 
the arterial wall. Section obtained from animal #16, Group 3 (ECppkE). 
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3.3.6. Statistical analysis of tail-vein blood samples 
Mineral Group Equilibration Established 
Chronic 
Renal Failure 
After 21 days 
intervention 




CRF (control) 43.1 ± 3.5 123.7  ± 26.9 315.2 ± 47.7 225.3 ± 38.5 
 E. coli 
ppk+pduABJKN
U 
47.6 ± 2.8b 103.4 ± 26.5 292.9 ± 53.6 226.3 ± 43.2 
 E. coli+ ppk 45.1  ± 2.3 82.0 ± 9.2b 236.3  ± 59.6b 193.4 ± 38.8 
 L. 
reuteri+ECppk 





2.00 ± 0.21 2.43 ± 0.48 4.52 ± 0.55 3.71 ± 0.78 
 E. coli 
ppk+pduABJKN
U 
2.12 ± 0.20 2.18 ± 0.40 4.44 ± 0.84 3.67 ± 0.73 
 E. coli+ ppk 2.02 ± 0.19 1.66 ± 0.15b 3.43 ± 0.84b 2.80 ± 0.58 b 
 L. 
reuteri+ECppk 





2.27 ± 0.16 2.59 ± 0.09 2.35 ± 0.24 2.42 ± 0.22 
 E. coli 
ppk+pduABJKN
U 
2.57 ± 0.15b 2.65 ± 0.21 2.51 ± 0.28 2.43 ± 0.22 b 
 E. coli+ ppk 2.46 ± 0.09b 2.55 ± 0.15 2.47 ± 0.17 2.66 ± 0.16 
 L. 
reuteri+ECppk 
2.51 ± 0.12b 2.77 ± 0.16b 2.46 ± 0.53 2.40 ± 0.36 
Table 3.35. Table indicating values from tail-vein blood samples from animal. Statistical analysis 
has been preformed. (bP < 0.05 versus CRF group at the same time point, Independent samples 
Kruskal-Wallis test). 
 
As indicated by the tail vein blood samples, initial variation amongst the 
differing groups already appears large before experimental work had taken place. 
This variation amongst groups was most likely due to existing genetic variation 
amongst the Sprague-Dawley rats (Fitzpatrick et al, 2013). The Sprague-Dawley 
breed is traditionally outbred, however the breed is widely used as a renal failure 
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model (Ye et al, 1997; Lacour et al, 2005). The large degree of variation 
therefore made the results of the bacterial intervention on the CRF state difficult 
to interpret. There appears to be a large decrease in phosphate level at post-
intervention for the E. coli+ppk group versus the control group, however with 
initial genetic variation between these two groups, it cannot be proved that this 
























	  	  	  	  	  	  




The principle of this study was to observe the effects of the constructs previously 
examined in Chapter II.  These constructs had proven efficacy in an in vitro 
environment, therefore a natural progression of study was to examine this same 
efficacy in vivo. However, the overall results of this study did not show any 
therapeutic effect of bacterial therapy, but there were large variations between 
the groups from the initial pre-intervention observations onwards, meaning it was 
difficult to examine the actual efficacy of the constructs on the CRF state. The 
published efficacy shown by lanthanum in reducing phosphataemia and vascular 
calcification in rat renal failure studies (Neven et al., 2009) was not shown by 
any of the constructs. No toxicity from bacterial delivery was apparent.  
In the pilot feeding trial, survival of bacterial samples in glucose supplemented 
feeding water, was poorer for Lactobacillus strains than E. coli K12 strains 
expressing ppk. This discrepancy reflects the stress survival effects of PPK 
(Motomura et al., 2014) because E. coli K12 does not generally survive in the rat 
gut but all the ppk-expressing clones were recovered by viable culture from 
faeces.  Lactobacillus reuteri strain survival in the rat gut was improved by 
addition of a carbon source not accessible to the host.  In the final large-scale 
trial, by changing the carbon supplement to gluconate from glucose we were 
successfully able to deliver and retrieve as many Lactobacillus cells from 
drinking water and faecal samples and gut samples as E. coli. This suggests that 
L. reuteri could be used to deliver therapeutic molecules by the oral inoculation 
system used in this thesis 
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The adenine diet successfully induced chronic renal failure in all animals. We 
observed microscopic calcification in blood vessels from the Group 4 (EcppkLR) 
animals, whilst little to none was observed in the blood vessels of the other 
groups. However assay results did not indicate any unusually high serum calcium 
or phosphate results for Group 4 vs. the other assayed Groups. This may be due 
to assay sensitivity or the sectioning of vessels initially. No consistent variations 
in calcium or phosphate excretion in faeces were noted with bacterial therapy.  
A key observation from the large-scale study was the successful delivery and 
retrieval of the bacterial strains from supplemented water. In the pilot trial, the 
difficulties encountered regarding this delivery and viability were improved upon 
greatly by the strict quality measures implemented for the large-scale trial. 
Analysis proved viability of bacterial constructs in the supplemented water 
source, while faecal and intestinal counts demonstrated viable cultures, 
indicating that the bacteria was indeed delivered from the water source to the 
animal and passed through the digestive tract.  
The behavioural and physiological responses of the animal examined during the 
study were anticipated in response to the adenine diet and resulting renal failure. 
However positive aspects of the study included the ability to successfully deliver 
and recover the bacterial constructs from the faeces and small intestine of the 
animals without evidence of toxicity, indicating future potential for water and 
diet delivery as a successful alternative to gavaging.  
Moving forward, this trial would ideally be repeated on a smaller scale, with 
strictly inbred rat models (e.g. Wistar) and with a positive control e.g. lanthanum 
or sevalamer. This will reduce the genetic variation and allow the effect of the 
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bacterial intervention to be analyzed independently. Although there was a 
discrepancy in the age of the initial 3 groups vs the final 4th group, the author 
could find no evidence indicating this may contribute an influencing factor 
regarding disease progression as these animals are still considered young rats 
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Investigation into changes in buoyant cell density of 
bacterial cells following induction of ethanolamine 
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Bacterial microcompartments (MCPs) are small proteinaceous structures 
originally observed within bacterial cells in the 1950s (Drews & Niklowitz, 
1956). They possess a distinct polygonal shape, which triggered their 
identification by electron microscopy. Their distinctive shape has been identified 
in genera as diverse as Klebsiella, Lactobacillus and Escherichia (Kerfeld et al., 
2010).  
The ethanolamine utilization (Eut) microcompartment and its gene cluster were 
initially identified in E. coli (Stojiljkovic et al., 1995). Ethanolamine is an amino 
alcohol produced in the gastrointestinal tract of mammals as a product of the 
degradation of phosphatidyl ethanolamine, which is present in large quantities in 
eukaryotic membranes.  
From the E. coli Reference (ECOR) Library strains, I screened 53 strains, with 
46% identifying as displaying a Eut-positive phenotype on ethanolamine 
MacConkey agar. These strains then underwent a selection of phenotypic 
analysis to observe their phenotypic characteristics. 
I hypothesized that strains containing a bacterial microcompartment would 
display increased buoyant density, and this hypothesis was supported by 
observations in E. coli strains expressing a recombinant pdu operon and in both 
Yersinia enterocolitica and Lactobacillus reuteri with a native operon. Strains all 
displayed increased density when grown in the presence of supplemented media 
to induce the presence of the microcompartment.  
In contrast, Eut-positive strains from the ECOR library, displayed the opposite 
phenotype i.e. they displayed decreased density when grown in ethanolamine-
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supplemented media. Expression of recombinant empty microcompartment 
shells in E.coli without an enzyme core, also resulted in decreased buoyant 
density compared with a complete enzyme-containing Pdu microcompartment, 
but the ethanolamine-induced ethanolamine-deaminase positive cells should 
make microcompartments with enzyme cores 
This discrepancy between the buoyant densities of cells on induction of the Eut 
microcompartment versus induced and overexpressed Pdu microcompartments 
may be hypothesized to be due to the production of ammonia within the Eut 
microcompartment, increasing buoyancy of the bacterial cell. This hypothesis 
requires additional investigation. 
  
	  	  	  	  	  	  




Ethanolamine is an amino alcohol produced in the gastrointestinal tract of 
mammals as a product of the degradation of phosphatidyl ethanolamine, which is 
present in large quantities in eukaryotic membranes. Its association with a 
bacterial microcompartment was first observed in E. coli in 1995 (Stojiljkovic et 
al., 1995) with the identification of the ethanolamine utilisation (eut) gene 
cluster.  
Since that initial observation, the role of ethanolamine in E. coli has been studied 
sporadically, with a number of studies indicating a relationship between 
pathogens and the ability to utilize ethanolamine (a readily available source of 
nutrients in the mammalian gut) (Bertin et al., 2011).  
The association between the metabolism and the benefit of the bacterial MCP 
enclosing the enzymes has not yet been fully elucidated – counter arguments 
from different studies indicate different hypothesis.  
 
Figure 4.1 Model of ethanolamine catabolism in E. coli (from Bertin et al., 2011) 
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Published literature from (Penrod & Roth, 2006) indicates a potential role in the 
retention of the volatile aldehyde intermediate, which would otherwise be lost 
during the gas phase. This is in agreement with additional theories regarding the 
role of bacterial MCPs (Kerfeld et al., 2010). However studies by (Havemann et 
al., 2002) have suggested the true role is regarding the mitigation of a toxic 
intermediate. This theory is supported by deletion mutant results, where the pduA 
mutants displayed interrupted growth at high concentrations of 1,2-propanediol, 
indicating accumulating toxicity within the cell. However, to date no one clear 
role has been identified and supported consistently. Both theories are supported 
by evidence, therefore it is can be hypothesized that the true role involves aspects 
of both theories and may even support both under differing physiological 
conditions. Further information on this topic can be found in Chapter 1b. 
The ECOR library collection was initially established in 1984 (Ochman & 
Selander, 1984) and has been widely used since as a standard reference 
collection of various E. coli strains from differing geographical and host 
backgrounds. Ideally, this reference library was to encompass representatives 
from the varying natural population. Using this ECOR library to study the 
presence/absence of the Eut MCP provided adequate strain and background 
variation to observe the effect of the MCP. 
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Figure 4.2: Figure illustrates the phylogenetic relationships amongst the strains of the ECOR 
library based upon a neighbour joining tree drawn from concatenated MLST data (Wirth, et al 
2006). Positive (+) sign indicates strains displaying B-12 dependent ethanolamine metabolism in 
this study, whilst negative (-) sign indicates strains, which did not display ethanolamine 
metabolism in this study (see Table 4.1. and 4.2. also) A, B, D are phylogenetic branches 
determined in the original Wirth study. 
 
To observe the effect of the Pdu MCP in another Enterobacteria, 
Yersinia enterocolitica was used. In general, virulence-related genes in Yersinia 
spp. can be divided into 3 main groups; Group 1 consists of genes present in all 
lineages, Group II consists of genes selectively gained or lost by entire lineages 
and Group III consists of genes specific for single isolates (Reuter et al., 2014). 
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In Yersinia spp., the ability to utilize 1,2-propanediol is a metabolic property 
encoded by Group II genes on contigs present in the enteric pathogen of 
mammals Yersinia enterocolitica and the majority of other Yersinia species. The 
Yersinia pdu operon strongly resembles the Salmonella pdu operon (Reuter et al., 
2014). This pathway is absent in the Yersinia pseudotuberculosis/Y. pestis 
lineage, and Y. ruckeri, Y. nurmii, and Y. similis and Y. entomophaga (none of 
which apart from Y. pseudotuberculosis are enteric pathogens of mammals). 
Therefore it is suggested that the ability of Y. enterocolitica to utilise 1,2-PD 
offers a competitive advantage over other commensal gut bacteria (Reuter et al., 
2014). 
Cells expressing inclusion bodies or increased polymer production have 
increased buoyant density (Eroglu & Melis, 2009). It was hypothesized that 
microcompartment expression, equivalent to an accumulation of organized 
inclusion bodies or elaborate polymer would have a similar effect. This study 
investigated whether the buoyant density of bacteria would be increased by the 
presence of an MCP, compared with an equivalent cell unable to make a 
microcompartment or in which the microcompartment was not induced.  
The analysis performed as part of this study focuses predominantly on 
phenotypic effects but there is an acknowledgement of the need for genetic 
investigation to provide a complete overview. 
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4.2. Methods & Materials 
4.2.1. Bacterial strains and culture conditions 
Bacterial strains used in this study are listed (Table 3.1). The majority of the E. 
coli strains used in this study were members of the E. coli Reference Library 
Collection (ECOR), kindly provided by Dr. David Clarke, University College 
Cork, but originating from the Ochman & Selander, 1984 study. An additional E. 
coli strain containing the recombinant Pdu construct, pAR3114, was also used. 
Yersinia strains used were provided by Dr. Tamara Ringwood, University 
College Cork.  
Strain Origin Reference 
ECOR Library (ECOR #1-54) Dr. David Clarke, University 
College Cork 
Ochman & Selander, 1984 
Yersinia enterocolitica 53/03 Dr. Tamara Ringwood, 
University College Cork 
Pathogen Research 
Group, Nottingham Trent 
University, Nottingham 
Yersinia enterocolitica 13/03 Dr. Tamara Ringwood, 
University College Cork 
Pathogen Research 
Group, Nottingham Trent 
University, Nottingham 
Yersinia enterocolitica NZ3 Dr. Tamara Ringwood, 
University College Cork 
Pathogen Research 
Group, Nottingham Trent 
University, Nottingham 
E. coli JM109 pAR3114 (Pdu 
operon) 
Dr. Joshua Parsons, University 
of Kent 
Parsons et al., 2008 
E. coli BL21 (DE3) pJP061  
(pETpduABJKNU)  
Dr. Joshua Parsons, University 
of Kent  
Parsons et al., 2008 
Lactobacillus reuteri DSM20016 National Collection of Dairy 
Organisms, Reading, UK 
Sriramulu et al., 2008 
Table 4.1. List of strains utilized in study, indicating strain and origin. 
 
E. coli strains were cultured on MacConkey agar, supplemented with 
ethanolamine and B12 (Table 4.2), and LB supplemented with ethanolamine and 
B12. For minimal growth conditions, E. coli was inoculated in ethanolamine 
minimal media (Table 4.3). Recombinant E. coli strains were grown in LB 
supplemented with relevant antibiotic selection. Yersinia strains were cultured on 
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MacConkey agar supplemented with 1,2-propanediol and B12, and also in LB 
supplemented with 1,2-propanediol and B12. Lactobacillus strains were grown in 
MRS supplemented with 1,2-propanediol and B12 for the induction of the Pdu 
MCP. Recombinant E. coli strains containing ppk were grown in LB 
supplemented with ampicillin. 
Table 4.2. Recipe list for MacConkey agar, supplemented with either i) ethanolamine ii) 
ethanolamine and B12 and iii) 1,2-propanediol and iv) 1,2-propanediol and B12 which were 
added post-autoclave 
Ingredients Amount (per Litre) 
Monopotassium Phosphate 3.94g/l 
Dipotassium Phosphate 4.97g/l 
Ammonium Sodium Phosphate Tetrahydrate 3.5g/l 
Magnesium Sulphate 0.2g/l 
Ethanolamine * 3.9g/l 
Adjust to pH 7.2 ±0.2 using 4NaOH  
B12 (200nM) * 600µl 
Table 4.3. Recipe list for NCE media, supplemented with ethanolamine, which was added post-
autoclave. 
Material Amount (per Litre) 
Tryptone from casein 10g/L 
Sodium chloride 10g/L 
Granulated Yeast Extract 5g/L 
Deionised Water 1L 
Ethanolamine (50mM) * 5g 
B12 (200nM) * 600µL 
1,2-propanediol * 4mLs 
Table 4.4. Recipe for Luria Broth (LB) for the growth of E. coli, supplemented with ethanolamine 
and B12 or 1,2-propanediol and B12. 
Ingredients Amount (per Litre) 
Soy Peptone 20g 
Ox-Bile 5g 
NaCl 5g 
Neutral Red 0.075g 
Agar 15g 
Adjust to pH 7.4 ±0.2 using 4NaOH  
Ethanolamine (50mM) * 5g 
B12 (200nM) * 600µL 
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Material Amount (per Litre) 
MRS broth 55g/L 
Deionised Water 1L 
B12 (200nM) * 600µl 
1,2-propanediol * 4mLs 
Table 4.5. Recipe for de Man-Rogosa-Sharpe (MRS) for the growth of lactobacilli, supplemented 
with 1,2-propanediol and B12. 
 
4.2.2. Eut utilization screening process 
54 strains from the provided ECOR library of 84 strains were used for the 
screening process. These 54 strains were selected based on their numerical order, 
with no further traits or attributes contributing to the decision.  
E. coli ECOR strains were initially picked from a 96 well plate library and 
directly inoculated into 50 mL Luria-Bertani broth (LB) (Sambrook et al., 1989) 
for overnight growth at 37°C with agitation, to confirm their growth ability and 
rate. Following this initial growth confirmation, selected strains were then 
streaked on to differential MacConkey agar, supplemented with ethanolamine 
50mM and 200nM cobalamin B12. Cobalamin B12 was added in order to 
determine if the ethanolamine was degraded in a cobalamin-dependant manner, 
as previously indicated based on work regarding the pdu operon in Salmonella 
and eut operon in E. coli (Lawrence & Roth, 1996). MacConkey agar plates were 
prepared fresh daily from a total 500mL flask preparation.  
Resulting colonies produced either a red (eut positive) or yellow (eut negative) 
colour. This colour difference is triggered by a pH shift due to acid production 
caused by the utilization of ethanolamine by the enzyme EAL (Ethanolamine 
ammonia-lyase) (Srikumar & Fuchs, 2011). This colour change can occur 
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without the addition of cobalamin in the agar, cobalamin dependence is 
established by more rapid occurrence on cobalamin-supplemented media vs non-
supplemented media. As previously mentioned, the EAL enzyme catalyzes the 
AdoCbl-dependent conversion of ethanolamine to acetaldehyde and ammonia 
(Bradbeer, 1964).  
 
Figure 4.3. Equation illustrating the conversion of ethanolamine to ammonia and acetaldehyde 
catalyzed by ethanolamine ammonia lyase (credit: brenda-enzymes.org) 
 
4.2.2.1. Growth analysis 
Following solid culture, colonies were then picked and transferred to liquid broth 
for further growth screening. In order to determine bacterial growth profiles, 100 
µl of LB broth was inoculated with a single colony of a selected E. coli strain 
whilst un-inoculated LB broth was used as a negative control. Cultures were 
incubated at 37°C for 27 hours with agitation, and the optical density at 600 nm 
(OD600) was determined during this period at 2 hour intervals using the Biotek 
plate reader. 
 
4.2.3. Phenotypic analysis  
After the identification of potential Eut positive/negative strains, the phenotypic 
screening processes begun. A number of analyses were applied based upon 
previous literature. 
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4.2.3.1. Density gradient and separation 
Cell density, or buoyant density is a measure of the tendency of a substance to 
float in some other substance. This can be measured by density-gradient 
ultracentrifugation, where samples with a high buoyant density will be found at 
the bottom of a gradient, whilst samples found near the top of the gradient will 
have a relatively low density (Mizushima et al., 1967) 
To observe this effect, the density gradient media Percoll (GE Healthcare 17-
0891-02) was used. Percoll is a cell separation solution consisting of a sodium-
stabilized colloid, which is iso-osmotic and pH neutral (Pertoft, 1999) and has 
been extensively used in literature as a method for E. coli cell separation 
(Makinoshima et al., 2002), (Pertoft, 1999). The principle of a density gradient 
separation, or isopycnic (meaning “of the same density”) centrifugation, is that 
particles suspended in a fluid whose density varies with depth will move 
downward until they encounter an area of fluid of the same density as themselves 
 
Figure 4.4. Image indicating the principle of density gradient separation (Frei, Sigma Aldrich) 
E. coli strains displaying a Eut-positive phenotype were induced with 
ethanolamine and vitamin B12, with a positive control provided by un-induced 
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strains (i.e. strains grown on plain, un-supplemented media) and a negative 
control provided by the use of Eut-negative strains. Selected strains were 
inoculated from MacConkey agar plates into 50mL LB broth supplemented with 
50mM ethanolamine and 200nM B12, and grown at 37°C for approx. 18 hours. 
Eut-negative strains were grown in 50mL LB broth without supplementation. 
After this overnight growth, cells were harvested by centrifugation at 6,000r.p.m. 
using the J10 Beckman Coulter rotor, with the resulting pellet washed twice with 
10mL PBS. The final cell pellet was then resuspended in 1mL phosphate 
buffered saline (PBS).  
To prepare the density separation gradient, 8 mL of Percoll was added to 1.25mL 
of PBS and 0.25 mL of density marker beads (supplied by Cospheric, Santa 
Barbara, CA USA) in PBS for 1 hour at 20,000 r.p.m. at 4°C with a Beckman 
SW40Ti rotor. 3 different densities of bead were used for the gradient; orange 
beads 1.04g/mL (UVPMS-BO-1.040 212-250um), red beads 1.10g/mL 
(REDPMS-1.10 425-500um) and red beads 1.12g/mL (REDPMS-1.12 212-
250um) (three different colours were not available). 
0.5mL of the bacterial resuspension was added to this prepared density gradient, 
amounting to a total volume of 10mL. The sample was then centrifuged at 
20,000r.p.m for 45 minutes at 4°C, once again using the Beckman SW40Ti rotor. 
This technique was also applied to observations of the propanediol (Pdu) MCP in 
Lactobacillus reuteri and Yersinia enterocolitica strains. 
Sample were removed from the Percoll gradient by pipette and sampled for 
imaging by transmission electron microscopy (see Chapter V for detailed 
methods). 
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4.2.3.2. Sedimentation & settling analysis 
Previously utilized by (Ramsay et al., 2011) to observe the presence of gas 
vesicles in Serratia spp., the protocol involved the static sedimentation of 
cultures over a certain time period, to again observe the potential effects of an 
intracellular body on the buoyant density of the bacterial cell. Cultures were 
grown overnight in 5mL culture at 37°C (E. coli was grown in LB supplemented 
with ethanolamine and B12; Yersinia was grown in LB supplemented with 1,2-
propanediol and B12, and Lactobacillus was grown in MRS supplemented with 
1,2-propanediol). After overnight growth to an OD600nm of 0.8, 1mL of 
relevant culture was inoculated into 10mL of fresh, unsupplemented broth, in 
clear open-top tubes that were sealed with paraffin to prevent contamination. 
Cultures were allowed to stand uninterrupted for a period of 24 hours, with 
regular visual observation.  
 
Figure 4.5. Diagram illustrating the principle of cell sedimentation. A bacterial culture will be 
allowed stand for a period of time, and the culture will naturally sediment over this time. (Frei, 
Sigma Aldrich) 
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4.3. Results & Discussion 
 
4.3.1. Screening of E. coli cultures 
54 strains from the ECOR E. coli library were screened on MacConkey agar 
plates supplemented and un-supplemented plates. Of the 54 screened strains, 24 
strains produced red colonies more rapidly on MacConkey agar supplemented 
with ethanolamine and B12 than ethanolamine alone. This indicated the 
cobalamin-dependant metabolism of ethanolamine, and the potential presence of 
the eut operon. 
 
 
Figure 4.6. McConkey agar plates cultured with ECOR E. coli #26. Plate on the left has been 
supplemented with ethanolamine and B12. Red colonies present on plate indicate positivity for 
the eut metabolism. Plate on the right has not been supplemented, and yellow colonies are 




	  	  	  	  	  	  




Figure 4.7. McConkey agar plates cultured with ECOR E. coli #41. Plate on the left has been 
supplemented with ethanolamine and B12. Red colonies present on plate indicate positivity for 
the eut metabolism. Plate on the right has not been supplemented, and yellow colonies are 




Figure 4.8. McConkey agar plates cultured with ECOR E. coli #50. Plate on the left has been 
supplemented with ethanolamine and B12. Plate on the right has not been supplemented, and 
yellow colonies are present, indicating the strain is phenotypically negative for cobalamin 
dependent ethanolamine metabolism. (Eut negative) 
 
Based upon the colony appearance of the E. coli ECOR strains on these 
MacConkey agar plates, they were classified as either Eut-positive or eEut-
negative in further analysis. The strains were re-streaked on the 
supplemented/un-supplemented MacConkey agar plates after each phenotypic 
analysis to ensure a consistent phenotype from the strain. 
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As illustrated in Table 4.7., the strains which this study identified as displaying 
Eut-positive phenotypes are not confined to any one particular branch of the 
ECOR phylogenetic tree (Figure 4.2). This observance is in agreement with 
previously published literature (Lawrence & Roth, 1996) which also used the 
ECOR library. However in comparison with the Lawrence & Roth, 1996 study, 
we only observed Eut-positive phenotypes in 24 of the 54 analysed strains, 
wheras Lawrence & Roth observed 47 Eut positive phenotypes testing the same 
ECOR strain numbers. This difference in the positive:negative ratio is most 
likely due to in vitro selection against the operon, leading to the observation of 
more negatives than previously noted over a decade ago (Lawrence & Roth, 
1996).  
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ECOR reference number Strain Origin Phenotypic Branch 
3 
Dog, Massachusetts Branch A 
10 
Adult human, New York Branch A 
11 
Urine, adult human, Sweden Branch A 
12 
Adult human, Sweden Branch A 
13 
Adult human, Sweden Branch A 
14 
Urinary tract, adult human, Sweden Branch A 
18 
Celebes ape, Seattle Zoo, Washington Branch A 
20 
Steer, Bali Branch A 
21 
Steer, Bali Branch A 
22 
Steer, Bali Branch A 
25 
Dog, New York Branch A 
26 
Human infant, Massachusetts Branch A 
27 
Giraffe, Seattle Zoo, Washington Branch B1 
28 
Adult human, Iowa Branch B2 
29 
Kangaroo rat, Nevada Branch B1 
39 
Adult human, Sweden Branch D 
40 
Urine, adult human, Sweden Branch D 
41 
Adult human, Tonga Branch D 
42 
Adult human, Massachusetts Branch D 
44 
Cougar, Seattle Zoo, Washington Branch D 
46 
Celebes ape, Seattle Zoo, Washington Branch D 
47 
Sheep, New Guinea Branch D 
48 
Urine, adult human, Sweden Branch D 
49 
Adult human, Sweden Branch D 
Table 4.7. Table illustrating the origin of the potential eut-positive strains for the ECOR library. 
This table references against Figure 2.1 which indicates the phylogenetic relationship of the 
strains (Modified from Ochman & Selander, 1984) 
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ECOR reference number Strain Origin Phenotypic Branch 
1 
















































































































Adult human, Iowa 
 
Branch B2 
Table 4.8. Table illustrating the origin of the potential eut-negative strains for the ECOR library. 
This table references against Figure 2.1 which indicates the phylogenetic relationship of the 
strains (Modified from Ochman & Selander, 1984) 
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4.3.2. Growth analysis 
 
Figure 4.9. Growth curve indicating the effect of ethanolamine and B12 supplementation. ECOR 
E. coli #26 (positive eut phenotype) is illustrated grown in LB without supplementation and also 
with supplementation of ethanolamine and B12. ECOR E. coli #50 (negative eut phenotype) is 
also illustrated grown in LB with and without supplementation, which appear to have no effect on 
growth rate. 
 
Analysis of the growth curves of the ECOR strains grown on LB vs. LB 
supplemented with ethanolamine and B12 demonstrated no obvious early growth 
advantage for strains. Selected strains displaying a positive Eut phenotype on 
plate screening (e.g. ECOR #26) appeared to have a diauxic growth pattern on 
LB with added ethanolamine, with slower growth and an additional lag phase but 
an increase in final OD600 compared with LB alone. 
4.3.3. Density gradient and separation 
For reproducibility and comparability it was necessary to use density marker 
beads to provide a visual indication of the density for comparison with cell bands 
for measurement (Woldringh et al., 1981). 
	  	  	  	  	  	  




Figure 4.10 Increased buoyant density of L. reuteri DSM20016 (pdu-positive) in isopycnic 
(density gradient) centrifugation when grown in Pdu operon inducing conditions. The white band 
represents bacterial cells. The tube on the left contains L. reuteri DSM20016, which was grown 
in MRS supplemented with 1,2-propanediol, and B12. The tube on the right also contains L. 





Figure 4.11. Increased buoyant density of Y. enterocolitica 53/03 (pdu-positive) in isopycnic 
(density gradient) centrifugation when grown in Pdu operon inducing conditions. The white 
bands are bacteria.  The tube on the left contains Y. enterocolitica 53/03 which was grown in LB 
supplemented with 1,2-propanediol and B12. The tube on the right also contains Y. enterocolitica 
53/03 which was also grown in LB, unsupplemented. 
	  	  	  	  	  	  





Figure 4.12. The tube on the left illustrates E. coli expressing the recombinant pduABJKNU 
(empty MCP shell) which was grown in LB supplemented with ampicillin. The tube on the right 
illustrates the recombinant Pdu MCP (pAR3114) in E. coli which was grown in LB supplemented 
with 1,2-propanediol and B12. 
 
In the instance of the Pdu-MCP samples (Y. enterocolitica, L. reuteri) the 
expected effect was observed i.e. the bacterial band from samples grown in 
microcompartment inducing conditions appears denser (higher buoyant density) 
than the control (Figure 4.11, 4.12). This result supports the original hypothesis 
that cells containing the MCP would have higher buoyant density than non-MCP 
containing cells. 
	  	  	  	  	  	  





Figure 4.13. Decreased buoyant density of ECOR E. coli #41 (eut-positive) in isopycnic (density 
gradient) centrifugation when grown in Eut operon inducing conditions. The tube on the left 
contains ECOR E. coli #41 that was grown in the presence of ethanolamine and B12. The tube on 
the right also contains ECOR E. coli #41 that was grown without ethanolamine and B12 
 
 
Figure 4.14. Decreased buoyant density of ECOR E. coli #26 (eut-positive) in isopycnic (density 
gradient) centrifugation when grown in Eut operon inducing conditions. The tube on the left 
contains ECOR E. coli #26 that was grown in LB supplemented with ethanolamine and B12. The 
tube on the right also contains ECOR E. coli #26 which was grown in LB, unsupplemented. 
	  	  	  	  	  	  





Figure 4.15. ECOR E. coli #50 (eut-negative) shows no change  in buoyant density on isopycnic 
(density gradient) centrifugation when grown in Eut operon inducing conditions. The tube on the 
left contains ECOR E. coli #50 that was grown in LB supplemented with ethanolamine and B12. 
The tube on the right also contains ECOR E. coli #50 which was grown in LB, unsupplemented. 
 
However, regarding the ethanolamine studies, it was observed in samples 
containing an induced Eut-positive E. coli culture versus a non-induced Eut-
positive E. coli culture, that the resulting bacterial band appears to be less dense 
(i.e. lower buoyant density) than its un-induced counterpart (Figure 4.13, 4.14). 
This trend was observable across examined samples from the ECOR library of 
Eut-positive strains. With the eut-negative strains, there appeared to be no 
difference amongst strains grown in the presence/absence of ethanolamine and 
B12 (Figure 4.15), suggesting a connection between the buoyant density and a 
functional Eut operon.  
4.3.4. Sedimentation & settling analysis 
The role of the settling and sedimentation analysis was to observe if the results 
identified through the isopycnic centrifugation were consistent with another 
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methodology. These observations were repeated in triplicate to ensure a 
consistent result.  
 
Figure 4.16. Increased sedimentation of Y. enterocolitica 53/03 grown in Pdu operon inducing 
conditions. The tube on the left contains Y. enterocolitica 53/03 grown in LB supplemented with 
1,2-propanediol and B12, and allowed to sediment. The tube on the right contains Y. 
enterocolitica 53/03 which was grown in LB, unsupplemented. 
 
Figure 4.17. Differential E. coli sedimentation with empty and full microcompartment 
expression. The tube on the left indicates the recombinant Pdu MCP (pAR3114) in E. coli which 
was grown in LB supplemented with 1,2-propanediol and B12. The tube on the right indicates E. 
coli expressing the recombinant empty MCP (pduABJKNU) which was grown in LB 
supplemented with ampicillin. 
 
As can be observed, the results are consistent and in agreement with previous 
observations from the isopycnic centrifugation. Pdu-inducing conditions for 
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Yersinia enterocolitica capable of expressing native MCP (data not shown) result 
in faster sedimentation or settling than the equivalent non-induced control cells 
(Figure 4.16).  
 
Figure 4.18. Increased sedimentation of Y. enterocolitica NZ3 grown in Pdu operon inducing 
conditions. The tube on the left contains Y. enterocolitica NZ3 grown in LB supplemented with 
1,2-propanediol and B12, and allowed to sediment. The tube on the right contains Y. 




Figure 4.19. Image illustrating results of ECOR E. coli #26. The tube on the left contains ECOR 
E. coli #26 grown in the presence of ethanolamine and B12, and allowed to sediment. 
 The tube on the right contains ECOR E. coli #26 grown in standard media conditions and 
allowed to sediment.  
 
Again, the results of the sedimentation test agree with the previous isopycnic 
centrifugation results. The Eut-positive E. coli cells (cobalamin-dependent 
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ethanolamine metabolism phenotype positive) sediment slower after being grown 
in Eut operon inducing conditions (ethanolamine) than when non-induced. 
Again, this result was consistent across the various Eut-positive ECOR strains 
(data not shown, 10 strains tested). 
4.3.5. TEM Imagery 
Samples from the Percoll gradient were obtained and underwent TEM imaging 
(see Chapter V for methodology). Samples from the upper part of the buoyant 
density band from ethanolamine-positive samples were observed under TEM and 
the presence of dark, electron dense masses could be seen indicative of bacterial 
microcompartments.   
 
Figure 4.20. Image illustrating microcompartments under TEM in the ethanolamine positive 
#ECOR3 sample following ethanolamine induction. This sample was from the upper part of the 
buoyant band observed in the percoll gradient. Sample at 40k magnification.  
	  	  	  	  	  	  




Figure 4.21. Image illustrating E. coli #ECOR3 grown without ethanolamine taken from the 





	  	  	  	  	  	  




Originally the focus of this study was to investigate the hypothesis that 
microcompartment expression inside a bacterial cell would affect an intrinsic 
physical characteristic of the whole cell: buoyant cell density. Due to the unique 
features of bacterial microcompartments, internal structures containing closely 
packed enzymes that form only when induced, it was hypothesized that their 
induction in a bacterial cell would lead to increased buoyant cell density in the 
same fashion as has been observed for inclusion body formation. To investigate 
this hypothesis, I made observations of cells with induced native Pdu MCP (L. 
reuteri and Y. enterocolitica), induced native Eut MCP (E. coli ECOR strains) 
and recombinant microcompartments (Pdu MCP and Pdu shell only). Selecting 
these models also allowed observation of any potential differences between 
Gram positive (L. reuteri) and Gram negative cell (E. coli, Y. enterocolitica) cell 
types.  
Growth in conditions known to induce native microcompartment formation 
resulted in increased buoyant density of Y. enterocolitica (Gram negative) 
(Figure 4.8) and Lactobacillus reuteri 20016 (Gram positive) (Figure 4.7) 
compared to growth in non-inducing conditions. Corresponding increases and 
decreases in sedimentation were observed. Increased sedimentation could reflect 
the known effect of microcompartment gene expression in elongating cells 
(Liang, Frank, Lunsdorf, Warren and Prentice, submitted for publication), 
because larger cells should sediment more rapidly, but slower sedimentation was 
observed for empty microcompartment expressing cells (Figure 4.14) which 
were correspondingly less dense. 
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This suggests “empty’ microcompartments seen to lack an electron dense core on 
TEM are indeed lacking some normal cytoplasmic contents and represent a 
separate enclosure within the cell.  
Screening the ECOR library, which provided the majority of the E. coli strains 
utilized in this study, approximately 46% of the tested ECOR E. coli strains 
displaying a Eut-positive phenotype. These positive strains were from various 
phylogenetic branches of the ECOR library (Figure 2.2 and Table 4.1) as in the 
previous study (Lawrence & Roth, 1996). However, of the 53 strains screened in 
the current study, 47 were Eut-positive in the previous study whereas in the 
current study only 24 strains were identified as Eut positive. The strains 
identified by this study as Eut-negative are also marked on the phylogenetic 
ECOR tree (Figure 2.2 and Table 4.2). This apparent discrepancy is most likely 
due to in vitro selection against the ethanolamine operon during growth on rich 
media, leading to the inactivation of the operon in many of the ECOR strains. 
Eut-positive ECOR strains grown in the presence of ethanolamine and B12 
exhibited diauxic growth (growth in two phases) (Figure 4.4). This trait was not 
identifiable in eut-negative strains. To identify which aspect of this diauxic 
growth curve corresponds with ethanolamine metabolism, serial assays 
(ethanolamine and acetaldehyde) would be required.  
These identified strains were observed, alongside the L. reuteri and Y. 
enterocolitica strains, for effects relating to the hypothesis regarding buoyant cell 
density. The Pdu-positive strains displayed expected effects, wherein Pdu-
induced samples appeared to be denser, and have a higher buoyant density than 
un-induced cells. This observance is in agreement with published literature about 
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recombinant protein expression (Cheng, 1983), (Pandey et al., 2013). 
Interestingly, empty microcompartments appeared to display decreased cell 
density vs. the recombinant Pdu MCP, pAR3114. A direct comparison with E. 
coli not expressing any microcompartments would be required to show if the 
empty microcompartments were less dense than normal cytoplasm and the 
recombinant Pdu microcompartment was more dense than normal cytoplasm.  
However, with regards to the native Eut microcompartment, the opposite effect 
was observed, where the ethanolamine-induced MCP containing cells appear to 
be less dense, or to have a lower buoyant density that the uninduced cells. This 
result was consistent across all observed E. coli strains. 
The reasons for these differing buoyant densities are still unclear. The Eut MCP 
has been previously linked to pathogenic E. coli competitive fitness in the 
intestines (Thiennimitr et al., 2011) due to the abundance of ethanolamine from 
membrane cell turnover, in the same way as Pdu microcompartments (Goudeau 
et al., 2012) but Eut microcompartments have been more difficult to extract and 
identify than Pdu microcompartments (Choudhary et al., 2012). 
If we assume that Eut microcompartments are similarly constructed to Pdu 
microcompartments, there are two hypotheses based on cell membrane or 
microcompartment permeability that could explain these unusual results. These 
relate to the cell membrane permeability of the substrate ethanolamine at ambient 
pH, or the retention in some form of ammonium ions generated by ethanolamine 
deaminase activity (Figure 3.1, 5.1).  
The bacterial cell membrane permeability of ethanolamine has previously been 
examined by (Penrod et al., 2004) where they established that ethanolamine 
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transferred across the cell membrane in a pH-dependant manner. Ethanolamine 
can pass through the cell membrane when uncharged, with this proportion 
decreasing at pH below the pKA of 9.4. (Lide, 2004). This diffusion of 
uncharged ethanolamine is likely facilitated by EutH (ethanolamine permease), 
which can shift the balance of uncharged ethanolamine.  
 
Figure 5.1. Schematic illustrating the initial shrinkage of the cell due to presence of 
ethanolamine in the environment. After this initial osmotic shift, balance is restored in the cell, 
with gradual uptake of ethanolamine. 
This can typically occur at within the pH range of 7-8. This can be illustrated by 
the observation of a large decrease in ethanolamine uptake in knockout models 
(Roof & Roth, 1989). Further studies (Penrod et al., 2004) indicated an osmotic 
pressure associated with the presence of ethanolamine, with cells shrinking 
initially on addition of ethanolamine at a pH in range 7-8.  Therefore it would be 
expected that ethanolamine-metabolising cells would initially appear less dense 
(due to shrinkage) before swelling again due to resumption of osmotic balance. 
In Salmonella, this initial shrinkage and then re-swelling can take approximately 
10 minutes (Penrod et al., 2004). However in the isopycnic centrifugation, and 
the sedimentation tests, there was no ethanolamine present in the test medium – 
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cultures were only exposed to ethanolamine and B12 during initial growth. For 
testing analysis, cultures were placed in PBS (isopycnic centrifugation) and 
unsupplemented LB (sedimentation). To explore this discrepancy further, 
experimentation with a point mutation of the EAL region would be interesting.  
Alternatively, the role of ammonia ions in attaining neutral buoyancy has been 
identified in cephalopods (Seibel et al., 2004). Ammonium (MW 18.03846) is a 
lighter cation than sodium (MW 22.989769) and replacement of sodium by 
ammonium in sequestered extracellular compartment fluid decreases buoyant 
density of the organism.   
NH4+ -> NH3 + H+    pKa = 9.24 
Ammonium -> Ammonia + H+ 
Figure 5.2. Equation illustrating the breakdown of ammonium to ammonia, releasing hydrogen. 
At physiological pH most of the total ammonium nitrogen is in the charged 
ammonium form, for which the cell membrane is impermeable. However, the 
small fraction of gaseous ammonia is continuously lost via the cell membrane 
and imposes an ammonium requirement. Ammonia/ammonium ion uptake by E. 
coli is very tightly regulated because ammonia is the preferred nitrogen source 
for E. coli and once taken up a proportion freely diffuses back through the cell 
membrane in this way (Kim et al., 2012). If large amounts of ammonium were 
generated by ethanolamine metabolism, the increased ammonium content might 
displace sodium and reduce density. Additionally, if the microcompartment 
provided any form of ammonia retention, for example by reduced pH decreasing 
the proportion of total ammonium nitrogen as ammonia, this could concentrate 
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ammonium ions relatively to other cations within the microcompartment and 
potentially decrease cell buoyant density over a longer period.  
A mutant disruption of the EAL region, whilst leaving the MCP structure intact, 
would be the next step in progressing this study and identifying the most 
probable hypothesis. Another potential progression would be the analysis of 
single cells, as this study focused on analysis of a population. This could be 
achieved using the techniques applied by (Godin et al., 2010), where they 
developed a dynamic fluidic control system which enabled the measurement of 
cell buoyant mass using a suspended microchannel resonator (SMR). As 
individual cells transit the microchannel, a shift in the resonant frequency of the 
SMR can be observed which corresponds to the buoyant mass of the cell (Godin 
et al., 2010). 
A further point of note is regarding cell phase or cell growth. Whilst this was not 
specifically observed in this study, there has been conflicting evidence regarding 
variations in cell density and cell growth phase (Makinoshima et al., 2002), 
(Kubitschek et al., 1984).  For this study, incubation time prior to centrifugation 
was sufficient to enter stationary phase, but more specific study into the potential 
connection between cell density and cell growth phase would be an interesting 
progress of this work. 
  
	  	  	  	  	  	  




• Bertin Y., Girardeau J., Chaucheyras-Durand F., Lyan B., Pujos-Guillot 
E., Harel J., Martin C. (2010) Enterohaemorrhagic Escherichia coli gains 
a competitive advantage by using ethanolamine as a nitrogen source in 
the bovine intestinal content. Environmental Microbiology 13:365-377. 
• Bobik T., Havemann G., Busch R., Williams D., Aldrich H. (1999) The 
Propanediol Utilization (pdu) Operon of Salmonella enterica Serovar 
Typhimurium LT2 Includes Genes Necessary for Formation of 
Polyhedral Organelles Involved in Coenzyme B12-Dependent 1,2-
Propanediol Degradation. Journal of Bacteriology p. 5967–5975. 
• Bradbeer C. (1964) The Clostridial Fermentations of Choline and 
Ethanolamine. The Journal of Biological Chemistry 240-252. 
• Cheng Y. (1983) Increased cell buoyant densities of protein 
overproducing Escherichia coli cells. Biochemical and Biophysical 
Research Communications 111:104-111 
• Choudhary S., Quin M., Sanders M., Johnson E., Schmidt-Dannert C. 
(2012) Engineered Protein Nano-Compartments for Targeted Enzyme 
Localization. PLoS ONE 7:e33342 
• Drews G., Niklowitz W. (1956) Beitrage zur Cytologie der Blaualgen. 
Archives of Microbiology 24:147–62 
• Eroglu E., Melis A. (2009) Density Equilibrium method for the 
quantitative and rapid in situ determination of lipid, hydrocarbon, or 
	  	  	  	  	  	  
	  	  	  	  	  	  
 
225 
biopolymer content in microorganisms. Biotechology and Bioengineering 
102:1406-1415 
• Godin M., Delgado F., Son S., Grover W., Bryan A., Tzur A., Jorgensen 
P., Payer K., Grossman A., Kirschner M., Manalis S. (2010) Using 
buoyant mass to measure the growth of single cells. Nature Methods 
7:387-390 
• Goudeau D., Parker C., Zhou Y., Sela S., Kroupitski Y., Brandl M. 
(2012) The Salmonella Transcriptome in Lettuce and Cilantro Soft Rot 
Reveals a Niche Overlap with the Animal Host Intestine. Applied and 
Environmental Microbiology 79:250-262 
• Havemann, G. D., Sampson, E. M., Bobik, T. A. (2002) PduA is a shell 
protein of polyhedral organelles involved in coenzyme B12 -dependent 
degradation of 1,2-propanediol in Salmonella enterica serovar 
Typhimurium LT2. Journal of Bacteriology. 184:1253–1261.  
• Kerfeld, C. A., Heinhorst, S., Cannon, G. C. (2010). Bacterial 
Microcompartments. Annual Review of Microbiology 64:391–408. 
• Kim, M., Zhang, Z., Okano, H., Yan, D., Groisman A., Hwa, T. (2012) 
Need-based activation of ammonium uptake in Escherichia coli. 
Molecular System Biology 8:616-630. 
• Krouwer J., Babiors B. (1977) Mechanism of Action of Ethanolamine 
Ammonia-lyase, an Adenosylcobalamin-dependent Enzyme. Journal of 
Biological Chemistry 252:5004-5009 
	  	  	  	  	  	  
	  	  	  	  	  	  
 
226 
• Kubitschek H., Baldwin W., Schroeter S., Graetzer R. (1984) 
Independence of buoyant cell density and growth rate in Escherichia coli. 
Journal of Bacteriology 158:296-299 
• Lawrence J., Roth J. (1996) Evolution of Coenzyme BI2 Synthesis 
Among Enteric Bacteria: Evidence for Loss and Reacquisition of a 
Multigene Complex. Genetics 142:11-24 
• Lide, D. R. (2001) Handbook of Chemistry and Physics (Chemical 
Rubber Publishing, Cleveland) 
• Makinoshima H., Aizawa S., Hayashi H., Miki T., Nishimura A., 
Ishihama A. (2003) Growth Phase-Coupled Alterations in Cell Structure 
and Function of Escherichia coli. Journal of Bacteriology 185:1338-
1345. 
• Makinoshima H., Nishimura A., Ishihama A. (2002) Fractionation of 
Escherichia coli cell populations at different stages during growth 
transition to stationary phase. Molecular Microbiology 43:269-279 
• Mizushima S., Miura T., Ishida M. (1967) Fractionation by density 
gradient centrifugation of membranous organella of Bacillus megaterium. 
Journal of Biochemistry 61(1):146–148. 
• Ochman H., Selander R. (1984) Evidence for clonal population structure 
in Escherichia coli. Proceedings of the National Academy of  Science 
81:198-201. 
• Pandey N., Sachan A., Chen Q., Ruebling-Jass K., Bhalla R., Panguluri 
K., Rouviere P., Cheng Q. (2013) Screening and identification of genetic 
	  	  	  	  	  	  
	  	  	  	  	  	  
 
227 
loci involved in producing more/denser inclusion bodies in Escherichia 
coli. Microbial Cell Factories 8:12-43 
• Parsons J., Dinesh S., Deery E., Leech H., Brindley A., Heldt D., Frank 
S., Smales C., Lunsdorf H., Rambach A., Gass M., Bleloch A., McClean 
K., Munro A., Rigby S., Warren M., Prentice M. (2008) Biochemical and 
Structural Insights into Bacterial Organelle Form and Biogenesis. Journal 
of Biological Chemistry 283:14366-14375 
• Penrod J., Mace C., Roth J. (2004) A pH-Sensitive Function and 
Phenotype: Evidence that EutH Facilitates Diffusion of Uncharged 
Ethanolamine in Salmonella enterica. Journal of Bacteriology 186:6885-
6890 
• Penrod, J. T., Roth, J. R. (2006) Conserving a Volatile Metabolite: a Role 
for Carboxysome-Like Organelles in Salmonella enterica. Journal of 
Bacteriology 188:2865–2874. 
• Pertoft H. (2000) Fractionation of cells and subcellular particles with 
Percoll. Journal of Biochemistry 44:1–30. 
• Ramsay J., Williamson N., Spring D., Salmond G. (2011) A quorum-
sensing molecule acts as a morphogen controlling gas vesicle organelle 
biogenesis and adaptive flotation in an enterobacterium. Proceedings of 
the National Academy of Sciences 108:14932-14937. 
• Reuter S., Connor T., Barquist L., Walker D., Feltwell T., Harris S., 
Fookes M., Hall M., Petty N., Fuchs T., Corander J., Dufour M., 
Ringwood T., Savin C., Bouchier C., Martin L., Miettinen M., Shubin M., 
	  	  	  	  	  	  
	  	  	  	  	  	  
 
228 
Riehm J., Laukkanen-Ninios R., Sihvonen L., Siitonen A., Skurnik M., 
Falcao J., Fukushima H., Scholz H., Prentice M., Wren B., Parkhill J., 
Carniel E., Achtman M., McNally A., Thomson N. (2014) Parallel 
independent evolution of pathogenicity within the genus Yersinia. 
Proceedings of the National Academy of Sciences 111:6768-6773. 
• Roof D., Roth J. (1989) Functions Required for Vitamin B12-Dependent 
Ethanolamine Utilization in Salmonella typhimurium. Journal Of 
Bacteriology 3316-3323 
• Sambrook J., Fritsch E.F., Maniatis T. (1989) Molecular Cloning: A 
Laboratory Manual, 2nd edn. Cold Spring Harbor Laboratory Press, Cold 
Spring Harbor, NY 
• Srikumar S., Fuchs T. (2010) Ethanolamine Utilization Contributes to 
Proliferation of Salmonella enterica Serovar Typhimurium in Food and in 
Nematodes. Applied and Environmental Microbiology 77:281-290. 
• Sriramulu, D. D., Liang, M., Hernandez-Romero, D., Raux-Deery, E., 
Lunsdorf, H. Parsons, J. B., Warren, M. J., Prentice, M.B., (2008). 
Lactobacillus reuteri DSM 20016 Produces Cobalamin-Dependent Diol 
Dehydratase in Metabolosomes and Metabolizes 1,2-Propanediol by 
Disproportionation. Journal of Bacteriology 190:4559–4567. 
• Stojiljkovic I., Baumer A.J., Heffron F. (1995) Ethanolamine utilization 
in Salmonella typhimurium: nucleotide sequence, protein expression, and 
mutational analysis of the cchA cchB eutE eutJ eutG eutH gene cluster. 
Journal of Bacteriology 177:1357–66. 
	  	  	  	  	  	  
	  	  	  	  	  	  
 
229 
• Thiennimitr P., Winter S., Winter M., Xavier M., Tolstikov V., Huseby 
D., Sterzenbach T., Tsolis R., Roth J., Baumer A. (2011) Intestinal 
inflammation allows Salmonella to use ethanolamine to compete with the 
microbiota. Proceedings of the National Academy of Sciences 
108:17480-17485. 
• Wirth T., Falush D., Lan R., Colles F., Mensa P., Wieler L., Karch H., 
Reeves P., Maiden M., Ochman H., Achtman M. (2006) Sex and 
virulence in Escherichia coli: an evolutionary perspective. Molecular 
Microbiology 60:1136-1151. 
• Woldringh, C., Binnerts J., Mans A. (1981) Variation in Escherichia coli 







	  	  	  	  	  	  



















	  	  	  	  	  	  







5.2. Materials & Methods 
  5.2.1. Bacterial strains & culture conditions 
5.2.2. Microcompartment extraction methodology 
5.2.2.1. BPER method 
5.2.2.2. YPER method 
5.2.2.3. BPER Gram positive cell variation  
5.2.3. Imaging & extraction 
5.2.3.1. Transmission Electron Microscopy 
 5.2.3.2. Focused Ion Beam Scanning Electron Microscopy   
  5.2.3.2.1. Sample Optimization 
5.3. Results & Discussion 
5.3.1. Microcompartment Extractions 
5.3.2. Imaging Extractions 
   5.3.2.1. Electron Microscopy 




	  	  	  	  	  	  





The ability to identify and extract bacterial microcompartments from bacterial 
cells is a key to research in this field, and an important aspect in distinguishing 
microcompartments from gas vesicles or other similarly sized intracellular 
components. Due to their proteinaceous nature, their extraction from cells is 
possible by adaptation of standard cell fractionation techniques, but poses 
technical difficulties. These difficulties include possible contamination from 
other substances within the bacterial cell, including other proteins and membrane 
fragments, and failure to obtain intact microcompartments rather than fragments. 
A number of different techniques have been described for microcompartment 
extraction, the majority of which are applicable only to Gram-negative cells. In 
this study we present the application and adaptation of these different techniques 
to our strains of focus, including a novel approach to extraction from Gram 
positive cells. 
Following on from these extraction experiments, I endeavoured to image these 
extracted microcompartments, along with whole cell samples, to identify any 
potential visual differences in the structure or presence of the 
microcompartments. This has been undertaken by using transmission electron 
microscopy (TEM) on extracted microcompartments and also through the novel 
application of the focused ion beam scanning electron microscope (FIB-SEM) to 
section whole cells.  
Microcompartment extractions were performed on E. coli strains containing both 
recombinant and native microcompartments. Additional novel changes to the 
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existing extractions methodology facilitated the extraction of the Pdu 
microcompartment from Lactobacillus reuteri, which had been previously 
unreported. Visualisation of the samples on TEM analysis highlighted putative 
microcompartments, which were also observable within whole bacterial cells. 
The use of the FIB-SEM was novel in its application to bacterial samples and 
required a number of optimisation steps. The use of glycerol protected the cells 
against excess ice accumulation, but may have led to cell aggregation, which 
created difficulties in attributing visualised putative microcompartments to 






	  	  	  	  	  	  




Bacterial microcompartments (MCPs) were originally identified within bacterial 
cells in the 1950s (Drews & Niklowitz, 1956). They possess a distinct polygonal 
shape, which triggered their identification by electron microscopy. In recent 
literature, more techniques have emerged to extract whole MCPs from cells, with 
an increased focus on quantifying the structural proteins (Sinha et al, 2012), 
(Sargent et al, 2013). 
Extracting the bacterial MCP is a process that heavily depends upon the lysis of 
the cell. This step can indeed be the most difficult, as failure to correctly lysis 
will lead to a low quality yield of MCP protein. The majority of MCP extractions 
in literature have focused on Gram negative cells (Sinha et al, 2012), (Havemann 
et al, 2003), which may be potentially due to the difficulties associated with 
obtaining good quality MCP from Gram positive cells, as the presence of the 
peptidoglycan wall can prevent sufficient cell lysis. 
Following cell lysis, the sample undergoes a procedure similar to a sucrose 
gradient, with the objective of separating the MCP from the cell. This initial 
technique has since been refined via the use of detergents and protease inhibitors, 
to remove the difficulty of contaminating proteins (Sinha et al, 2012). 
However, whilst it has been possible to view these extracts under the electron 
microscope, the ability to view the MCP in situ in the bacterial cell would 
potentially reveal additional information regarding the dimensions and 
intracellular population of the MCP. To achieve this, collaboration began 
between the Prentice lab and the Tyndall National Institute. The Tyndall 
National Institute had recently acquired a focused ion beam scanning electron 
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microscopy (FIB-SEM), with applications mainly focusing on materials 
technology, but with a view to experiment with biological samples. This 
provided an opportunity to explore the various viewpoints available for 
identifying the MCPs whilst present within in the bacterial cell. 
The functionality of the FIB-SEM is based upon its ability to make a deliberate 
focused cut in the sample. The narrow ion beam, which is typically gallium, cuts 
into the sample, which has been covered with a platinum-palladium layer. An 
electron beam is then angled at the ion beam, and scans the resulting cut, 
producing an image.  
 
Figure 5.1. Diagram illustrating the cut technique of the FIB-SEM (credit: Cocco et al, 2013) 
The cut surface is then milled by the ion beam, and a second cut made, allowing 
the imaging process to be repeated. Through successive cross-sectional cuts, the 
produced images can be reconciled together, allowing a 3-dimension object to be 
created using software technology.  
As previously mentioned, this technology has been widely used in recent years 
for materials science (Phelan et al, 2012) so a foray into the biological sphere is a 
recent approach (Alhede et al, 2012), (Soares Medeiros et al, 2012). 
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The choice to utilize the FIB-SEM for visualization of the MCPs was to alleviate 
some of the issues typically associated with standard TEM. The embedding 
procedure required for TEM usage typically requires the infiltration of the 
sample with transitional solvent, followed by infiltration with resin, then 
embedding, curing and finally cutting (Milani et al, 2007). This series of 
processes can lead to disruption and warping of the cell’s natural intracellular 
architecture, and can prevent obtaining reliable insight in to molecular structures 
(Pilhofer, 2010). The benefit of using cryo-imaging is the removal of these 
preparative treatments, as the cells are observable in a fully hydrated state. With 
FIB-SEM, there is also possibility to recreate 3D reconstructions of samples 
using the previously mentioned ability of the FIB to sequentially slice and image 
samples (Milani et al, 2007).  
 
Figure 5.2. Schematic illustrating electron microscopy imaging methods (credit Pilhofer, 2010). 
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5.2. Materials & Methods 
5.2.1. Bacterial strains & culture conditions 
Bacterial strains used in this study are listed (Table 3.1). A variety of different 
strains, Gram-positive and Gram-negative, native and recombinant, were used in 
this study. 
Strain Origin Presence of MCP 
ECOR Library (ECOR 
#1-54) 
Dr. David Clarke, University 
College Cork 
Selected strains display positivity on 
ethanolamine McConkey agar 
Yersinia enterocolitica 
53/03 
Dr. Tamara Ringwood, 
University College Cork 
Display positivity on propanediol 




Dr. Tamara Ringwood, 
University College Cork 
Display positivity on propanediol 




Dr. Tamara Ringwood, 
University College Cork 
Display positivity on propanediol 




Prentice lab Display positivity on propanediol 
MRS agar, presence of pdu operon 
genes 
E. coli JM109 pAR3114 Dr. Joshua Parsons, 
University of Kent 
Display positivity on propanediol LB 
agar, presence of pdu operon genes 
E. coli JM109 Prentice lab No Pdu MCP genes present in 
genome 
Table 5.1. Table indicating strains used in study and their origins. 
E. coli strains with ethanolamine positivity were grown on ethanolamine and 
B12-supplemented McConkey agar, and in ethanolamine and B12-supplemented 
LB broth. pAR3114 E. coli JM109, which utilizes 1,2-propanediol, was grown in 
LB broth supplemented with 1,2-propanediol and B12.  Yersinia strains, which 
utilize 1,2-propanediol, were grown in 1,2-propanediol supplemented McConkey 
agar and supplemented LB broth. Finally Lactobacilli strains were cultured in 
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1,2-propanediol supplemented de Man-Rogosa-Sharpe (MRS) and modified 
MRS (Table 3.5) and grown anaerobically at 37°C. 
Table 5.2. Composition of MacConkey agar, supplemented with either i) ethanolamine* and B12 
or   ii) 1,2-propanediol+ and B12, which were added post-autoclave. 
 
Ingredients Amount (per Litre) 
Monopotassium Phosphate 3.94g/L 
Dipotassium Phosphate 4.97g/L 
Ammonium Sodium Phosphate Tetrahydrate 3.5g/L 
Magnesium Sulphate 0.2g/L 
Ethanolamine (50mM) * 5g/L 
Adjust to pH 7.2 ±0.2 using 4NaOH  
B12 (200nM) * 600µL 
Table 5.3. Recipe list for NCE media, supplemented with ethanolamine, which was added post-
autoclave. 
Material Quantity 
Tryptone from casein 10g/L 
Sodium chloride 10g/L 
Granulated Yeast Extract 5g/L 
Deionised Water 1L 
Ethanolamine (50mM) * 5g/L 
1,2-propanediol (40mM) + 40mL 
B12 (200nM) * 600µL 
Table 5.4. Recipe for Luria Broth (LB) for the growth of E. coli. Supplemented with either i) 
ethanolamine* and B12 or ii) 1,2-propanediol+ and B12, which were added post-autoclave. 
  
Ingredients Amount (per Litre) 
Soy Peptone 20g 
Ox-Bile 5g 
NaCl 5g 
Neutral Red 0.075g 
Agar 15g 
Adjust to pH 7.4 ±0.2 using 4NaOH 
Ethanolamine (50mM) * 5g 
1,2-propanediol (40mM) + 40mL 
B12 (200nM)  600µL 
	  	  	  	  	  	  





MRS broth 55g/L 
Deionised Water 1L 
1,2-propanediol (40mM) + 40mL 
B12 (200nM) * 600µl 
Table 5.5. Composition of de Man-Rogosa-Sharpe (MRS) for the growth of lactobacilli, 




Granulated Yeast Extract 2g/L 






1,2-propanediol (40mM) + 40mL 
B12 (200nM) * 600µL 
Table 5.6. Composition of MRS-Modified (MRS-MOD) for the growth of L. reuteri. 
Supplemented with 1,2-propanediol and B12 
5.2.2. Microcompartment extraction methodology 
Initially, two differing methods of MCP extraction or purification were used, 
both of which utilized detergents to remove the whole MCP.  
5.2.2.1. B-PER Method 
This method was originally presented in the PhD thesis of Gregory Havemann, 
of the Bobik lab, and its most current iteration was published in 2012 (Sinha et 
al, 2012) and utilized the proprietary detergent B-PER. B-PER (Bacterial Protein 
Extraction Reagent, Pierce, Thermo Scientific) is a proprietary detergent product 
designed to lyse cells obtain high molecular weight proteins without 
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denaturation. This protocol includes a number of additional steps designed to 
purify the extraction process via different supernatants and pellets. 
400mL of LB (Luria Bertani) broth was inoculated with 2mL of overnight E. coli 
BL21 culture, containing the recombinant pAR3114, which is a cosmid 
containing an 30-kb construct including the pdu operon (Parsons et al, 2008). 
This recombinant construct expresses the pdu MCP when induced with 1,2-
propanediol and B12.  
This overnight culture was incubated at 30°C shaking at 200rpm, until the 
OD600 reached 0.4. Cells were then harvested at 8000rpm for 10 minutes at 4°C 
(Beckman Coulter, rotor JA 25.50). Ensuring the centrifugation was pre-chilled 
to this temperature was essential to obtain a good quality pellet. The cell pellet 
was then washed twice with 40mL B-PER Buffer A (50 mM Tris-HCl [pH 8.0], 
500 mM KCl, 12.5 mM MgCl2).  
Approximately 1g wet weight of cells were resuspended in a mixture of 10mL 
Buffer A and 15mL B-PER solution, supplemented with 5mM β-
mercaptoethanol (Sigma Aldrich), one Complete Protease Inhibitor Cocktail 
(Roche), 25mg lysozyme (Sigma Aldrich) and 2mg DNase I (Sigma Aldrich). 
The suspension was incubated at room temperature with shaking at 60 rpm for 30 
minutes, and then placed on ice for 5 minutes.  
Cell debris was removed by centrifugation twice at 12,000g for 5 minutes at 4°C, 
with the supernatant (containing MCPs) transferred to a new centrifuge tube after 
each round of centrifugation. Careful transfer of supernatant is essential to avoid 
contamination with additional proteins and cell debris. The MCPs were then 
spun from the suspension at 20,000g for 20 minutes at 4°C (Beckman Coulter, 
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SW40Ti rotor). The MCPs pellet was resuspended in 1000µL Tris-HCL pH 7.5. 
As with the Y-PER method, an SDS-PAGE protein gel is typically performed 
afterwards to confirm the quality of the extraction. 
5.2.2.2. Y-PER Method 
The Y-PER method was originally provided by our collaborator Dr. Stephanie 
Frank, University of Kent. The method is based upon utilizing the detergent Y-
PER (a yeast-specific version of the previously mentioned B-PER), and protein 
precipitation using varying salt concentration, as protein solubility is affected by 
ions. At a very high ionic strength, the additional of a neutral salt increases 
protein-protein interaction. An increase in the salt concentration causes the 
charges of the proteins to interact directly with the salt, resulting in hydrophobic 
patches on the protein, and aggregation, eventually resulting in the precipiatation 
of the protein. This action of protein solubility decreasing as ionic strength 
increases is a process referred to as ‘salting-out’ (Lorsch, 2014).  
Y-PER (Y-PER Plus Dialyzable Yeast Protein Extraction Reagent, Pierce, 
Thermo Scientific) is a proprietary detergent product designed to lyse cells 
obtain high molecular weight proteins without denaturation. Traditionally, cell 
lysis was achieved using glass beads or sonication, however the use of a 
detergent-based cell lysis buffer such as Y-PER eliminates this need to use 
mechanical treatments involving chemicals, pH and temperature extremes to 
disrupt the proteinaceous cell envelope. This protocol also utilizes a number of 
additional steps designed to purify the extraction process via different 
supernatants and pellets.  
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200mL of LB (Luria Bertani) broth was inoculated with 2mL of overnight E. coli 
BL21 culture, containing the recombinant pAR3114. This culture was incubated 
at 37°C, with shaking at 160 rpm until an OD600 of 0.8 was reached. At this 
point, the Pdu microcompartment was induced via the addition of 1,2-
propanediol and B12, and incubated at 37ºC overnight, with shaking at 160 rpm. 
Following overnight incubation, the cells were harvested by centrifugation for 10 
minutes at 4 °C. 
Following harvesting, approximately 1g wet cell pellet was re-suspended in 10 
mL Y-PER Plus supplemented with 1 tablet of Complete Protease Inhibitor 
Cocktail (Roche) and 1250 units Benzonase® Nuclease (5 µL per 10 mL Y-
PER). The resulting lysate was incubated for 3 hours at room temperature and 
gently agitated. The lysate was then pelleted for 5 min at 11,00 x g (Beckman 
Coulter, rotor JA 25.50) at 4°C.  
The supernatant and MCP-containing pellet were collected, with the pellet then 
re-suspended in 2mL of a solution containing 20mM Tris-HCl (pH 8.0), and 20 
mM NaCl. This suspension was centrifuged at 4 °C for 5 min at 11,000 x g, with 
the resulting supernatant now containing the MCPs.  
The NaCl concentration of the supernatant was raised to 80 mM by the addition 
of 5 M NaCl, followed by centrifugation at 4 °C for 5 min at 11,000 x g. This 
produced another pellet, which now contained the MCPs. 
This MCP-containing pellet was re-suspended in 1 mL of 20 mM Tris-HCl, pH 
8.0 and clarified by centrifugation (4 °C for 5 min at 11,000 x g). The final 
supernatant now contained the purest MCPs, as the initial salt precipitation 
removed any contaminating proteins, whilst the final salt precipitation released 
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the MCP proteins. In order to ascertain the quality of the extraction, a sodium 
dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) protein gel is 
typically performed afterwards to visualize individual MCP proteins. 
 
 
Figure 5.3 Schematic of Y-PER Method of Microcompartment Extraction as described above. 
B-PER is specifically for bacterial cells however, whilst Y-PER can also be used 
on yeast cells. 
5.2.2.3. B-PER Gram positive cell variation 
As previously mentioned, there has been little advancement in MCP extraction 
for Gram positive cells. To extract the Pdu MCP from Lactobacillus reuteri 
DSM20016, we utilized a variation of the previously mentioned B-PER 
extraction method. 1L of Lactobacillus culture was inoculated with an overnight 
culture of L. reuteri and grown anaerobically at 35°C in MRS media 
supplemented with 1,2-propanediol and B12 to induce the production of the Pdu 
MCP, until an OD600nm of 0.5 was reached. Cells were centrifuged as 
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previously and the pellet washed with washed twice with 40mL B-PER Buffer A 
(50 mM Tris-HCl [pH 8.0], 500 mM KCl, 12.5 mM MgCl2).  
In a novel change to the protocol, 1g of cells were resuspended in 100mL of 
protoplast buffer). Protoplast buffer is typically used for genome extraction of 
Gram positive bacteria (Lee-Wickner & Chassy, 1984) and consists of 20 mM 
Tris-HCL (pH 7.5), 5 mM EDTA, 0.75 M Sucrose, 10 mg/mL Lysozyme and 50 
U mutanolysin. The cells were then allowed to incubate in the protoplast buffer 
for 45 minutes at 37°C. Following this incubation, the protocol reverted to the 
original protocol, and the cells underwent incubation in a mixture of 10mL 
Buffer A and 15mL B-PER-II solution (a 2X version of the original B-PER 
detergent), supplemented with 5mM β-mercaptoethanol, one Complete Protease 
Inhibitor Cocktail, 25mg lysozyme and 2mg DNase I. The suspension was again 
incubated for 30 minutes at room temperature, followed then by ice chilling. 
Centrifugation protocols were the same as the previously mentioned protocol 
(Section 3.1.2.1).   
5.2.3. Imaging & electron microscopy 
5.2.3.1. Transmission Electron Microscopy (TEM) 
After extraction, the samples were then brought for electron microscopy 
imaging. In University College Cork, the BioSciences Imaging Centre (BSIC), 
which is located in the Department of Anatomy & Neuroscience, BioSciences 
Institute provided access to the electron microscopy suite. Extracts were 
negatively stained using freshly prepared 1% Uranyl Acetate.  
For each sample, a drop of bacterial extract suspension was placed onto parafilm 
and a 400-mesh carbon film copper grid (Agar Scientific, Essex, UK) was 
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inverted onto the drop for 2 minutes. Excess moisture was wicked away with 
filter paper. A droplet of 1% Uranyl Acetate stain was placed onto parafilm and 
the grids were inverted onto the drop for 2 minutes, removed and excess 
moisture was again wicked away with filter paper. Specimens were then 
examined using a JEOL Transmission Electron Microscope (TEM) JEM 
2000FXII (Jeol Ltd., Tokyo, Japan), operated at 80 kV. Electron micrographs 
were obtained of areas of interest using a Megaview-III digital camera and 
AnalySIS software. 
5.2.3.2. Focused Ion Beam Scanning Electron Microscopy (FIB-SEM) 
As previously mentioned, the FIB-SEM (FEI Helios NanoLab™ 600i 
DualBeam) was a recent acquisition by the Tyndall National Institute, and as 
such, its application to biological samples was experimental. Sample preparation 
and imaging underwent a number of changes to optimize the protocol for our 
samples. 
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Figure 5.4. Image of the FEI Helios NanoLab™ 600i DualBeam FIB-SEM and cryo chamber 
(credit:WormAtlas Database) 
For the purposes of the FIB-SEM, whole cell samples were used. A control 
sample (E. coli JM109, not expressing microcompartments when grown in these 
conditions) was grown in 20mL Luria-Broth (LB) was grown overnight at 37°C 
with shaking. This was then subcultured to an OD0.1 and allowed to incubate 
until an approximate OD0.8 was achieved. This culture was then pelleted via 
centrifugation at 4,000rpm (Beckman Coulter Allegra 64R).  
For an experimental culture, the recombinant pAR3114 construct expressing 
recombinant microcompartments was used as before. 20mL of LB (Luria 
Bertani) broth was inoculated with 2mL of overnight pAR3114 E. coli JM109 
culture. This culture was incubated overnight at 37°C, with shaking. This was 
then subcultured and the Pdu microcompartment was induced via the addition of 
1,2-propanediol and B12, and incubated at 37 ºC until an approximate OD0.8 
was achieved. This culture was pelleted via centrifugation at 4,000rpm. 
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Figure 5.5. Image illustrating the sample holder required for cryo FIB-SEM                         
(Credit:Muller-Reichert & Verkade, 2012) 
Approximately 10ul of the sample was loaded onto an aluminum holder, which 
was then plunge-frozen in liquid nitrogen, as previously mentioned. The frozen 
sample was then transferred under vacuum to the cryo-preparation chamber of 
the FIB-SEM. This initial preparation of the stage is delicate process – the stage 
can require 4 hours of cooling to reach the appropriate temperature, and is highly 
sensitive to vibration, which can lead to distortion of images. The high vacuum 
of the cryo-chamber is also another point of contention, as disruption or breaking 
of the vacuum can lead to the machine becoming unavailable for the rest of a 
session, therefore a skilled technician is essential for a successful imaging 
session (Rubino et al, 2014). 
Following successful loading of the sample into the cryo-chamber, the 
temperature was then raised to −95ºC for 30 minutes sublimation. Sublimation is 
a process that removes condensed ice from the sample, which can accumulate 
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from the plunge-freeze process. Typically sublimation is done for approximately 
3 minutes, however on previous imaging sessions, it was observed that the 
excess ice accumulation obscured viewing of the sample, preventing any quality 
view of the bacterial cells. The sublimation was gradually increased in 5 minute 
increments to obtain an optimal sample, with the final 30 minute sublimation 
providing the clearest view and the least ice accumulation.  
In order to avoid excess charge on the sample, and to make the surface 
electrically conductive, a layer of gold-palladium sputter coating was deployed 
over the sample to a thickness of 20nm. SEM imaging was taken from number of 
different sites within the samples, whilst the FIB was utilized on the sites deemed 
most promising. The electron beam and ion beam can be turned on 
simultaneously yet operate independently, which allows fine control over sample 
imaging. 
5.2.3.2.1. Sample optimization 
As the FIB-SEM is typically used for materials technology, the process of 
sample optimization was important in determining the success of the use of the 
machine. Initially, samples were prepared as previously described, and loaded 
directly into the cryo-chamber of the machine. A key aspect of cryo-EM is the 
facility to allow samples to be observed without addition of contrast-enhancing 
agents (Pilhofer et al, 2010). Following the use of an un-stained sample, cells 
were then prepared using 2mL toluidine blue stain. This stain has been used for 
general bacterial staining for brightfield microscopy (Morris & Groves, 2013).  
Due to excess ice accumulation on the sample from the cryo-preparation process, 
glycerol was also experimentally added to the culture-stain solution, again in a 
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1:1 ratio. The cryo-preparation is typically achieved via a process called plunge-
freezing, where the sample is quickly submerged in liquid nitrogen at 
approximately −210ºC (Umrath, 1974). However optimization of the sublimation 
process greatly reduced this ice accumulation. The addition of glycerol, coupled 
with possible surface tension interaction (Tanner et al, 2012), lead to excessive 
aggregation of the bacteria cultures, preventing the identification of a singular 
bacteria cell for FIB slicing. To alleviate this, bacitracin, a protein disulfide 
isomerase inhibitor that prevents cell-cell adhesion (Chapin et al, 2001) was 
added to the sample solution. Bacitracin has been previously utilised as a cell 
wetting agent to reduce surface tension associated with microscopy samples 
(Dykstra, 1992). It was added in a 1:1 ratio with the sample culture and toluidine 
blue.  
Previously prepared resin samples of pAR3114 (prepared by Don O’Leary, 
BSIC) were also sectioned and imaged using the scanning transmission electron 
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5.3. Results & Discussion 
5.3.1. Microcompartment Extractions 
As previously described, after extraction, protein samples were run on an SDS-
PAGE protein gel to identify the structural and enzymatic proteins indicated 
through previous analysis as being associated with the presence of the 
microcompartment. It is typically quite difficult to identify the structural 
proteins, as these are the smallest and travel to the bottom of the SDS-PAGE gel 













Figure 5.6. SDS-PAGE illustrating the extraction of the Pdu MCP from pAR3114 using the 
BPER extraction method. Lane 1 represents the molecular ladder standard (Biolab P7706L). 
Lane 2 represents the MCP extract containing the enzyme PPK and the structural proteins PduA-




































	  	  	  	  	  	  






                              
                                                                          





















Figure 5.7. SDS-PAGE illustrating the extraction of the Pdu MCP from L. reuteri using the 
modified BPER Gram positive extraction method. Lane 1 represents the molecular ladder 




MALDI analysis of these observed proteins was not performed due to the 
unavailability of the instrument during the required time period, however it can 
be observed that the positioning of the bands in the protein gels are similar to 
those previously published (Parsons et al, 2010). 
 
5.3.2. Imaging Extractions 
5.3.2.1. Electron microscopy 
A number of varying microcompartment extractions were imaged by technician 
Suzanne Crotty of the Bioscience Imaging Centre (SC), while whole sections of 
samples were imaged by Dr. Don O’Leary (DoL) of the Bioscience Imaging 
Centre. FIB-SEM images were taken by Dr Michael Schimdt (MS) and Dr 
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Figure 5.8. TEM image of the recombinant microcompartment extraction from E.coli (containing 
genes encoding functional Pdu MCP). Image taken at 80k magnification. (image by SC) 
 
 
The above image Figure 5.8 represents a microcompartment extraction from the 
recombinant E.coli JM109 pAR3114, which encodes the Citrobacter propanediol 
(Pdu) microcompartment. In this image, a number of potential 
microcompartments can be observed, and are identifiable by their thin electron-
dense shell which is often linear. These microcompartments are approximately 
100nm in diameter, which is a typical size for these recombinant structures 
(Parsons et al,  2010).  
	  	  	  	  	  	  





Figure 5.9. TEM image of the recombinant E.coli JM109  pAR3114 (containing genes encoding 
functional Pdu MCP) microcompartment extraction. Image taken at 40k magnification. (image 
by DoL) 
 
The above image represents a whole cell sample of the pAR3114 recombinant 
sample, which has been sectioned using a diamond knife, and negatively stained 
with osmium tetroxide. Obvious electron dense masses, typical of 
microcompartments, can be observed within the cell, whilst the cell itself is also 
elongated.  
	  	  	  	  	  	  





Figure 5.10. TEM image of the E.coli ECOR#10 Eut microcompartment extraction. Image taken 
at 40k magnification. (image by SC). Arrows indicate putative microcompartments 
 
In contrast to the previous extraction image, the microcompartments associated 
with the metabolism of ethanolamine (Eut) appear more spherical, and less rigid. 
However (Choudhary et al, 2012), previously described this appearance with Eut 
microcompartments. Again, the Eut microcompartments are approximately 
100nm in diameter. 
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5.3.2.1. FIB-SEM Cyro-Imaging 
 
Figure 5.11. FIB-SEM image of recombinant E.coli JM109 pAR3114 (containing genes encoding 




Figure 5.12. FIB-SEM image of recombinant E.coli JM109 pAR3114 (containing genes encoding 
functional Pdu MCP), unstained. Vibration of the stage results in poor image resolution (POC).  
	  	  	  	  	  	  






Figure 5.13. STEM image of recombinant E.coli JM109 pAR3114 (containing genes encoding 
functional Pdu MCP), resin embedded sectioned and negatively stained with osmium. Light areas 
indicate electron light, dark areas indicate electron dense. 
 
 
Figure 5.14 FIB-SEM image of the recombinant E.coli JM109 pAR3114 (containing genes 
encoding functional Pdu MCP), stained with toluidine blue and glycerol, with bacterial cells 
identifiable on the surface (image by PC). 
	  	  	  	  	  	  





Figure 5.15. FIB-SEM image of the recombinant E.coli JM109 pAR3114 (containing genes 
encoding functional Pdu MCP), stained with toluidine blue and bacitracin, with bacterial cells 
identifiable on the surface (image by PC). 
As previously mentioned, one of the largest difficulties with regards to utilizing 
the FIB-SEM was optimizing the quality of the field of view. Issues with ice 
accumulation and cell aggregation made identification of individual cells 
(necessary for FIB slicing) difficult. Experimentation with different agents 
(glycerol, bacitracin) provided information but no one agent proved to improve 
the sample resolution greatly. Due to a lack of individual cells, FIB cut locations 
were selected in the presence of identifiable cell clusters, which unfortunately 
made reconciling any observable intracellular structures with the corresponding 
individual cell highly difficult. 
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Typically, once a suitable location is identified, the FIB aspect is engaged, and 
milling of the sample begins. The next three images illustrate a site being milled 
inward.  
 
Figure 5.16. FIB-SEM image of the recombinant E.coli JM109 pAR3114 (containing genes 
encoding functional Pdu MCP), whole cell sample being sectioned by FIB. 
 Image A illustrates an initial cut site. 
 Image B illustrates view after 100nm milling upwards in the sample. 
 Image C illustrates view after an additional 100nm milling upwards in the sample (image by 
PC). Glycerol was supplemented to this sample in a 1:1 ratio. Arrows illustrate putative 
microcompartments observed within cells. 
As can be viewed from the images, it is possible to see defects approximately 
100-200 nm across typical of the size of bacterial microcompartments, of varying 
dimensions within the bacterial cell sample. However because of the difficulties 
in identifying individual cells, it is not possible to quantify the number of these 
putative intracellular compartments per bacterial cell. 
 
	  	  	  	  	  	  




Extraction of microcompartments from Gram negative bacterial cells has been 
optimized over the years since the first description (Cannon & Shively, 1983), 
and the need for a full cell fractionation procedure with sucrose density gradient 
centrifugation has been reduced by the use of proprietary detergent based lysis 
and solubilization systems. However development of microcompartment 
extraction from Gram positive cells has been more stagnant, most likely due to 
difficulties associated with high quality lysis of the Gram positive membrane and 
cell wall (Mahalanabis et al, 2012). The successful extraction of the Pdu 
microcompartment from Lactobacillus reuteri DSM20016 using novel 
adaptations has potential applications for other Gram positive 
microcompartments and for future protein extractions from Gram positive 
bacteria. 
The experimentation into the extraction and imaging of the bacterial 
microcompartment was to act as a compliment to the previous studies of this 
thesis. Through this study, a number of different extraction methods were 
utilized in order to identify the optimal method. Through these methods, we 
achieved a number of successful microcompartment extractions, which enabled 
imaging studies. The resulting images correlated with previously published 
imagery of the microcompartments, with noticeable difference between the 
visual appearance of the Pdu microcompartment versus the Eut 
microcompartment.  
The application of the FIB-SEM to the study of microcompartments has not 
previously been reported and was made possible by the Tyndall National 
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Institute’s National Access Program (NAP), which provided funding and access 
to the FIB-SEM facilities. However the application of a technique typically 
utilized for materials science to biological samples led to a number of technical 
difficulties. Various iterations of the sample preparation protocol were utilized, 
with obstacles such as excess ice accumulation and a difficulty in creating 
sufficient contrast.  
SEM-FIB has the potential to image microcompartments in native cells if the 
difficulties in sample optimization were achieved. Good progress had been made 
on this issue during the course of this study, and further optimization should 
include further study on the use of wetting agents such as bacitracin and bovine 
serum albumin (BSA), which when used in combination with an additional 
agent, may prevent the excess cellular aggregation which prohibited viewing 
individual cells (Michen et al, 2015). The extension of the sublimation time 
proved to be highly useful in reducing ice accumulation, and perhaps a further 
extension of this time to 40-45 minutes may remove the need for additional 
cryoprotectants such as glycerol. A key area of optimization also lies in the need 
to generate intracellular contrast. Although a key aspect of the FIB-SEM is the 
apparent non-requirement for stains to generate contrast, this did not translate 
well to our study, where more intracellular contrast would be essential to 
highlight the interior of the bacterial cells. In addition, the use of a cryogenic 
stage, while in theory allowing native structures tobe imaged without fixation 
arfetfact reduces the number of specimens which can be observed, because it 
requires several hours to achieve operating temperature.  
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Finally to progress this project, a multidisciplinary technical team would be 
utilized to provide wider expertise on the nature of the technology along with the 
nature of the biological sample. The FIB-SEM is a technology that has been 
primarily applied to the field of materials chemistry and electronics, which is 
very different from the study of biological material. However, technician 
expertise is required for the FIB-SEM capabilities to be used fully, and distinctly 
from a standard SEM. An increased knowledge of biological sample preparation 
and staining methodologies would provide greater insight and build on the 
foundation of optimization developed in this study. 
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This thesis describes investigations into the function of native bacterial 
microcompartments, with a particular focus on the ethanolamine utilization 
microcompartment (Eut) and the propanediol utilization microcompartment 
(Pdu), and on a hypothesis of a biotechnological application of recombinant 
microcompartments linked to polyphosphate metabolism. In recent years, the 
potential of the bacterial microcompartments to act as a biotechnological tool has 
been increasingly discussed, and this thesis explored the possibility of their 
application in a clinical setting. 
In Chapter 1 the literature background for bacterial microcompartments and 
phosphate metabolism was reviewed, centred on the role of polyphosphate 
kinases .  
The main biotechnological goal of the thesis was establishing the potential 
application of bacteria expressing microcompartment targeted polyphosphate 
kinases and bacterial  microcompartments as a tool to remove phosphate from 
the environment, with a potential clinical application. The model organisms E. 
coli and Lactobacillus reuteri  20016 were used as expression hosts because of 
their non-pathogenic status and known capacity to make microcompartments. A 
link between microcompartment inducing conditions and polyphosphate 
formation was found in L. reuteri. Through the creation of constructs utilizing 
microcompartment-targeted E. coli polyphosphate kinase enzyme (PPK1) alone 
this research (Chapter 2) demonstrated an increase in short term phosphate 
uptake and polyphosphate storage by Lactobacillus reuteri and E. coli in vitro, 
utilizing lyophilized bacterial cultures added to sugar-supplemented water over 5 
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hours (Chapter II). E. coli cells co-expressing an empty microcompartment and 
microcompartment targeted PPK1 retained more polyphosphate and removed 
more phosphate from the supernatant than those expressing PPK1 alone.  
Gluconate proved to be the optimal carbon source to be added to water in these 
experiments to create a salt free isotonic solution, promoting revival after 
lyophilisation and phosphate uptake without overgrowth. It also has the 
advantage that it is not utilized as a carbon source by rats. Quantitative estimates 
(Chapter III) suggested that deliverable numbers of bacteria in gluconate water   
could be capable of taking up comparable amounts of phosphate to that normally 
absorbed in the rat gut. E. coli and L. reuteri constructs overexpressing E. coli 
PPK1 alone and E. coli expressing microcompartment-targeted PPK1 with an 
empty microcompartment, were applied to an animal model study (Sprague-
Dawley rats) evaluating their in vivo effect on reducing hyperphosphatemia of 
renal failure (Chapter III).  
Whilst the results of this animal study on calcium and phosphate balance were 
difficult to interpret due to baseline variation in the study groups arising before 
therapeutic intervention, the ability to successfully deliver lyophilized bacterial 
cultures through a supplemented sugar-water source as viable bacteria, and 
successful recovery of bacterial cultures from animal faeces, and the intestines 
post-sacrifice was demonstrated. Interestingly, E. coli K12 MG1665 strains over 
expressing E.coli PPK1 persisted longer than the control MG1655 strain 
following single in vivo oral inoculations and were recovered in large numbers 
from rat faeces during the continuous dosing experiment. E. coli K12 strains 
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generally require streptomycin treatment to colonise rodents (Miranda et al., 
2004) and PPK1 overexpression seems to enhance their gut survival. 
For further work, the use of an inbred rat strain model would likely provide more 
interpretable inter-group difference that would allow extension of the observed in 
vitro observations in an in vivo model. The creation of a chromosomally 
integrated ppk-pduABJKNU (empty microcompartment) in Lactobacillus, as 
originally intended, would also likely provide interesting information regarding 
the uptake capacity of the Lactobacillus strain in vivo. Validation of this ability 
for the ppk and Pdu microcompartment constructs to remove phosphate from 
surrounding environments may have future applications regarding clinical care 
via the use of probiotic strains such as Lactobacillus, or indeed further 
development of the MEBPR (Microcompartment Enhanced Biological 
Phosphorus Removal) system for environmental uses.  
Additional thesis research regarding the properties of the native Pdu and Eut 
microcompartment has contributed to current knowledge regarding these two 
microcompartments. No previous literature, to the author’s knowledge, exists 
discussing the effects on buoyant density of the cell of microcompartment 
expression, and the observable difference between the Pdu and Eut 
microcompartments regarding this (Chapter IV). This observation indicated a 
number of potential research avenues regarding the cause of this difference, and 
may be due to the production of ammonia gas or membrane permeability. Further 
investigation into these properties may provide interesting information and 
clarify the functional advantages conferred by Pdu and Eut microcompartments. 
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Eut extraction samples under EM appear to be electron-dense, indicating that the 
Eut microcompartment is not empty during these observations. 
This investigation into the properties of the Pdu and Eut microcompartment, and 
the encountered difficulties in identifying quality imagery of microcompartments 
both in situ in the bacterial cell and also on extraction from the cell, led to 
experimentation with various cell fractionation and microscopy techniques 
(Chapter V). This research attempted to apply FIB-SEM to characterise 
microcompartments in situ within the cell without fixation using a cryogenic 
stage.  The optimization of the extraction of bacterial microcompartments from 
the cell, particularly from the Gram-positive Lactobacillus cell, allowed 
improved sample quality, which in turn contribute to better sample imagery. 
The use of the FIB-SEM in particular was a novel application regarding the study 
of microcompartments, and image quality was refined by the use of glycerol 
suspension, 3D reconstruction of sectioned native microcompartments by SEM-
FIB may in future contribute to research regarding the development of synthetic 
microcompartment constructs. Whilst difficulties were encountered regarding the 
image quality after cryo-processing, this study represented a new avenue of 
exploration for identifiying bacterial microcompartments in situ, and potentially 
reconstructing these sectioned images into a 3D form using tomographical 
software if problems with cell clumping can be eliminated by addition of surface 
active compounds. 
Overall, this thesis explores novel functional aspects of native bacterial 
microcompartments, and the possible uses of the properties of recombinant 
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microcompartments as a synthetic metabolic hub, as a clinical/environmental 
intervention. 
  
	  	  	  	  	  	  




• Miranda, R., Conway, T., Leatham, M., Chang, D., Norris, W., Allen, J., 
Stevenson, S., Laux, D. & Cohen, P. (2004). Glycolytic and 
Gluconeogenic Growth of Escherichia coli O157:H7 (EDL933) and E. 
coli K-12 (MG1655) in the Mouse Intestine. Infection and Immunity 72, 
1666-1676. 
• Penrod, J. T., Roth, J. R. (2006). Conserving a Volatile Metabolite: a 
Role for Carboxysome-Like Organelles in Salmonella enterica. Journal 




	  	  	  	  	  	  




Firstly, I would like to thank my supervisor Prof. Michael Prentice for his 
guidance and support during the course of this research, and the writing of this 
thesis. Secondly, an enormous thank you to our postdoc, 
Dr. Mingzhi Liang. Without Mingzhi’s support, advice and guidance, my 
research experience would have been much more difficult. Plus he introduced me 
to the best Chinese food in Cork, to make him more invaluable! Also to the 
former members of 403, Tamara and Kamila, for being so friendly and 
supportive.    
To the School of Microbiology – a great place to spend my college years, with a 
great academic and research team, plus the friendliest community of people. 
Huge thanks to Maire for constant order demands, to Morris for much rat advice, 
to Dan for saving computers and of course to Paddy for enormous help and 
advice regarding the mass lyophilisation experiments. To the APC staff also – in 
particular Catherine who was a great mentor away from the lab, and continues to 
be now.   
A very special thank you must go to Elaine Barry, who is still probably confused 
as to how she got landed with me, but became a great friend and made a difficult 
time enjoyable. The light at the end of the tunnel is near! Additional thanks to the 
rest of the Physiology gang for being so lovely, and to Helen and Amr in 
Pathology for all their help.  
The office of 406 was a great place to be based during this time and always 
allowed rants and laughs. To Adam, Aoife, Marc, John, Alli, Ian and Emma - all 
past and present have been great friends and always supportive. Plus a special 
mention to Jill, for great advice and help throughout.  
	  	  	  	  	  	  
	  	  	  	  	  	  
 
274 
My second lab home was 335/337 where baked goods were always a given! To 
Lorraine, Karen and Des – thanks for always alerting me to cakes and creating a 
laugh! You all continue to be my Christmas desk gurus! Of course a huge sappy 
thanks to my lab partner-in-crime – to Alicia (Camps) for not only being a great 
roomie but for also knowing my medical history for those times that the knee 
won’t stay in! I’m returning all those favours to you now – and then we can gloat 
together!  
Away from the lab, I was lucky to have friends who kept things light-hearted but 
were always there for the tea-times and breaks for freedom – Fiona for 
the constant trashy tv and nights out, Linda for making sure I didn’t look like an 
urchin, and Lynda for being interested from the other side of the world. Plus 
fellow foodies Ruth and Cole – #microbiologistsforlife.  
Finally, although they probably hadn’t (and still haven’t) got a clue what exactly 
I do, I am lucky to have a great family who don’t need explanations, just offer 
tea and laughs. Sarah and Elaine – my two blonde superiors who just get things 
and always supported the nerd. To my beloved Nan and Granda, who always 
bought me books. To Aoife, who insists she isn’t loved but in fact is the most 
loved – you are a great babydoll. Most importantly to my parents for always 
being proud of me and making me proud of them, in every way.  









	  	  	  	  	  	  
	  	  	  	  	  	  
 
275 
 
 
 
